data_2mlb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mlb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.57 0.224 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 p -107.93 150.95 26.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 111.429 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -126.43 162.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.811 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -117.34 136.63 53.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.995 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.12 116.35 45.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.005 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 119.26 32.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.541 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -99.41 163.18 19.09 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.828 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 11.4 Cg_endo -55.76 -21.07 30.85 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.946 2.431 . . . . 0.0 113.702 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.31 -22.01 63.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.34 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.84 -18.55 49.7 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.609 -0.805 . . . . 0.0 114.093 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -84.34 173.22 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.53 0.665 . . . . 0.0 110.082 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -129.82 150.41 51.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.954 0.407 . . . . 0.0 111.488 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 149.84 41.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.797 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.76 123.28 49.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -136.36 159.95 40.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.05 139.25 34.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.712 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.9 148.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.748 0.309 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 p -139.25 157.23 71.32 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.32 -6.7 19.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.648 2.232 . . . . 0.0 112.577 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -97.48 -12.11 23.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.325 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.22 144.99 28.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 p -97.56 169.55 9.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.93 -33.04 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 110.05 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -72.43 -37.98 68.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.6 tt0 -71.18 -49.11 47.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.09 -34.96 74.19 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.349 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.17 70.79 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -70.66 -24.83 62.77 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -51.52 18.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 tp -69.33 -32.33 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.959 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.13 66.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.662 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -65.96 -33.35 75.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.874 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -80.3 -22.98 41.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.676 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 -18.22 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.682 0.277 . . . . 0.0 111.073 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.65 42.15 9.31 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.818 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -129.57 178.08 6.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.7 p -108.15 145.15 30.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.85 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.39 -23.25 44.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.896 2.398 . . . . 0.0 114.078 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -75.51 -9.03 58.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.83 -27.72 10.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.509 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -91.11 132.46 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -123.52 134.94 53.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.14 132.8 35.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.215 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.61 125.79 43.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.056 0.455 . . . . 0.0 111.247 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' HD1' ' ND2' ' A' ' 47' ' ' ASN . 1.7 t-80 -135.38 122.87 22.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.408 ' ND2' ' HD1' ' A' ' 46' ' ' HIS . 70.7 m-80 64.04 24.98 13.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.666 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.08 -14.95 62.15 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.115 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.33 148.83 23.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.897 0.379 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -96.98 154.98 16.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.8 135.84 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.43 141.15 23.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.13 -22.01 54.92 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.221 2.614 . . . . 0.0 113.503 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -75.46 -25.16 57.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.55 -174.5 4.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.343 0.592 . . . . 0.0 111.752 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -115.27 164.4 14.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.254 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.31 -30.05 63.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.01 -9.09 59.67 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.94 -31.64 27.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 0.0 110.469 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -82.17 -19.72 39.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.654 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.71 45.65 5.99 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.53 141.32 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.375 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -123.21 155.09 65.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.969 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.26 143.29 48.0 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.613 2.208 . . . . 0.0 112.112 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.49 47.12 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.728 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.8 m -99.44 164.98 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.408 . . . . 0.0 110.69 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 16.2 p -96.15 125.45 40.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.848 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.55 138.26 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.882 0.372 . . . . 0.0 111.22 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.13 130.34 55.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -103.55 161.48 13.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.56 147.74 36.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.786 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.372 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.9 0.381 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -113.65 149.74 34.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -130.81 159.17 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.775 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.463 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -110.24 129.25 55.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.0 109.97 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.87 111.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.57 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 132.5 33.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.858 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 162.98 20.98 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.992 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -0.88 9.68 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.247 1.965 . . . . 0.0 112.152 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.02 -14.68 30.93 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.37 52.2 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.231 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -107.47 147.47 30.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.099 0.476 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 p -102.59 157.21 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 149.95 51.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.522 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.21 128.29 54.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.832 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 tp -128.83 152.04 48.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 106.18 17.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.336 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.1 174.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 7.4 p -141.17 161.31 53.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.311 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 19' ' ' THR . 19.3 Cg_endo -61.55 -15.29 40.49 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.653 2.235 . . . . 0.0 112.732 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -82.5 -9.93 59.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.749 0.309 . . . . 0.0 111.256 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.98 160.59 21.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.0 p -93.76 166.43 12.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.566 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -69.9 -31.35 47.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.018 0.437 . . . . 0.0 110.213 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -68.41 -36.67 79.44 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -70.58 -47.34 60.72 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.043 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -59.77 -39.13 83.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.07 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.68 70.94 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.2 pt-20 -74.14 -24.67 59.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -74.08 -46.7 41.36 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.7 -33.34 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.563 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 37' ' ' LEU . . . -69.07 -28.12 66.23 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.788 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.56 -33.53 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -77.31 -31.48 54.71 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -97.26 -18.21 19.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.89 47.76 6.09 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.773 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.8 mt -131.69 178.6 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 42' ' ' ILE . 64.1 m -104.15 147.54 34.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.669 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.06 -23.35 53.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.991 2.461 . . . . 0.0 113.215 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.26 -15.41 60.53 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 111.59 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -96.38 -32.28 12.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.252 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.23 117.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.293 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -109.6 133.11 53.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.93 125.42 39.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 126.06 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.083 0.468 . . . . 0.0 111.365 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -134.47 117.78 16.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 65.02 25.18 12.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.687 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.4 -15.11 63.04 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.023 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.93 144.0 29.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.41 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.42 150.78 19.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.9 135.68 40.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 137.22 22.59 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -62.79 -22.41 73.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.02 2.48 . . . . 0.0 113.655 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -78.34 -27.04 46.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.9 -174.34 5.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.573 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 70.8 p -113.87 158.76 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.94 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.86 -31.79 64.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.865 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.17 -9.52 59.58 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.9 tp10 -82.73 -20.76 35.37 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.03 0.443 . . . . 0.0 110.55 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.2 -19.92 23.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.332 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.81 45.42 5.45 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.848 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.42 141.87 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 111.382 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.5 p -122.97 158.88 56.15 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.88 138.48 53.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.538 2.159 . . . . 0.0 112.014 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.02 3.44 26.37 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.632 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 p -98.86 172.26 7.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.463 HG21 ' ND2' ' A' ' 5' ' ' ASN . 11.8 p -95.84 120.44 36.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 126.07 74.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.72 128.73 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.67 161.5 13.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.041 0.448 . . . . 0.0 111.124 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -140.49 144.34 35.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.218 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.845 0.355 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -111.15 152.13 27.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -126.37 161.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.676 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.46 129.58 56.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.78 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.42 111.95 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.741 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.98 132.13 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.668 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.4 161.42 25.33 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.16 -0.51 9.23 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.087 1.858 . . . . 0.0 112.097 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -91.61 -14.61 29.91 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.58 5.48 51.49 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.2 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -111.34 144.68 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -104.76 155.42 18.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.844 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.58 150.0 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.28 122.09 43.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -134.25 161.84 33.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.185 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -96.44 146.89 24.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 110.799 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.77 148.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -140.36 157.03 69.42 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.03 -6.51 19.11 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.727 2.285 . . . . 0.0 112.55 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.29 -11.99 22.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.73 143.69 29.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.385 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.8 p -97.33 170.38 9.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.33 -31.91 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.244 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -72.3 -39.97 67.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.64 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.8 tt0 -70.37 -47.13 62.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.798 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.68 -31.23 71.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -34.48 68.73 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.972 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -73.39 -24.88 60.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.618 0.247 . . . . 0.0 110.824 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.55 -49.68 52.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -69.43 -32.68 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.93 -28.36 66.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.887 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -70.94 -33.28 70.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -76.24 -29.2 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.92 -18.06 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.13 45.17 6.72 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.018 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.434 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 6.3 mt -132.07 178.55 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 6.1 p -105.13 147.44 34.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.644 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -67.43 -17.72 49.17 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.049 2.499 . . . . 0.0 113.627 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.17 -20.32 59.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.53 -29.49 13.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.63 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.74 121.5 43.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -114.68 135.14 54.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.39 122.16 35.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.55 54.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.395 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.66 116.3 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.306 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 64.37 24.86 13.33 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.627 0.579 . . . . 0.0 111.774 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.04 76.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.867 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.54 142.12 33.38 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -92.98 151.03 20.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.203 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -100.22 135.97 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.425 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -85.78 130.97 48.7 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.248 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.2 Cg_exo -66.13 -22.14 54.74 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.061 2.508 . . . . 0.0 113.508 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -80.32 -27.96 38.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.27 -174.56 4.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.411 0.624 . . . . 0.0 111.922 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.6 p -107.3 157.96 17.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.365 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.4 -32.3 64.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.829 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.98 -15.52 60.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.7 tt0 -82.79 -19.78 37.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.887 0.375 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.87 -19.7 24.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.387 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.34 45.44 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.986 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.13 136.79 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -123.84 155.99 66.04 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.142 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.54 145.56 52.97 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.766 2.31 . . . . 0.0 112.173 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.01 10.56 48.79 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.633 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 m -100.86 164.6 11.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.425 HG23 ' ND2' ' A' ' 5' ' ' ASN . 9.8 p -96.86 119.69 35.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.94 138.85 48.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.353 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 126.51 52.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.05 161.52 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.288 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.84 134.38 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.626 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.632 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.718 0.294 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -111.75 148.88 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -129.58 154.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.425 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.8 136.08 48.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 113.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 123.1 32.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.461 . . . . 0.0 111.657 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.3 166.09 13.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.793 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.03 -23.3 34.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.957 2.438 . . . . 0.0 113.684 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.35 -24.53 65.72 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.438 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.4 -8.84 55.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.405 -0.902 . . . . 0.0 114.208 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -90.13 166.74 13.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.502 0.651 . . . . 0.0 110.16 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.7 p -106.61 148.23 28.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 150.17 40.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.191 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 124.96 44.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.923 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -129.58 146.06 51.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 115.19 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.76 176.76 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.0 p -136.31 165.47 35.29 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.07 -15.12 47.53 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.622 2.215 . . . . 0.0 112.651 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.75 -5.75 59.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -80.13 139.78 36.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.223 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 p -86.93 167.53 14.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 t -66.9 -34.13 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.352 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -70.91 -31.9 68.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.69 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.9 -48.93 32.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.31 -34.34 72.2 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -35.94 69.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.311 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -74.17 -24.6 59.41 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -44.74 35.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.997 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 tp -71.13 -34.26 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.405 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.31 80.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -68.76 -33.39 73.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.36 61.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.16 -17.89 24.27 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.89 34.95 11.98 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.81 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.0 178.55 6.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.703 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.4 m -98.57 146.71 32.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.924 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.28 -20.62 42.68 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.95 2.433 . . . . 0.0 113.054 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -75.08 -15.13 60.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.587 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -96.96 -37.11 10.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.69 121.72 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -115.94 137.75 51.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mt -93.47 133.29 36.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.1 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.64 128.63 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 111.412 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -128.52 126.38 40.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.364 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.46 1.94 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 113.227 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.61 22.96 41.16 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.06 -0.591 . . . . 0.0 114.046 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.0 141.33 44.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 p -89.99 149.25 22.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.42 136.04 39.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.384 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.62 127.52 56.12 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.36 -23.01 65.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.341 2.694 . . . . 0.0 113.864 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.9 m -79.05 -27.28 43.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.33 -174.0 4.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.334 0.587 . . . . 0.0 111.859 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 49.4 p -109.56 155.93 20.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.1 mt -73.22 -34.39 65.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.81 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.38 -16.04 61.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.91 -20.27 35.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -90.18 -19.52 24.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.208 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.7 45.38 4.28 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.84 137.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.76 157.13 63.83 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.43 137.96 37.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.391 2.061 . . . . 0.0 111.964 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.52 13.94 31.35 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.346 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.6 t -103.64 161.94 13.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.425 HG21 ' ND2' ' A' ' 5' ' ' ASN . 12.2 p -88.16 121.91 31.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.157 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.94 128.38 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.727 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 130.67 54.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.72 160.99 13.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.028 0.442 . . . . 0.0 111.166 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -141.13 143.25 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.559 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 179.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.575 0.226 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -108.26 154.8 21.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.412 . . . . 0.0 111.3 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.47 160.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.428 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -105.44 131.28 53.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.077 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' THR . 5.3 mm -105.37 108.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.069 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -95.14 113.22 24.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 162.64 22.53 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.319 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.31 -0.46 9.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.7 -18.34 26.61 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 5.88 52.53 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.387 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -109.06 147.32 32.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 20.4 p -114.82 144.85 42.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.79 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.59 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.498 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.86 120.78 41.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.74 155.98 48.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.51 135.98 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.07 149.0 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 111.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -137.55 156.71 74.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.308 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.09 -6.38 18.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.761 2.307 . . . . 0.0 112.694 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.64 -9.76 22.78 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.733 0.302 . . . . 0.0 111.414 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.57 138.02 32.97 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.407 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -93.87 169.75 10.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.7 t -66.98 -32.6 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.306 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -71.9 -36.05 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.7 tt0 -72.57 -49.46 32.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.17 -32.23 70.87 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -36.6 69.67 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.925 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.2 -24.87 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.289 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.18 -51.2 40.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.31 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 tp -70.58 -32.65 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.802 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.82 67.9 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.808 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -67.22 -33.41 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.939 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -85.45 -17.3 36.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.789 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.6 mt -98.12 -18.05 18.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 111.421 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.67 33.29 22.29 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.009 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -132.43 178.45 6.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.014 0.435 . . . . 0.0 110.997 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 42' ' ' ILE . 48.8 m -103.84 140.93 21.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.67 -18.45 58.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.179 2.586 . . . . 0.0 113.686 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.43 -21.67 57.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 111.719 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.03 -28.9 15.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.536 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.76 128.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.461 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -109.84 134.17 52.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.69 129.08 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.182 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 132.27 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -133.58 125.2 28.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.285 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.42 31.57 1.95 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.094 0.958 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.31 23.46 37.23 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.991 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -136.29 139.48 42.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.941 0.371 . . . . 0.0 110.805 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 p -92.51 145.65 24.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.18 135.98 41.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.42 138.11 27.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.6 Cg_exo -64.44 -22.26 65.81 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.747 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 p -78.55 -28.38 46.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.71 -175.46 5.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 112.036 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.5 p -115.74 162.4 17.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.239 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.3 -30.25 63.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.869 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.54 -8.74 59.76 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.91 -31.03 28.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.097 0.475 . . . . 0.0 110.521 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -82.08 -19.79 39.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.691 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.64 5.65 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.705 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.52 136.6 30.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.4 p -123.74 156.67 64.68 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.859 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -69.74 136.33 32.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.627 2.218 . . . . 0.0 112.136 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.11 25.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.696 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.5 p -98.06 161.53 13.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.936 0.398 . . . . 0.0 110.763 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.428 HG23 ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -93.47 123.24 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.62 146.7 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.267 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 110.3 16.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 137.45 34.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.279 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.11 131.76 42.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.579 -179.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -111.05 152.08 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.208 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pt -128.48 156.94 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.148 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -99.32 154.42 18.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.296 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -136.44 114.64 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.704 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.03 122.07 39.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 111.786 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.32 163.86 19.71 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.11 -1.56 9.76 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.235 1.957 . . . . 0.0 111.895 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.87 -17.76 25.95 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.62 6.03 50.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -106.9 142.47 36.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.079 0.466 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.3 p -111.17 153.86 25.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.367 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.43 150.16 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.573 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.29 128.33 55.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -125.28 145.39 50.03 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 120.65 40.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.069 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.25 -179.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.037 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.8 p -133.84 164.98 40.13 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.81 -15.41 50.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.593 2.195 . . . . 0.0 112.584 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -86.09 -4.75 59.23 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.4 m-85 -80.75 137.34 36.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -90.18 170.26 10.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.68 -33.04 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -71.24 -34.38 70.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.924 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.7 -48.73 36.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.763 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.23 -36.13 77.01 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.906 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.76 -36.63 70.44 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.306 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.84 -25.17 61.87 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.93 -46.46 24.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.654 0.264 . . . . 0.0 111.176 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -72.01 -36.32 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.911 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.23 79.07 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.364 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -70.94 -33.41 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -26.96 61.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.452 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 mt -99.56 -18.22 17.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.62 47.66 5.29 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.15 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.28 177.93 7.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.994 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 42' ' ' ILE . 51.1 m -100.82 125.66 37.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.802 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.99 -20.21 71.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.133 2.555 . . . . 0.0 113.606 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.12 -19.96 59.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.39 -25.09 15.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.91 126.25 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.421 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -118.68 135.67 54.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.15 126.99 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.02 125.04 44.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 111.467 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -132.43 119.42 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 65.01 24.87 12.64 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.586 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -15.5 62.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.15 143.79 29.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.36 152.47 18.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 136.12 40.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.16 139.95 24.39 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.822 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.2 Cg_exo -63.7 -22.22 69.87 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.862 2.375 . . . . 0.0 113.408 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -82.26 -26.18 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.05 -174.72 5.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 111.659 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.5 p -115.25 160.73 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.868 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.14 -32.76 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.825 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.05 59.64 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.69 -19.84 37.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.073 0.463 . . . . 0.0 110.715 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -89.38 -19.57 25.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.52 4.84 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.649 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.17 142.28 27.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.01 0.433 . . . . 0.0 111.469 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -118.2 157.33 49.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.739 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.09 148.08 68.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.767 2.311 . . . . 0.0 112.495 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.93 6.3 52.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.695 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 p -101.01 158.37 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 110.66 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p -88.51 122.62 32.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.57 132.99 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.239 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.45 134.84 48.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -106.84 161.21 14.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.78 0.324 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -137.44 138.65 40.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.679 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.734 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -112.07 153.69 26.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.402 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' THR . 3.3 pt -120.98 160.72 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.056 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -97.71 151.87 19.69 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.181 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 13' ' ' THR . 16.4 mm -126.6 116.24 44.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.413 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.21 115.18 29.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 111.44 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.78 163.64 21.79 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.92 -2.27 11.25 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.295 1.997 . . . . 0.0 111.832 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.12 -18.22 26.23 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.42 5.53 51.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.168 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -104.23 145.07 30.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.195 0.521 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.7 p -113.73 151.51 31.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.286 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.08 145.04 45.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.354 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -108.08 123.13 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 111.479 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -124.59 153.38 42.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.05 131.8 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.748 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.28 147.55 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.985 0.421 . . . . 0.0 111.429 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -140.07 157.78 68.48 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.235 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.48 -6.28 18.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.695 2.263 . . . . 0.0 112.527 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -97.33 -14.93 20.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.349 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.8 140.64 32.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -94.17 171.05 9.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.3 -32.92 57.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -71.73 -37.45 70.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.993 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tt0 -72.23 -47.83 47.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.716 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.76 -32.4 72.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.598 0.237 . . . . 0.0 111.126 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.75 -37.87 70.49 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.677 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -69.96 -24.67 63.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.39 0.138 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.57 -53.05 25.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 110.765 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.45 -32.67 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.84 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.7 -27.82 66.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.772 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.49 -33.28 74.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -75.62 -31.35 59.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.79 -18.27 19.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.49 48.29 5.99 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.085 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.66 178.22 6.8 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.097 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 42' ' ' ILE . 37.9 m -106.25 143.89 27.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.87 -21.99 49.63 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.957 2.438 . . . . 0.0 113.305 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.26 -17.17 60.37 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 111.774 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -95.97 -30.29 13.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.367 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.37 122.54 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.437 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -110.53 129.3 55.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.27 130.1 39.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.163 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.36 127.19 49.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.01 0.433 . . . . 0.0 111.294 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -133.03 117.48 17.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 64.7 24.91 12.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.658 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.93 -13.89 66.55 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.744 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -100.18 140.79 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -91.96 151.56 20.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.128 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.47 136.04 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.301 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.8 t70 -95.38 138.02 21.97 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -63.89 -22.28 68.81 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.05 2.5 . . . . 0.0 113.444 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -80.35 -27.12 38.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.56 -174.32 4.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.539 0.685 . . . . 0.0 111.548 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.6 p -115.55 166.48 11.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.092 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.12 -30.57 63.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 -7.7 59.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.84 -22.39 34.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.062 0.458 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.34 -19.41 24.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.739 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.54 45.78 6.33 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.81 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.08 142.63 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -122.86 148.43 53.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.077 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.13 149.88 71.38 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.76 2.307 . . . . 0.0 112.572 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.51 1.76 35.06 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.631 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.0 m -107.88 159.44 16.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.846 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 p -89.1 127.0 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.77 121.08 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.853 0.358 . . . . 0.0 111.066 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.27 135.22 42.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -114.6 161.44 18.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.646 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -141.94 133.61 26.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.441 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.959 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -109.31 153.54 23.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.76 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.34 162.12 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.556 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 129.35 56.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.926 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.83 113.13 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.664 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 135.08 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.968 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.14 162.35 20.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.25 -1.89 10.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.22 1.947 . . . . 0.0 111.696 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.01 -15.98 28.71 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.22 51.76 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -108.17 148.89 29.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -113.26 155.24 25.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.429 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.75 150.09 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.88 126.11 52.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.259 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.3 160.75 36.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.3 136.88 38.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.783 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.67 146.75 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.599 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.9 p -139.01 157.69 70.99 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.057 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.5 -6.03 18.08 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.78 2.32 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.18 -11.12 20.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.682 0.277 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.13 140.71 32.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.813 0.339 . . . . 0.0 110.363 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -94.88 171.92 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 t -68.22 -33.27 59.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.964 0.411 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.876 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.2 -47.86 54.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.14 -39.01 88.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.401 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.47 63.27 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.99 -27.16 63.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.995 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.41 -50.87 23.25 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -66.14 -32.58 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.878 0.371 . . . . 0.0 111.442 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.03 65.85 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.85 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -69.71 -33.59 72.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -76.66 -31.16 57.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.77 -18.01 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.84 5.5 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.961 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.25 178.53 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.97 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 42' ' ' ILE . 6.4 p -109.61 147.53 36.29 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.2 Cg_exo -67.84 -17.69 47.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.131 2.554 . . . . 0.0 113.605 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.22 -19.95 59.51 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.01 -28.15 13.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.585 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.25 124.97 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 111.386 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -117.75 132.29 56.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.468 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -92.03 132.21 36.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.49 125.27 44.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -135.51 123.74 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.6 t30 64.61 25.14 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.853 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.87 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.771 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -100.66 150.04 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.067 0.46 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 p -93.38 158.41 15.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.333 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.37 135.8 43.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.016 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -88.96 135.19 32.11 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.011 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.8 Cg_exo -65.08 -22.28 62.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.072 2.515 . . . . 0.0 113.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 m -80.27 -27.45 38.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.34 -174.91 5.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.365 0.602 . . . . 0.0 111.862 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.2 p -113.29 158.94 19.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.0 mt -73.39 -31.29 63.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.77 -21.33 34.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.995 0.426 . . . . 0.0 110.909 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -88.28 -19.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 45.6 5.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.708 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.36 137.91 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.976 0.417 . . . . 0.0 111.514 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -123.34 156.95 62.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.925 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.81 146.14 52.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.722 2.282 . . . . 0.0 112.395 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.78 45.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.522 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.7 p -98.98 165.94 11.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -96.53 124.89 40.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.36 136.05 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.12 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.43 126.34 51.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.709 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pp -93.6 160.86 14.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.878 0.37 . . . . 0.0 111.252 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.47 149.51 45.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.473 179.66 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.771 0.319 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -107.91 151.37 25.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.093 0.473 . . . . 0.0 111.424 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.47 161.97 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.632 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.4 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.09 131.77 54.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.803 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.08 113.48 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.298 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 132.96 35.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.935 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 161.8 22.69 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.884 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.02 -1.78 10.54 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.34 2.027 . . . . 0.0 111.812 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.25 -16.71 27.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.5 5.57 51.6 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.295 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -108.07 141.18 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.6 p -102.68 155.32 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.77 150.0 50.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.503 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.51 121.25 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.53 161.97 33.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.92 139.03 35.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.832 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.76 149.3 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.539 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 p -139.13 149.72 62.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.95 -9.57 26.34 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.635 2.223 . . . . 0.0 112.64 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -94.3 -9.34 36.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.94 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.55 145.85 26.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.4 p -96.43 169.36 9.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.53 -30.54 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.402 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.3 -39.48 68.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.022 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.63 -47.95 51.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.949 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.73 -33.37 72.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.224 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.96 69.61 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.7 pt-20 -72.26 -25.15 61.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -51.06 26.27 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.531 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 tp -67.45 -32.78 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.873 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.08 69.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -68.31 -33.48 74.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -84.87 -13.86 49.65 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -100.83 -18.09 16.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.612 0.244 . . . . 0.0 111.362 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.86 32.76 20.45 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.963 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.22 178.09 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.019 0.437 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.4 p -103.04 139.98 20.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.667 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.06 -17.04 45.82 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.015 2.476 . . . . 0.0 113.801 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.48 -21.5 58.01 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.37 -27.56 14.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.568 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 38' ' ' SER . 1.7 mt -87.52 123.4 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.432 . . . . 0.0 111.491 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.82 137.62 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.84 130.98 37.51 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.211 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.55 125.98 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -135.16 122.64 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.0 t30 62.87 26.56 15.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.793 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.8 -19.63 47.29 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.275 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -97.19 149.7 21.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -96.04 155.52 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.139 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 135.75 43.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.188 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -89.8 137.43 28.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 19.8 Cg_exo -65.1 -22.26 62.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.111 2.54 . . . . 0.0 113.388 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -77.7 -26.14 49.96 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.42 -174.88 5.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.2 p -115.25 163.89 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.356 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -73.37 -30.92 63.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.872 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.36 -7.77 59.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.416 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -82.9 -31.85 27.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.658 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -81.63 -19.89 40.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.663 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.71 5.37 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.23 141.53 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.786 0.327 . . . . 0.0 111.365 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.7 p -124.81 156.66 68.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.24 137.86 38.04 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.42 12.06 31.89 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t -101.71 160.1 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.4 HG23 ' ND2' ' A' ' 5' ' ' ASN . 13.9 p -87.52 124.38 33.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.181 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.02 127.63 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.983 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.25 125.44 53.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.93 161.06 14.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.332 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -139.73 144.42 37.48 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.477 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.743 0.306 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 p -110.45 151.98 26.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.513 . . . . 0.0 111.382 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.66 157.66 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -101.7 153.92 19.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.79 113.1 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.266 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.31 121.69 38.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.935 0.398 . . . . 0.0 111.553 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 163.67 19.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.58 -1.27 10.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.321 2.014 . . . . 0.0 112.032 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.44 -17.93 26.3 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.64 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.31 5.49 52.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.385 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -104.43 146.42 28.87 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 110.717 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p -109.86 156.5 20.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.567 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 150.25 46.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.292 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 125.14 50.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.283 . . . . 0.0 111.329 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.1 165.53 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.45 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.95 143.15 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.86 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.42 148.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.381 . . . . 0.0 111.641 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 p -139.43 157.38 70.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.079 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.41 -5.99 18.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.691 2.26 . . . . 0.0 112.675 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -99.69 -13.94 19.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.375 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.53 141.36 32.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.759 0.314 . . . . 0.0 110.33 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 p -94.92 171.79 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.89 -32.57 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.045 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -71.83 -39.18 69.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.113 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 5.1 tt0 -72.15 -45.04 62.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.71 -31.15 72.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 110.648 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.74 69.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.832 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -70.16 -26.19 63.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.408 0.147 . . . . 0.0 111.107 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.43 -53.35 29.81 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.94 -32.85 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.612 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.97 65.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -68.54 -33.46 74.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -77.33 -28.52 53.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.897 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.32 -18.11 18.52 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.31 47.82 5.59 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.108 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.12 178.29 6.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 111.313 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.6 t -107.2 141.99 24.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.58 -23.23 64.24 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.94 2.426 . . . . 0.0 113.495 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.4 -15.71 60.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.69 -31.87 12.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.62 124.28 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.628 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -113.0 131.7 55.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.384 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.64 124.24 34.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 127.21 52.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.708 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.87 115.84 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.379 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.04 24.96 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.06 -7.54 78.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.743 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -102.44 138.74 38.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -91.06 151.2 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.321 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 136.12 42.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.321 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -87.29 132.71 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.236 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 16.8 Cg_exo -66.0 -22.31 55.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.09 2.527 . . . . 0.0 113.543 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.1 m -78.84 -26.26 44.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.96 -174.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.435 0.636 . . . . 0.0 111.663 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.4 p -108.93 160.71 15.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.261 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.16 -32.02 64.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.661 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -9.63 59.65 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.62 -23.76 34.16 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 110.787 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.66 -19.75 23.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.631 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.27 5.53 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.862 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.34 136.71 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -123.37 155.48 65.21 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.59 155.72 62.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.88 2.387 . . . . 0.0 112.5 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.19 57.36 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.4 m -107.85 153.3 23.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 0.0 110.732 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -88.61 127.08 35.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.642 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -110.91 129.52 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 135.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.514 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -107.57 161.05 15.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.935 0.397 . . . . 0.0 111.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -140.07 135.43 32.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.351 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.667 -179.851 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 p -110.02 154.33 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -130.32 161.62 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.17 130.03 56.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.099 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.68 113.53 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.663 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.5 132.91 34.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.873 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.28 24.78 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.75 -1.08 9.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.162 1.908 . . . . 0.0 111.736 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.07 -15.33 29.68 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.43 6.02 51.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.442 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -109.6 151.82 26.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 110.878 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -112.95 146.43 39.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.708 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.03 150.08 37.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.526 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.27 123.39 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 111.071 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.39 161.09 37.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.599 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.24 134.56 40.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.644 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.49 148.5 17.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.817 0.342 . . . . 0.0 111.647 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 p -139.39 157.19 71.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.213 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.4 -6.26 18.51 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.696 2.264 . . . . 0.0 112.58 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.31 -9.72 22.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.43 142.73 29.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.4 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -95.52 171.57 8.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -68.8 -32.78 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 0.0 110.076 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -72.49 -36.62 68.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.914 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.1 tt0 -71.32 -48.12 52.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.82 -33.82 74.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.145 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.41 69.47 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.077 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.4 pt-20 -70.24 -24.93 63.16 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.02 -50.18 30.72 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.807 0.337 . . . . 0.0 110.356 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tp -70.12 -32.95 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 37' ' ' LEU . . . -67.98 -33.02 73.85 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -62.38 -33.47 74.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.817 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -87.56 -10.54 51.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.753 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.12 -18.84 19.84 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.314 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.22 -6.32 78.47 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.263 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -119.74 164.13 16.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 110.998 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 48.8 m -83.59 154.7 65.61 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.396 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 20.0 Cg_exo -65.69 -16.34 53.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.715 2.943 . . . . 0.0 113.245 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.32 -23.84 66.01 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.08 -24.58 14.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.711 0.291 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -92.07 127.18 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -123.64 140.23 53.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.025 0.44 . . . . 0.0 110.516 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.7 135.39 36.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.413 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.54 126.12 35.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.679 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -137.23 127.05 25.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 63.98 25.02 13.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.609 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 -18.76 44.1 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.868 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -96.04 149.96 21.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.775 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.6 p -96.0 156.87 16.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.16 135.15 48.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.076 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -92.37 137.99 24.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.761 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.3 Cg_exo -63.96 -22.13 68.46 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.899 2.399 . . . . 0.0 113.525 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -79.51 -27.97 41.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -83.64 -175.06 5.63 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.283 0.564 . . . . 0.0 111.951 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.8 p -116.05 163.28 16.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.119 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -73.23 -31.01 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.63 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.05 59.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.84 -24.54 33.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.973 0.416 . . . . 0.0 110.72 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.5 -20.2 26.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.498 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.98 45.29 5.73 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 141.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 111.549 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.6 t -122.5 144.49 42.33 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.569 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.6 Cg_exo -67.32 137.55 43.81 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.406 2.071 . . . . 0.0 112.097 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.96 4.65 27.61 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 t -99.4 168.54 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.445 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.5 p -93.75 122.61 36.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.12 134.75 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 128.41 55.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pp -101.12 159.42 15.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.137 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -139.73 148.71 42.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.102 179.556 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.834 0.35 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.8 p -107.73 149.44 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.57 156.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.44 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.52 127.96 54.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.509 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.33 111.02 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.726 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 125.0 35.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.82 161.57 24.53 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.118 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.82 -0.53 7.09 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.326 2.017 . . . . 0.0 111.92 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.38 -18.23 24.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.3 52.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.495 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -109.34 140.91 42.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.094 0.473 . . . . 0.0 110.874 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -108.4 151.92 25.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.035 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.72 149.89 52.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.8 122.75 48.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tp -131.88 151.52 51.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.084 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.84 120.8 41.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.98 170.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.964 0.412 . . . . 0.0 111.519 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 p -135.63 164.87 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.36 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.11 -12.5 35.74 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.875 2.383 . . . . 0.0 112.592 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -89.2 -6.1 57.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.878 0.371 . . . . 0.0 110.879 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 m-85 -80.91 139.82 35.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -91.0 169.29 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.77 -33.86 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.035 0.445 . . . . 0.0 110.169 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -70.96 -32.71 69.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.829 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.576 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.6 tt0 -72.62 -51.23 20.47 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.709 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.88 -36.18 72.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.09 70.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.92 -24.6 61.66 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -48.01 26.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.854 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.73 -33.27 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.543 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.11 65.76 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.24 -33.37 75.6 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.85 -21.1 34.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.776 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.72 -18.17 18.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.252 . . . . 0.0 111.436 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.63 9.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.105 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.97 177.82 7.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.203 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 42' ' ' ILE . 3.2 p -106.04 126.24 31.1 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.593 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 32.5 Cg_exo -59.18 -18.05 42.29 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.393 2.729 . . . . 0.0 114.017 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.04 -14.7 60.62 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -109.12 -20.65 12.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.535 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.72 141.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -133.31 148.79 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 111.121 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.01 135.47 44.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.25 124.31 43.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -134.5 117.96 16.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.55 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 65.28 25.1 12.2 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.532 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.73 -16.47 60.14 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.824 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.26 146.77 25.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -95.26 149.43 21.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.06 135.82 44.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.01 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 141.79 24.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.015 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.9 -22.08 56.45 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.196 2.598 . . . . 0.0 113.548 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 m -76.12 -24.69 54.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.83 -174.63 4.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.4 0.619 . . . . 0.0 111.93 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.4 p -115.62 157.12 24.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.265 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 22' ' ' PHE . 12.8 mt -73.33 -31.6 64.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.776 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.78 -17.21 60.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.7 tt0 -82.75 -19.96 36.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -90.34 -20.06 23.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.144 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.52 45.34 5.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.614 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.35 135.53 44.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -125.64 155.65 72.02 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.631 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -69.74 139.35 40.08 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.655 2.237 . . . . 0.0 112.031 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.92 -6.13 30.9 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.436 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -94.66 165.16 12.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.557 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.44 HG23 ' ND2' ' A' ' 5' ' ' ASN . 8.2 p -91.0 125.83 35.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.41 145.33 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.41 116.9 31.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.39 140.71 39.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.43 144.19 50.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.628 179.599 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.726 0.298 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.3 p -108.95 152.34 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.036 0.446 . . . . 0.0 111.697 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.05 158.93 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -103.07 153.67 20.04 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -136.91 122.58 27.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.07 112.3 25.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 111.312 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -96.26 164.15 19.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.188 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 9.7 Cg_endo -54.35 -23.25 29.88 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.136 2.557 . . . . 0.0 113.583 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.27 -24.67 65.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.703 0.287 . . . . 0.0 110.541 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -6.17 52.88 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.441 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -94.35 167.62 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.552 0.676 . . . . 0.0 110.231 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.3 p -117.84 151.03 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.733 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.43 150.08 49.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.225 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.25 123.0 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.26 164.72 21.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.686 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -99.93 137.76 37.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.623 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.02 150.0 23.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.872 0.368 . . . . 0.0 111.547 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 p -138.73 156.87 72.73 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.344 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.98 -6.86 19.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.705 2.27 . . . . 0.0 112.564 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.23 -12.0 22.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.25 140.1 31.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.4 p -93.24 169.36 10.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.576 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -67.86 -30.35 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 110.239 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -71.56 -39.9 70.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.149 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.01 -48.72 51.49 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.27 -32.34 71.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.247 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.92 -37.27 70.08 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.8 pt-20 -71.16 -24.82 62.32 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -51.32 23.86 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-O 120.786 0.326 . . . . 0.0 110.695 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.9 -32.76 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.936 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -28.41 66.67 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -69.07 -33.36 73.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -25.97 45.78 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.9 -17.98 21.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.39 41.61 9.94 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.235 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.94 178.12 7.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' HG13 ' A' ' 42' ' ' ILE . 21.7 m -97.98 133.3 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.61 -21.19 46.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.975 2.45 . . . . 0.0 113.961 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -75.66 -14.76 60.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.65 -29.44 13.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.311 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.69 124.11 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.305 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -114.04 133.93 55.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.489 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.31 134.48 34.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.205 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.21 125.21 44.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -134.86 122.92 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.67 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 t30 63.65 25.92 14.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.803 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.04 -19.83 46.71 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.341 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.99 150.43 21.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.947 0.404 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 p -95.63 155.89 16.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.082 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.54 135.97 41.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.067 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.42 133.49 36.38 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.33 -22.21 60.38 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.051 2.501 . . . . 0.0 113.358 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 -27.97 32.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.62 -174.53 4.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.307 0.575 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 43.7 p -108.83 161.28 15.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 62' ' ' ILE . 9.3 mt -73.32 -30.06 63.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.764 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.21 -7.01 59.61 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.5 tm-20 -82.77 -26.92 31.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -83.13 -19.46 36.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.72 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 45.64 5.82 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 57' ' ' LEU . 2.1 mt -103.4 143.72 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -121.98 153.79 60.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.071 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 156.57 58.98 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.775 2.317 . . . . 0.0 112.491 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.91 2.14 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.505 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -104.12 156.1 18.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.99 0.424 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 p -88.92 125.87 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.464 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.28 138.11 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.351 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 131.93 56.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.341 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.5 161.07 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -139.24 151.77 46.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.212 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.655 0.264 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -108.02 148.9 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.841 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -134.41 156.86 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.65 153.64 19.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.682 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -138.97 118.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.979 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 116.41 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.14 0.495 . . . . 0.0 111.115 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.28 166.85 12.57 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.844 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -54.54 -21.86 25.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.979 2.453 . . . . 0.0 113.617 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.45 -25.06 64.82 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.876 0.37 . . . . 0.0 110.377 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -8.55 55.1 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.375 -0.917 . . . . 0.0 114.386 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -92.22 163.34 13.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.533 0.666 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.1 p -115.96 156.31 26.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.33 150.15 52.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.14 122.41 46.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.77 149.13 47.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.72 117.84 33.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.746 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 179.17 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.227 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 p -135.26 165.1 39.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.266 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.2 -13.75 39.76 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 112.703 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.23 -7.3 58.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.04 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.3 m-85 -80.59 138.59 36.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.993 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -87.89 170.93 10.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.403 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.6 -32.25 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.044 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -72.11 -32.71 67.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.834 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.6 tt0 -72.25 -48.04 45.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.11 -34.61 75.22 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.786 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.72 -36.11 70.41 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -72.47 -24.91 61.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.619 0.247 . . . . 0.0 111.236 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.22 -50.34 28.25 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.831 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 tp -68.73 -33.05 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.876 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.32 66.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -70.45 -33.52 71.39 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -79.62 -26.63 41.11 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 -18.17 21.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.561 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.21 39.42 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.032 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.0 178.26 6.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.059 0.457 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.1 t -99.22 136.73 20.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.528 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.94 -17.27 51.39 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 123.164 2.576 . . . . 0.0 113.653 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.34 -21.73 58.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.668 0.27 . . . . 0.0 111.46 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.21 -28.28 16.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 38' ' ' SER . 1.2 mt -90.07 121.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.359 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -112.22 142.9 44.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.593 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.63 132.25 40.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.28 124.2 41.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 111.296 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -131.73 117.89 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.8 24.99 12.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.712 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.41 69.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.857 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.46 143.3 29.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 p -94.26 151.68 19.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.142 0.496 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.84 135.94 46.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.235 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.28 138.42 27.18 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.4 Cg_exo -63.78 -22.15 69.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.928 2.419 . . . . 0.0 113.759 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.6 p -78.83 -26.25 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -82.3 -174.59 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.334 0.587 . . . . 0.0 111.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -118.11 158.53 24.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.6 mt -73.21 -30.65 63.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.847 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.15 60.01 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.85 -27.95 30.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.427 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -83.23 -20.01 35.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.57 45.71 6.01 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.786 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -101.13 140.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.859 0.362 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -124.16 154.44 68.44 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.989 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.19 149.11 57.26 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.772 2.315 . . . . 0.0 112.339 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.46 6.59 54.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.408 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.2 t -106.45 161.6 14.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.898 0.38 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 p -93.17 121.22 34.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.34 126.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.032 0.444 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.13 143.76 32.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.669 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -117.61 161.81 19.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 111.054 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -136.26 132.2 35.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.337 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.768 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.776 0.322 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.2 p -111.67 150.39 30.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -129.96 160.35 41.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.684 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.43 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.36 129.29 56.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.11 0.481 . . . . 0.0 110.13 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.96 112.28 37.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.683 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.48 133.7 33.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.93 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.76 162.8 20.42 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.977 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.06 -1.11 9.02 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.221 1.947 . . . . 0.0 111.969 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.69 -16.86 27.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.75 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.95 50.89 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.286 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -106.03 149.02 27.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.138 0.494 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -105.31 153.88 21.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.668 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.92 149.86 51.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 125.24 50.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.003 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -127.96 147.01 50.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.51 115.57 30.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.6 174.8 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 12.7 p -137.74 166.12 28.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.55 -14.6 40.58 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.791 2.328 . . . . 0.0 112.65 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -85.38 -7.6 58.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.836 0.351 . . . . 0.0 111.19 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' THR . 3.3 m-85 -81.32 141.37 34.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 p -88.43 167.39 13.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.22 -33.96 67.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.069 0.461 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -71.44 -31.99 67.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.846 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 4.5 tt0 -72.91 -45.83 55.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.61 -36.5 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.395 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.34 67.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -73.74 -26.06 60.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.78 -45.9 48.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.118 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 tp -70.2 -32.79 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.712 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.7 77.35 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.634 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -65.73 -33.35 75.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -75.46 -25.75 57.67 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.06 -18.25 22.02 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.594 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.29 -5.69 83.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.544 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -98.83 176.54 5.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.223 0.512 . . . . 0.0 110.888 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 54.0 m -89.16 151.06 46.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.318 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 12.7 Cg_exo -69.04 -16.84 40.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.392 2.728 . . . . 0.0 113.051 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.12 -14.99 62.91 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.679 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.64 -20.88 18.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.36 148.03 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.999 0.428 . . . . 0.0 111.606 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -137.76 128.18 26.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.341 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.85 121.41 31.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.43 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.08 127.52 55.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.127 0.489 . . . . 0.0 111.384 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -138.35 120.03 15.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.339 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 65.01 24.93 12.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.789 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -19.42 50.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.906 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.45 149.9 22.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -94.49 150.13 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.07 135.84 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.23 137.55 29.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.66 -22.08 64.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.013 2.475 . . . . 0.0 113.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -77.36 -27.69 52.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.65 -174.02 4.38 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.337 0.589 . . . . 0.0 111.904 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 71.7 p -113.6 157.84 21.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.376 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.32 -30.16 63.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.06 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 -7.63 59.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -83.13 -32.0 26.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.522 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.92 -19.68 34.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.776 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.03 45.64 3.82 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.011 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.58 136.16 39.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.81 0.305 . . . . 0.0 111.056 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.38 157.71 58.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 138.52 37.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.6 7.71 33.77 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -98.93 170.05 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 110.75 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.43 HG21 ' ND2' ' A' ' 5' ' ' ASN . 10.0 p -95.58 122.4 38.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.18 129.83 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.4 126.98 55.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.513 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.5 161.01 14.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.75 145.89 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.363 179.533 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -110.38 151.97 26.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.74 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pt -131.18 156.12 42.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.519 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.92 112.69 36.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.73 133.93 33.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.94 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.73 162.44 21.14 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.817 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.46 -2.05 10.68 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.384 2.056 . . . . 0.0 111.801 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -91.17 -15.67 28.96 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.02 52.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.253 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -106.8 143.83 34.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 p -104.04 156.93 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.608 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.42 150.03 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.539 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.986 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 154.88 49.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.687 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.0 120.51 39.57 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.14 170.58 19.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.78 0.324 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 p -136.72 162.57 55.24 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.411 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.16 -14.92 44.95 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.741 2.294 . . . . 0.0 112.526 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.17 -3.64 59.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.898 0.38 . . . . 0.0 111.023 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.08 142.2 32.5 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.887 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.1 p -90.95 169.24 11.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 t -66.71 -33.55 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.94 0.4 . . . . 0.0 110.112 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.79 -34.3 69.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.803 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.21 -47.6 49.36 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.29 -35.55 77.62 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.759 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.02 69.87 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.95 -24.92 61.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.484 0.183 . . . . 0.0 111.444 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.81 -47.78 28.77 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -70.19 -32.71 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.9 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.88 76.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.21 -33.59 75.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -88.11 -9.48 53.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.518 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.32 -18.12 20.21 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.209 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.84 82.7 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.13 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.8 164.39 16.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.47 0.635 . . . . 0.0 111.539 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -76.77 148.52 79.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.713 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.39 -16.77 53.81 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.368 2.712 . . . . 0.0 113.24 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.5 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.38 -27.04 14.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.388 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.13 128.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.77 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -121.9 141.88 50.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.31 126.51 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.59 127.08 55.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.99 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -136.83 121.23 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t30 64.39 26.5 13.56 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.68 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.47 -19.87 44.71 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.323 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -101.09 151.76 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.881 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 p -92.4 150.68 20.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.228 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.72 135.59 38.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.67 135.79 28.72 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.41 -22.16 59.88 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.019 2.479 . . . . 0.0 113.871 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.2 m -78.42 -27.84 46.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -88.89 -174.39 4.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.428 0.632 . . . . 0.0 112.041 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 42.1 p -110.05 155.85 21.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.466 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.34 -37.32 66.14 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.977 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.81 -14.42 62.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.96 -22.14 33.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.971 0.415 . . . . 0.0 110.822 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.68 -20.17 23.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.416 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.74 45.38 3.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.046 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.78 139.39 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.9 157.06 64.54 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.34 137.53 31.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.626 2.217 . . . . 0.0 112.135 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.98 14.91 29.94 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.118 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 t -99.74 169.85 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.438 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -95.21 123.21 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.694 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.75 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.33 125.6 54.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.45 161.22 14.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.63 152.8 44.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.468 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 -179.743 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.717 0.294 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 p -110.4 149.7 29.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.019 0.438 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.73 155.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.961 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -102.57 153.69 19.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -135.94 120.77 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.02 122.49 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.13 161.78 24.31 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.168 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 -1.03 7.75 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.358 2.039 . . . . 0.0 111.744 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.46 -19.51 23.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.81 51.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.413 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -106.22 146.05 30.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.066 0.46 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -105.14 152.19 23.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 149.87 52.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -114.79 126.73 55.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.874 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.3 tp -125.82 148.48 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.775 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.41 117.77 35.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 178.08 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 16.0 p -132.38 164.57 42.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.208 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.43 -14.39 43.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.742 2.295 . . . . 0.0 112.918 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.4 -10.85 53.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -75.27 136.33 40.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.17 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.8 p -88.21 172.14 9.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.156 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.64 -33.07 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 110.13 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -70.64 -35.17 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.719 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -71.58 -48.6 47.2 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.18 -40.16 89.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.952 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -30.17 67.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -70.62 -26.22 63.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.77 -49.51 25.1 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.78 -32.89 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.853 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.07 -28.17 66.28 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.701 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -72.56 -33.37 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.39 -34.28 58.86 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.66 -18.17 21.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.23 51.07 5.89 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.116 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -130.02 178.07 6.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.126 0.489 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 42' ' ' ILE . 11.9 t -105.57 141.98 23.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.438 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.71 -17.41 58.87 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.86 2.374 . . . . 0.0 113.568 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.19 -21.51 58.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.303 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.69 -27.68 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.527 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 38' ' ' SER . 2.0 mt -87.07 134.67 27.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.957 0.408 . . . . 0.0 111.329 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -128.01 128.99 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -95.43 132.69 40.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.48 141.3 51.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.064 0.459 . . . . 0.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -145.12 106.47 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 67.17 25.22 9.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.71 74.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.943 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -102.27 139.68 37.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -93.25 145.69 24.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.54 135.89 36.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.308 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.22 138.98 22.9 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.92 -22.5 73.86 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.15 2.567 . . . . 0.0 114.019 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.2 p -81.85 -25.44 35.11 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -174.72 5.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.273 0.559 . . . . 0.0 111.752 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.9 p -117.19 161.89 18.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 22' ' ' PHE . 9.9 mt -73.0 -32.78 65.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.749 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.49 -11.56 59.96 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.61 -20.73 35.81 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.997 0.427 . . . . 0.0 110.626 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.04 -19.87 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.176 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 45.5 4.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.71 137.97 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.18 157.19 65.02 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.904 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.75 144.67 54.84 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.762 2.308 . . . . 0.0 112.071 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.79 1.03 34.37 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.587 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -107.74 159.0 16.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 p -88.58 123.93 33.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.83 148.55 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.92 135.82 48.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.064 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.35 140.12 52.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.499 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -132.6 131.65 41.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.771 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -109.72 153.12 24.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.0 111.669 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.04 162.43 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.57 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.31 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.88 112.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.184 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 122.68 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.977 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 163.29 21.19 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.999 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.78 -1.68 9.71 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.239 1.96 . . . . 0.0 112.059 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -89.86 -19.54 24.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.8 51.07 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.474 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -102.44 150.02 23.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.73 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 p -111.76 152.22 28.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.736 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.82 150.07 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.471 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.37 121.95 46.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.126 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -132.34 159.47 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.604 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.17 134.01 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.754 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.24 147.23 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 111.436 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 p -138.76 157.28 72.12 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.32 -6.09 18.25 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -98.29 -12.46 21.53 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.244 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.36 142.43 31.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.312 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 p -96.42 170.67 9.07 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.42 -33.09 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 110.267 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -72.21 -37.14 69.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.36 -47.83 46.48 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.679 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.11 -31.57 71.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.03 69.88 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.823 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -71.14 -24.91 62.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.49 0.186 . . . . 0.0 111.35 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.12 -51.0 42.93 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.76 -33.95 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.764 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.23 -28.58 66.48 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -67.1 -33.56 75.73 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.9 -16.33 38.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.704 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -100.46 -18.35 16.73 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.579 0.228 . . . . 0.0 111.48 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.18 39.72 12.44 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.011 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -131.5 178.19 6.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.225 0.536 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 42' ' ' ILE . 9.5 t -105.22 142.26 24.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.599 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.77 -18.95 59.21 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.06 2.507 . . . . 0.0 113.408 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.29 -20.34 59.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.639 0.257 . . . . 0.0 111.622 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -94.8 -30.24 14.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.7 123.04 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.652 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -115.21 138.85 50.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.443 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.94 131.07 38.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.24 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.5 125.32 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.977 0.417 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -134.17 121.98 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 62.45 26.84 15.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.669 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.64 -17.76 55.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.366 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.77 149.31 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.829 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -97.11 153.83 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.119 0.485 . . . . 0.0 111.108 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.52 136.11 42.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.214 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -90.03 138.16 27.72 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.3 Cg_exo -65.01 -22.1 62.83 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.433 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -78.51 -24.98 45.54 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.58 -175.12 5.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.267 0.556 . . . . 0.0 111.673 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.9 p -115.32 161.86 17.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.312 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.35 -29.73 62.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.12 -8.35 59.65 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.88 -31.16 28.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.088 0.471 . . . . 0.0 110.572 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -81.75 -19.95 40.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.736 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 45.61 6.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.651 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -98.19 139.53 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 0.0 111.606 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -124.28 156.56 66.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.916 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.54 146.38 55.23 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.614 2.21 . . . . 0.0 112.25 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.5 6.59 50.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.573 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -102.89 162.27 13.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.1 p -90.03 122.16 32.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.06 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.3 mm -112.57 119.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.977 0.418 . . . . 0.0 110.761 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.23 123.44 48.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.71 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -96.63 159.29 15.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.132 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.346 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.697 0.284 . . . . 0.0 110.614 -179.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.734 0.302 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -111.15 152.05 27.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.21 153.82 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.22 135.06 43.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mm -111.92 111.71 37.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.68 119.66 34.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.5 161.44 24.53 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.19 -0.88 8.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.266 1.977 . . . . 0.0 111.759 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.96 -18.78 24.11 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.48 6.13 50.92 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.335 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -107.36 145.87 32.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.863 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 17.5 p -112.68 146.22 39.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.504 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.2 150.51 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.33 121.15 41.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.685 0.278 . . . . 0.0 110.881 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.04 142.24 49.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -101.77 133.1 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.75 176.58 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.631 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 p -135.98 165.58 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.185 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.44 -12.47 30.91 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 113.018 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.44 -14.36 43.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' O ' HD11 ' A' ' 57' ' ' LEU . 3.2 m-85 -75.62 135.62 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 p -85.44 170.75 12.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.288 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.4 -33.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.059 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -72.11 -32.3 66.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.703 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.1 tt0 -72.0 -47.84 49.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.722 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.31 -36.18 79.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.703 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.0 70.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.301 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -72.26 -24.78 61.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.485 0.183 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.06 -49.67 27.35 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.877 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.83 -34.25 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.727 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.1 -27.88 65.99 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.825 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -69.35 -33.48 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -30.37 47.09 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.23 -18.15 20.26 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.47 49.3 5.88 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.073 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.61 178.24 6.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.429 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.0 t -105.33 142.03 23.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.563 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.85 -17.33 55.74 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.833 2.355 . . . . 0.0 113.377 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.33 -18.62 59.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.77 -29.78 12.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -89.48 126.23 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 0.0 111.441 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -121.89 135.29 54.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.794 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.18 133.85 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.67 129.52 47.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.294 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -130.38 125.22 34.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.399 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.94 32.39 1.83 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.95 . . . . 0.0 113.188 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.81 22.95 37.34 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.945 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -134.39 140.27 46.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.013 0.407 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -93.56 147.24 23.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.01 135.82 42.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.123 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 -91.27 138.08 25.87 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.2 Cg_exo -64.25 -22.36 66.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.1 2.533 . . . . 0.0 113.503 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.2 t -79.94 -28.11 39.73 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.42 -174.85 5.52 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 112.061 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 68.4 p -116.66 157.76 24.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.121 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 22' ' ' PHE . 10.1 mt -73.05 -31.18 64.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.08 -15.04 59.72 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.68 -20.2 36.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.053 0.454 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -89.14 -20.26 24.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.57 45.46 4.61 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -111.61 137.67 43.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.932 0.396 . . . . 0.0 111.453 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.34 158.16 62.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.576 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.27 141.02 46.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.484 2.122 . . . . 0.0 112.002 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.09 3.16 36.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -100.45 165.35 11.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -88.12 126.31 35.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.5 mm -104.52 149.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.678 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.63 115.34 25.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.124 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.37 127.34 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.99 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.07 131.04 38.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.446 -179.674 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -109.68 152.15 25.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.469 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -130.13 156.69 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -98.49 153.75 18.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.88 0.372 . . . . 0.0 111.333 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.06 117.15 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.524 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 119.91 38.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.407 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 163.14 23.21 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 -1.0 9.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.268 1.978 . . . . 0.0 112.236 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -89.41 -18.21 27.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 5.75 51.56 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -105.47 146.41 29.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -108.85 154.78 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.383 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.74 149.99 46.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.317 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 126.01 52.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.069 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.5 tp -120.05 148.56 43.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.93 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.97 116.37 32.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 -179.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.2 p -137.92 165.12 36.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.241 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.3 -13.05 35.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.537 2.158 . . . . 0.0 112.676 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.08 -6.49 58.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.081 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 m-85 -81.22 144.95 31.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.072 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -91.43 168.47 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -67.54 -32.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.417 . . . . 0.0 110.251 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -71.72 -34.38 69.53 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -71.59 -47.97 51.3 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.19 -36.21 77.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.841 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.26 -37.59 71.93 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.9 pt-20 -71.2 -24.95 62.32 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.45 -50.63 20.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.595 0.236 . . . . 0.0 110.836 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 tp -69.6 -35.5 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -28.24 66.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -68.03 -33.57 74.83 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.38 -18.65 33.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.68 -18.21 18.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.594 0.235 . . . . 0.0 111.417 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.46 41.19 16.96 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.131 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.53 178.0 6.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 32.7 m -98.3 131.43 26.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.828 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 23.0 Cg_exo -63.18 -25.24 72.57 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.02 2.48 . . . . 0.0 113.542 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.24 -15.65 60.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.42 -28.11 14.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.439 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -88.79 123.66 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.85 0.357 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -110.73 137.68 48.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.33 133.51 35.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 128.9 46.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.069 0.462 . . . . 0.0 111.445 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -130.56 124.73 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.49 1.96 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.024 0.93 . . . . 0.0 113.399 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.9 22.92 37.13 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.839 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -132.31 135.41 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 p -89.25 149.35 23.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 136.11 54.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.04 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.03 145.31 29.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.92 -22.19 56.19 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.206 2.604 . . . . 0.0 113.958 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m -74.02 -26.92 60.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -174.41 5.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.244 0.545 . . . . 0.0 111.848 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -114.33 157.51 22.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.257 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.0 mt -73.04 -32.17 64.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.06 -11.52 59.96 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.88 -28.77 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -84.74 -19.79 32.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.59 45.67 6.35 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.008 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.9 142.95 13.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.851 0.358 . . . . 0.0 111.505 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.0 p -124.32 155.55 68.27 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.72 146.6 54.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.616 2.211 . . . . 0.0 112.3 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.16 10.95 53.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.0 p -106.7 157.68 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.011 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -90.97 122.16 33.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.94 127.49 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.72 137.69 39.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.292 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.17 161.22 15.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.955 0.407 . . . . 0.0 111.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -138.97 134.33 32.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.281 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.407 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 65.1 mtt . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -139.08 -8.14 1.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.18 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 p -107.93 150.95 26.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 111.429 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -126.43 162.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.811 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -117.34 136.63 53.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.995 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.12 116.35 45.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.005 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 119.26 32.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.541 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -99.41 163.18 19.09 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.828 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 11.4 Cg_endo -55.76 -21.07 30.85 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.946 2.431 . . . . 0.0 113.702 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.31 -22.01 63.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.34 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.84 -18.55 49.7 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.609 -0.805 . . . . 0.0 114.093 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -84.34 173.22 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.53 0.665 . . . . 0.0 110.082 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -129.82 150.41 51.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.954 0.407 . . . . 0.0 111.488 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 149.84 41.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.797 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.76 123.28 49.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -136.36 159.95 40.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.05 139.25 34.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.712 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.9 148.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.748 0.309 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 p -139.25 157.23 71.32 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.32 -6.7 19.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.648 2.232 . . . . 0.0 112.577 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -97.48 -12.11 23.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.325 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.22 144.99 28.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 p -97.56 169.55 9.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.93 -33.04 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 110.05 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -72.43 -37.98 68.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.6 tt0 -71.18 -49.11 47.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.09 -34.96 74.19 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.349 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.17 70.79 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -70.66 -24.83 62.77 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -51.52 18.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 tp -69.33 -32.33 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.959 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.13 66.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.662 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -65.96 -33.35 75.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.874 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -80.3 -22.98 41.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.676 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 -18.22 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.682 0.277 . . . . 0.0 111.073 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.65 42.15 9.31 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.818 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -129.57 178.08 6.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.7 p -108.15 145.15 30.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.85 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.39 -23.25 44.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.896 2.398 . . . . 0.0 114.078 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -75.51 -9.03 58.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.83 -27.72 10.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.509 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -91.11 132.46 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -123.52 134.94 53.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.14 132.8 35.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.215 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.61 125.79 43.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.056 0.455 . . . . 0.0 111.247 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' HD1' ' ND2' ' A' ' 47' ' ' ASN . 1.7 t-80 -135.38 122.87 22.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.408 ' ND2' ' HD1' ' A' ' 46' ' ' HIS . 70.7 m-80 64.04 24.98 13.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.666 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.08 -14.95 62.15 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.115 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.33 148.83 23.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.897 0.379 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -96.98 154.98 16.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.8 135.84 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.43 141.15 23.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.13 -22.01 54.92 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.221 2.614 . . . . 0.0 113.503 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -75.46 -25.16 57.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.55 -174.5 4.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.343 0.592 . . . . 0.0 111.752 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -115.27 164.4 14.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.254 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.31 -30.05 63.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.01 -9.09 59.67 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.94 -31.64 27.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 0.0 110.469 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -82.17 -19.72 39.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.654 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.71 45.65 5.99 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.53 141.32 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.375 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -123.21 155.09 65.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.969 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.26 143.29 48.0 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.613 2.208 . . . . 0.0 112.112 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 98.67 11.49 47.12 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.728 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.8 m -99.44 164.98 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.408 . . . . 0.0 110.69 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 16.2 p -96.15 125.45 40.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.848 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.55 138.26 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.882 0.372 . . . . 0.0 111.22 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.13 130.34 55.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -103.55 161.48 13.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.56 147.74 36.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.786 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.3 145.58 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.372 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -102.2 128.58 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.529 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.62 149.75 36.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.61 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -128.36 135.1 49.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.643 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.33 -69.1 0.77 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.342 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.58 -139.3 3.29 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.44 -46.82 5.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.4 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.418 179.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.52 -6.74 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -113.65 149.74 34.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -130.81 159.17 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.775 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.463 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -110.24 129.25 55.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.0 109.97 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -118.87 111.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.57 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 132.5 33.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.858 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 162.98 20.98 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.992 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -0.88 9.68 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.247 1.965 . . . . 0.0 112.152 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.02 -14.68 30.93 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.37 52.2 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.231 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -107.47 147.47 30.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.099 0.476 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 p -102.59 157.21 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 149.95 51.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.522 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.21 128.29 54.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.832 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 tp -128.83 152.04 48.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 106.18 17.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.336 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.1 174.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 7.4 p -141.17 161.31 53.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.311 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 19' ' ' THR . 19.3 Cg_endo -61.55 -15.29 40.49 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.653 2.235 . . . . 0.0 112.732 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -82.5 -9.93 59.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.749 0.309 . . . . 0.0 111.256 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.98 160.59 21.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.0 p -93.76 166.43 12.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.566 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -69.9 -31.35 47.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.018 0.437 . . . . 0.0 110.213 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -68.41 -36.67 79.44 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -70.58 -47.34 60.72 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.043 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -59.77 -39.13 83.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.07 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.68 70.94 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.2 pt-20 -74.14 -24.67 59.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -74.08 -46.7 41.36 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.7 -33.34 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.563 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 37' ' ' LEU . . . -69.07 -28.12 66.23 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.788 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.56 -33.53 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -77.31 -31.48 54.71 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -97.26 -18.21 19.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.89 47.76 6.09 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.773 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.8 mt -131.69 178.6 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 42' ' ' ILE . 64.1 m -104.15 147.54 34.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.669 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.06 -23.35 53.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.991 2.461 . . . . 0.0 113.215 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.26 -15.41 60.53 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 111.59 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -96.38 -32.28 12.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.252 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.23 117.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.293 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -109.6 133.11 53.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.93 125.42 39.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 126.06 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.083 0.468 . . . . 0.0 111.365 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -134.47 117.78 16.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 65.02 25.18 12.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.687 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.4 -15.11 63.04 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.023 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.93 144.0 29.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.41 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.42 150.78 19.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.9 135.68 40.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 137.22 22.59 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -62.79 -22.41 73.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.02 2.48 . . . . 0.0 113.655 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -78.34 -27.04 46.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.9 -174.34 5.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.573 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 70.8 p -113.87 158.76 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.94 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.86 -31.79 64.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.865 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.17 -9.52 59.58 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.9 tp10 -82.73 -20.76 35.37 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.03 0.443 . . . . 0.0 110.55 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.2 -19.92 23.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.332 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.81 45.42 5.45 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.848 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.42 141.87 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 111.382 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.5 p -122.97 158.88 56.15 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.88 138.48 53.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.538 2.159 . . . . 0.0 112.014 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.02 3.44 26.37 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.632 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 p -98.86 172.26 7.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.463 HG21 ' ND2' ' A' ' 5' ' ' ASN . 11.8 p -95.84 120.44 36.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 126.07 74.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.72 128.73 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.67 161.5 13.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.041 0.448 . . . . 0.0 111.124 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -140.49 144.34 35.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.76 146.58 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.218 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -98.91 127.85 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -116.9 146.1 43.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.68 142.98 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.6 -91.59 0.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.671 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 78' ' ' LEU . . . 119.64 -116.7 3.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 16.8 mt 71.43 116.7 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.413 0.625 . . . . 0.0 111.85 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.154 -179.414 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.735 0.302 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.67 -9.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -111.15 152.13 27.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -126.37 161.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.676 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.46 129.58 56.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.78 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.42 111.95 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.741 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.98 132.13 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.668 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.4 161.42 25.33 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.16 -0.51 9.23 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.087 1.858 . . . . 0.0 112.097 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -91.61 -14.61 29.91 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.58 5.48 51.49 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.2 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -111.34 144.68 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -104.76 155.42 18.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.844 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.58 150.0 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.28 122.09 43.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -134.25 161.84 33.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.185 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -96.44 146.89 24.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 110.799 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.77 148.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -140.36 157.03 69.42 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.03 -6.51 19.11 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.727 2.285 . . . . 0.0 112.55 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.29 -11.99 22.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.73 143.69 29.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.385 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.8 p -97.33 170.38 9.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.33 -31.91 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.244 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -72.3 -39.97 67.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.64 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.8 tt0 -70.37 -47.13 62.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.798 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.68 -31.23 71.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -34.48 68.73 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.972 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -73.39 -24.88 60.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.618 0.247 . . . . 0.0 110.824 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.55 -49.68 52.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -69.43 -32.68 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.93 -28.36 66.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.887 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -70.94 -33.28 70.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -76.24 -29.2 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.92 -18.06 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.13 45.17 6.72 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.018 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.434 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 6.3 mt -132.07 178.55 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 6.1 p -105.13 147.44 34.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.644 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -67.43 -17.72 49.17 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.049 2.499 . . . . 0.0 113.627 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.17 -20.32 59.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.53 -29.49 13.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.63 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.74 121.5 43.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -114.68 135.14 54.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.39 122.16 35.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.55 54.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.395 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.66 116.3 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.306 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 64.37 24.86 13.33 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.627 0.579 . . . . 0.0 111.774 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.04 76.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.867 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.54 142.12 33.38 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -92.98 151.03 20.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.203 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -100.22 135.97 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.425 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -85.78 130.97 48.7 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.248 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.2 Cg_exo -66.13 -22.14 54.74 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.061 2.508 . . . . 0.0 113.508 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -80.32 -27.96 38.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.27 -174.56 4.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.411 0.624 . . . . 0.0 111.922 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.6 p -107.3 157.96 17.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.365 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.4 -32.3 64.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.829 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.98 -15.52 60.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.7 tt0 -82.79 -19.78 37.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.887 0.375 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.87 -19.7 24.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.387 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.34 45.44 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.986 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.13 136.79 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -123.84 155.99 66.04 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.142 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.54 145.56 52.97 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.766 2.31 . . . . 0.0 112.173 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.01 10.56 48.79 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.633 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 m -100.86 164.6 11.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.425 HG23 ' ND2' ' A' ' 5' ' ' ASN . 9.8 p -96.86 119.69 35.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.94 138.85 48.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.353 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 126.51 52.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.05 161.52 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.288 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.84 134.38 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.626 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.26 142.69 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.632 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.5 119.97 25.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -133.43 135.98 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.954 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -132.49 130.51 40.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.54 151.59 23.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.781 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 159.3 62.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.182 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.86 129.87 44.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.574 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.879 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.89 -6.28 2.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.126 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -111.75 148.88 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -129.58 154.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.425 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.8 136.08 48.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.53 113.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 123.1 32.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.461 . . . . 0.0 111.657 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.3 166.09 13.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.793 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.03 -23.3 34.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.957 2.438 . . . . 0.0 113.684 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.35 -24.53 65.72 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.438 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.4 -8.84 55.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.405 -0.902 . . . . 0.0 114.208 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -90.13 166.74 13.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.502 0.651 . . . . 0.0 110.16 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.7 p -106.61 148.23 28.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 150.17 40.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.191 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 124.96 44.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.923 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -129.58 146.06 51.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 115.19 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.76 176.76 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.0 p -136.31 165.47 35.29 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.07 -15.12 47.53 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.622 2.215 . . . . 0.0 112.651 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.75 -5.75 59.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -80.13 139.78 36.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.223 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 p -86.93 167.53 14.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 t -66.9 -34.13 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.352 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -70.91 -31.9 68.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.69 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.9 -48.93 32.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.31 -34.34 72.2 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -35.94 69.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.311 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -74.17 -24.6 59.41 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -44.74 35.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.997 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 tp -71.13 -34.26 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.405 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.31 80.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -68.76 -33.39 73.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.36 61.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.16 -17.89 24.27 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.89 34.95 11.98 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.81 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.0 178.55 6.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.703 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.4 m -98.57 146.71 32.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.924 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.28 -20.62 42.68 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.95 2.433 . . . . 0.0 113.054 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -75.08 -15.13 60.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.587 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -96.96 -37.11 10.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.69 121.72 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -115.94 137.75 51.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mt -93.47 133.29 36.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.1 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.64 128.63 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 111.412 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -128.52 126.38 40.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.364 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.46 1.94 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 113.227 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.61 22.96 41.16 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.06 -0.591 . . . . 0.0 114.046 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.0 141.33 44.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 p -89.99 149.25 22.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.42 136.04 39.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.384 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.62 127.52 56.12 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.36 -23.01 65.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.341 2.694 . . . . 0.0 113.864 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.9 m -79.05 -27.28 43.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.33 -174.0 4.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.334 0.587 . . . . 0.0 111.859 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 49.4 p -109.56 155.93 20.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.1 mt -73.22 -34.39 65.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.81 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.38 -16.04 61.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.91 -20.27 35.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -90.18 -19.52 24.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.208 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.7 45.38 4.28 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.84 137.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.76 157.13 63.83 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.43 137.96 37.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.391 2.061 . . . . 0.0 111.964 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.52 13.94 31.35 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.346 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.6 t -103.64 161.94 13.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.425 HG21 ' ND2' ' A' ' 5' ' ' ASN . 12.2 p -88.16 121.91 31.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.157 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.94 128.38 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.727 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 130.67 54.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.72 160.99 13.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.028 0.442 . . . . 0.0 111.166 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -141.13 143.25 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.559 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.01 145.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.91 148.58 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.97 155.38 17.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -101.32 144.16 30.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.523 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.71 -114.05 1.91 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.8 -93.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.468 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.97 -43.37 6.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.412 179.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.0 -13.22 1.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.968 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -108.26 154.8 21.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.412 . . . . 0.0 111.3 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.47 160.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.428 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -105.44 131.28 53.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.077 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' THR . 5.3 mm -105.37 108.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.069 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -95.14 113.22 24.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 162.64 22.53 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.319 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.31 -0.46 9.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.7 -18.34 26.61 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 5.88 52.53 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.387 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -109.06 147.32 32.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 20.4 p -114.82 144.85 42.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.79 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.59 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.498 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.86 120.78 41.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.74 155.98 48.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.51 135.98 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.07 149.0 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 111.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -137.55 156.71 74.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.308 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.09 -6.38 18.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.761 2.307 . . . . 0.0 112.694 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.64 -9.76 22.78 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.733 0.302 . . . . 0.0 111.414 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.57 138.02 32.97 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.407 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -93.87 169.75 10.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.7 t -66.98 -32.6 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.306 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -71.9 -36.05 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.7 tt0 -72.57 -49.46 32.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.17 -32.23 70.87 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -36.6 69.67 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.925 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.2 -24.87 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.289 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.18 -51.2 40.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.31 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 tp -70.58 -32.65 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.802 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.82 67.9 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.808 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -67.22 -33.41 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.939 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -85.45 -17.3 36.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.789 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.6 mt -98.12 -18.05 18.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 111.421 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.67 33.29 22.29 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.009 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -132.43 178.45 6.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.014 0.435 . . . . 0.0 110.997 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 42' ' ' ILE . 48.8 m -103.84 140.93 21.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.67 -18.45 58.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.179 2.586 . . . . 0.0 113.686 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.43 -21.67 57.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 111.719 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.03 -28.9 15.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.536 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.76 128.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.461 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -109.84 134.17 52.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.69 129.08 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.182 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 132.27 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -133.58 125.2 28.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.285 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.42 31.57 1.95 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.094 0.958 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.31 23.46 37.23 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.991 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -136.29 139.48 42.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.941 0.371 . . . . 0.0 110.805 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 p -92.51 145.65 24.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.18 135.98 41.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.42 138.11 27.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.6 Cg_exo -64.44 -22.26 65.81 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.747 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 p -78.55 -28.38 46.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.71 -175.46 5.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 112.036 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.5 p -115.74 162.4 17.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.239 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.3 -30.25 63.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.869 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.54 -8.74 59.76 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.91 -31.03 28.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.097 0.475 . . . . 0.0 110.521 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -82.08 -19.79 39.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.691 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.64 5.65 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.705 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.52 136.6 30.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.4 p -123.74 156.67 64.68 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.859 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -69.74 136.33 32.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.627 2.218 . . . . 0.0 112.136 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.11 25.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.696 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.5 p -98.06 161.53 13.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.936 0.398 . . . . 0.0 110.763 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.428 HG23 ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -93.47 123.24 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.62 146.7 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.267 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 110.3 16.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 137.45 34.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.279 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.11 131.76 42.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.55 138.57 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.579 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -116.84 122.34 44.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.849 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -136.96 148.62 47.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -121.92 132.4 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.33 144.41 4.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.77 99.74 0.47 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.683 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 tt -107.42 128.44 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.484 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.818 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 63.1 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.746 0.307 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -134.06 -2.62 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -111.05 152.08 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.208 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pt -128.48 156.94 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.148 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -99.32 154.42 18.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.296 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -136.44 114.64 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.704 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.03 122.07 39.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 111.786 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.32 163.86 19.71 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.11 -1.56 9.76 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.235 1.957 . . . . 0.0 111.895 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.87 -17.76 25.95 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.62 6.03 50.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -106.9 142.47 36.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.079 0.466 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.3 p -111.17 153.86 25.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.367 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.43 150.16 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.573 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.29 128.33 55.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -125.28 145.39 50.03 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 120.65 40.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.069 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.25 -179.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.037 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.8 p -133.84 164.98 40.13 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.81 -15.41 50.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.593 2.195 . . . . 0.0 112.584 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -86.09 -4.75 59.23 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.4 m-85 -80.75 137.34 36.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -90.18 170.26 10.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.68 -33.04 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -71.24 -34.38 70.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.924 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.7 -48.73 36.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.763 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.23 -36.13 77.01 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.906 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.76 -36.63 70.44 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.306 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.84 -25.17 61.87 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.93 -46.46 24.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.654 0.264 . . . . 0.0 111.176 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -72.01 -36.32 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.911 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.23 79.07 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.364 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -70.94 -33.41 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -26.96 61.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.452 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 mt -99.56 -18.22 17.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.62 47.66 5.29 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.15 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.28 177.93 7.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.994 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 42' ' ' ILE . 51.1 m -100.82 125.66 37.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.802 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.99 -20.21 71.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.133 2.555 . . . . 0.0 113.606 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.12 -19.96 59.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.39 -25.09 15.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.91 126.25 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.421 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -118.68 135.67 54.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.15 126.99 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.02 125.04 44.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 111.467 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -132.43 119.42 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 65.01 24.87 12.64 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.586 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -15.5 62.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.15 143.79 29.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.36 152.47 18.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 136.12 40.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.16 139.95 24.39 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.822 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.2 Cg_exo -63.7 -22.22 69.87 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.862 2.375 . . . . 0.0 113.408 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -82.26 -26.18 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.05 -174.72 5.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 111.659 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.5 p -115.25 160.73 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.868 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.14 -32.76 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.825 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.05 59.64 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.69 -19.84 37.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.073 0.463 . . . . 0.0 110.715 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -89.38 -19.57 25.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.52 4.84 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.649 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.17 142.28 27.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.01 0.433 . . . . 0.0 111.469 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -118.2 157.33 49.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.739 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.09 148.08 68.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.767 2.311 . . . . 0.0 112.495 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 100.93 6.3 52.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.695 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 p -101.01 158.37 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 110.66 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p -88.51 122.62 32.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.57 132.99 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.239 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.45 134.84 48.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -106.84 161.21 14.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.78 0.324 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -137.44 138.65 40.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.679 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mt -122.68 145.02 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.734 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.21 145.83 26.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.032 0.444 . . . . 0.0 111.073 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.98 146.85 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.822 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.63 152.58 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.858 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -102.68 -109.96 3.38 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -112.16 87.84 0.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.34 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.01 -43.77 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.711 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -133.99 -11.67 2.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -112.07 153.69 26.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.402 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' THR . 3.3 pt -120.98 160.72 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.056 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -97.71 151.87 19.69 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.181 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 13' ' ' THR . 16.4 mm -126.6 116.24 44.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.413 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.21 115.18 29.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 111.44 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.78 163.64 21.79 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.92 -2.27 11.25 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.295 1.997 . . . . 0.0 111.832 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.12 -18.22 26.23 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.42 5.53 51.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.168 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -104.23 145.07 30.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.195 0.521 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.7 p -113.73 151.51 31.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.286 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.08 145.04 45.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.354 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -108.08 123.13 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 111.479 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -124.59 153.38 42.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.05 131.8 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.748 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.28 147.55 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.985 0.421 . . . . 0.0 111.429 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -140.07 157.78 68.48 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.235 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.48 -6.28 18.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.695 2.263 . . . . 0.0 112.527 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -97.33 -14.93 20.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.349 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.8 140.64 32.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -94.17 171.05 9.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.3 -32.92 57.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -71.73 -37.45 70.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.993 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tt0 -72.23 -47.83 47.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.716 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.76 -32.4 72.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.598 0.237 . . . . 0.0 111.126 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.75 -37.87 70.49 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.677 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -69.96 -24.67 63.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.39 0.138 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.57 -53.05 25.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 110.765 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.45 -32.67 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.84 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.7 -27.82 66.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.772 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.49 -33.28 74.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -75.62 -31.35 59.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.79 -18.27 19.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.49 48.29 5.99 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.085 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.66 178.22 6.8 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.097 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 42' ' ' ILE . 37.9 m -106.25 143.89 27.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.87 -21.99 49.63 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.957 2.438 . . . . 0.0 113.305 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.26 -17.17 60.37 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 111.774 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -95.97 -30.29 13.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.367 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.37 122.54 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.437 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -110.53 129.3 55.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.27 130.1 39.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.163 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.36 127.19 49.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.01 0.433 . . . . 0.0 111.294 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -133.03 117.48 17.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 64.7 24.91 12.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.658 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.93 -13.89 66.55 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.744 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -100.18 140.79 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -91.96 151.56 20.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.128 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.47 136.04 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.301 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.8 t70 -95.38 138.02 21.97 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -63.89 -22.28 68.81 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.05 2.5 . . . . 0.0 113.444 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -80.35 -27.12 38.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.56 -174.32 4.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.539 0.685 . . . . 0.0 111.548 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.6 p -115.55 166.48 11.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.092 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.12 -30.57 63.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 -7.7 59.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.84 -22.39 34.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.062 0.458 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.34 -19.41 24.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.739 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.54 45.78 6.33 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.81 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.08 142.63 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -122.86 148.43 53.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.077 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.13 149.88 71.38 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.76 2.307 . . . . 0.0 112.572 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.51 1.76 35.06 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.631 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.0 m -107.88 159.44 16.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.846 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 p -89.1 127.0 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.77 121.08 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.853 0.358 . . . . 0.0 111.066 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.27 135.22 42.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -114.6 161.44 18.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.646 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -141.94 133.61 26.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.441 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.66 140.42 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.959 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -101.27 132.79 46.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.41 149.47 40.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.767 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -114.12 147.1 39.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.44 131.93 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.485 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.97 -112.35 0.91 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.7 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -99.53 -42.94 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.584 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.656 0.265 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -137.51 -19.35 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.98 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -109.31 153.54 23.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.76 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.34 162.12 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.556 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 129.35 56.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.926 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.83 113.13 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.664 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 135.08 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.968 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.14 162.35 20.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.728 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.25 -1.89 10.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.22 1.947 . . . . 0.0 111.696 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.01 -15.98 28.71 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.22 51.76 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -108.17 148.89 29.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -113.26 155.24 25.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.429 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.75 150.09 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.88 126.11 52.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.259 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.3 160.75 36.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.3 136.88 38.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.783 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.67 146.75 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.599 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.9 p -139.01 157.69 70.99 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.057 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.5 -6.03 18.08 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.78 2.32 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.18 -11.12 20.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.682 0.277 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.13 140.71 32.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.813 0.339 . . . . 0.0 110.363 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -94.88 171.92 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 t -68.22 -33.27 59.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.964 0.411 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.876 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.2 -47.86 54.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.14 -39.01 88.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.401 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.47 63.27 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.99 -27.16 63.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.995 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.41 -50.87 23.25 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -66.14 -32.58 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.878 0.371 . . . . 0.0 111.442 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.03 65.85 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.85 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -69.71 -33.59 72.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -76.66 -31.16 57.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.77 -18.01 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.84 5.5 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.961 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.25 178.53 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.97 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 42' ' ' ILE . 6.4 p -109.61 147.53 36.29 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.2 Cg_exo -67.84 -17.69 47.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.131 2.554 . . . . 0.0 113.605 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.22 -19.95 59.51 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.01 -28.15 13.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.585 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.25 124.97 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 111.386 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -117.75 132.29 56.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.468 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -92.03 132.21 36.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.49 125.27 44.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -135.51 123.74 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.6 t30 64.61 25.14 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.853 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.87 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.771 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -100.66 150.04 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.067 0.46 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 p -93.38 158.41 15.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.333 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.37 135.8 43.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.016 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -88.96 135.19 32.11 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.011 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.8 Cg_exo -65.08 -22.28 62.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.072 2.515 . . . . 0.0 113.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 m -80.27 -27.45 38.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.34 -174.91 5.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.365 0.602 . . . . 0.0 111.862 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.2 p -113.29 158.94 19.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.0 mt -73.39 -31.29 63.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.77 -21.33 34.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.995 0.426 . . . . 0.0 110.909 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -88.28 -19.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 45.6 5.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.708 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.36 137.91 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.976 0.417 . . . . 0.0 111.514 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -123.34 156.95 62.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.925 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.81 146.14 52.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.722 2.282 . . . . 0.0 112.395 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.78 45.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.522 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.7 p -98.98 165.94 11.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -96.53 124.89 40.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.36 136.05 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.12 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.43 126.34 51.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.709 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pp -93.6 160.86 14.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.878 0.37 . . . . 0.0 111.252 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.47 149.51 45.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.39 145.3 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.473 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -123.58 137.77 54.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -107.75 148.65 29.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -125.89 146.27 49.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.79 76.32 1.07 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.784 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 78' ' ' LEU . . . 118.39 149.41 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.312 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 15.0 mt 76.61 -54.54 0.58 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.43 0.692 . . . . 0.0 111.673 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.624 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 65.8 mtt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.756 0.312 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.89 -11.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -107.91 151.37 25.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.093 0.473 . . . . 0.0 111.424 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.47 161.97 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.632 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.4 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.09 131.77 54.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.803 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.08 113.48 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.298 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 132.96 35.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.935 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.78 161.8 22.69 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.884 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.02 -1.78 10.54 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.34 2.027 . . . . 0.0 111.812 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.25 -16.71 27.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.5 5.57 51.6 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.295 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -108.07 141.18 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.6 p -102.68 155.32 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.77 150.0 50.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.503 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.51 121.25 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.53 161.97 33.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.92 139.03 35.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.832 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.76 149.3 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.539 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 p -139.13 149.72 62.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.95 -9.57 26.34 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.635 2.223 . . . . 0.0 112.64 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -94.3 -9.34 36.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.94 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.55 145.85 26.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.4 p -96.43 169.36 9.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.53 -30.54 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.402 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.3 -39.48 68.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.022 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.63 -47.95 51.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.949 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.73 -33.37 72.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.224 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.96 69.61 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.7 pt-20 -72.26 -25.15 61.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -51.06 26.27 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.531 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 tp -67.45 -32.78 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.873 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.08 69.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -68.31 -33.48 74.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -84.87 -13.86 49.65 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -100.83 -18.09 16.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.612 0.244 . . . . 0.0 111.362 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.86 32.76 20.45 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.963 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.22 178.09 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.019 0.437 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.4 p -103.04 139.98 20.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.667 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.06 -17.04 45.82 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.015 2.476 . . . . 0.0 113.801 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.48 -21.5 58.01 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.37 -27.56 14.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.568 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 38' ' ' SER . 1.7 mt -87.52 123.4 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.432 . . . . 0.0 111.491 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.82 137.62 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.84 130.98 37.51 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.211 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.55 125.98 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -135.16 122.64 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.0 t30 62.87 26.56 15.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.793 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.8 -19.63 47.29 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.275 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -97.19 149.7 21.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -96.04 155.52 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.139 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 135.75 43.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.188 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -89.8 137.43 28.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 19.8 Cg_exo -65.1 -22.26 62.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.111 2.54 . . . . 0.0 113.388 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -77.7 -26.14 49.96 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.42 -174.88 5.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.2 p -115.25 163.89 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.356 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -73.37 -30.92 63.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.872 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.36 -7.77 59.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -82.9 -31.85 27.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.658 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -81.63 -19.89 40.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.663 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.71 5.37 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.23 141.53 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.786 0.327 . . . . 0.0 111.365 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.7 p -124.81 156.66 68.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.24 137.86 38.04 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 103.42 12.06 31.89 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.459 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t -101.71 160.1 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.4 HG23 ' ND2' ' A' ' 5' ' ' ASN . 13.9 p -87.52 124.38 33.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.181 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.02 127.63 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.983 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.25 125.44 53.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.93 161.06 14.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.332 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -139.73 144.42 37.48 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -127.0 148.46 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.477 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -122.4 120.02 32.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.749 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -134.49 151.38 51.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -129.8 137.88 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.44 140.99 3.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.801 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 142.97 142.2 3.96 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.602 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -101.29 130.79 47.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.378 . . . . 0.0 110.723 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.945 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -137.17 -1.2 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 p -110.45 151.98 26.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.513 . . . . 0.0 111.382 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.66 157.66 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -101.7 153.92 19.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.79 113.1 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.266 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.31 121.69 38.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.935 0.398 . . . . 0.0 111.553 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 163.67 19.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.58 -1.27 10.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.321 2.014 . . . . 0.0 112.032 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.44 -17.93 26.3 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.64 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.31 5.49 52.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.385 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -104.43 146.42 28.87 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 110.717 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p -109.86 156.5 20.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.567 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 150.25 46.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.292 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 125.14 50.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.283 . . . . 0.0 111.329 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.1 165.53 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.45 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.95 143.15 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.86 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.42 148.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.381 . . . . 0.0 111.641 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 p -139.43 157.38 70.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.079 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.41 -5.99 18.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.691 2.26 . . . . 0.0 112.675 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -99.69 -13.94 19.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.375 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.53 141.36 32.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.759 0.314 . . . . 0.0 110.33 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 p -94.92 171.79 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.89 -32.57 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.045 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -71.83 -39.18 69.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.113 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 5.1 tt0 -72.15 -45.04 62.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.71 -31.15 72.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 110.648 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.74 69.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.832 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -70.16 -26.19 63.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.408 0.147 . . . . 0.0 111.107 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.43 -53.35 29.81 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.94 -32.85 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.612 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.97 65.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -68.54 -33.46 74.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -77.33 -28.52 53.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.897 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.32 -18.11 18.52 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.31 47.82 5.59 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.108 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.12 178.29 6.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 111.313 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.6 t -107.2 141.99 24.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.58 -23.23 64.24 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.94 2.426 . . . . 0.0 113.495 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.4 -15.71 60.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.69 -31.87 12.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.62 124.28 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.628 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -113.0 131.7 55.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.384 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.64 124.24 34.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 127.21 52.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.708 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.87 115.84 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.379 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.04 24.96 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.06 -7.54 78.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.743 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -102.44 138.74 38.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -91.06 151.2 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.321 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 136.12 42.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.321 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -87.29 132.71 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.236 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 16.8 Cg_exo -66.0 -22.31 55.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.09 2.527 . . . . 0.0 113.543 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.1 m -78.84 -26.26 44.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.96 -174.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.435 0.636 . . . . 0.0 111.663 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.4 p -108.93 160.71 15.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.261 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.16 -32.02 64.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.661 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -9.63 59.65 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.62 -23.76 34.16 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 110.787 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.66 -19.75 23.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.631 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.27 5.53 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.862 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.34 136.71 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -123.37 155.48 65.21 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.59 155.72 62.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.88 2.387 . . . . 0.0 112.5 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.19 57.36 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.4 m -107.85 153.3 23.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 0.0 110.732 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -88.61 127.08 35.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.642 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -110.91 129.52 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 135.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.514 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -107.57 161.05 15.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.935 0.397 . . . . 0.0 111.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -140.07 135.43 32.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.351 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.82 144.2 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.667 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.83 149.27 22.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -129.98 -44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.96 148.19 37.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.1 -88.16 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.276 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.38 -98.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.331 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 mt -124.1 -43.52 2.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.903 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.694 0.283 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -141.23 -26.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 p -110.02 154.33 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -130.32 161.62 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.17 130.03 56.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.099 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.68 113.53 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.663 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.5 132.91 34.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.873 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.28 24.78 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.75 -1.08 9.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.162 1.908 . . . . 0.0 111.736 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.07 -15.33 29.68 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.43 6.02 51.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.442 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -109.6 151.82 26.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 110.878 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -112.95 146.43 39.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.708 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.03 150.08 37.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.526 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.27 123.39 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 111.071 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.39 161.09 37.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.599 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.24 134.56 40.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.644 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.49 148.5 17.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.817 0.342 . . . . 0.0 111.647 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 p -139.39 157.19 71.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.213 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.4 -6.26 18.51 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.696 2.264 . . . . 0.0 112.58 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.31 -9.72 22.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.43 142.73 29.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.4 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -95.52 171.57 8.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -68.8 -32.78 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 0.0 110.076 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -72.49 -36.62 68.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.914 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.1 tt0 -71.32 -48.12 52.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.82 -33.82 74.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.145 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.41 69.47 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.077 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.4 pt-20 -70.24 -24.93 63.16 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.02 -50.18 30.72 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.807 0.337 . . . . 0.0 110.356 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tp -70.12 -32.95 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 37' ' ' LEU . . . -67.98 -33.02 73.85 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -62.38 -33.47 74.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.817 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -87.56 -10.54 51.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.753 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.12 -18.84 19.84 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.314 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.22 -6.32 78.47 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.263 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -119.74 164.13 16.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 110.998 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 48.8 m -83.59 154.7 65.61 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.396 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 20.0 Cg_exo -65.69 -16.34 53.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.715 2.943 . . . . 0.0 113.245 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.32 -23.84 66.01 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.08 -24.58 14.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.711 0.291 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -92.07 127.18 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -123.64 140.23 53.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.025 0.44 . . . . 0.0 110.516 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.7 135.39 36.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.413 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.54 126.12 35.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.679 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -137.23 127.05 25.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 63.98 25.02 13.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.609 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 -18.76 44.1 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.868 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -96.04 149.96 21.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.775 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.6 p -96.0 156.87 16.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.16 135.15 48.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.076 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -92.37 137.99 24.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.761 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.3 Cg_exo -63.96 -22.13 68.46 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.899 2.399 . . . . 0.0 113.525 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -79.51 -27.97 41.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -83.64 -175.06 5.63 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.283 0.564 . . . . 0.0 111.951 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.8 p -116.05 163.28 16.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.119 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -73.23 -31.01 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.63 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.05 59.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.84 -24.54 33.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.973 0.416 . . . . 0.0 110.72 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.5 -20.2 26.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.498 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.98 45.29 5.73 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 141.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 111.549 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.6 t -122.5 144.49 42.33 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.569 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.6 Cg_exo -67.32 137.55 43.81 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.406 2.071 . . . . 0.0 112.097 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.96 4.65 27.61 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 t -99.4 168.54 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.445 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.5 p -93.75 122.61 36.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.12 134.75 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 128.41 55.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pp -101.12 159.42 15.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.137 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -139.73 148.71 42.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.28 143.0 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.102 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -103.59 147.56 27.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -124.51 -46.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.73 133.43 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.14 -51.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.503 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.86 -46.6 1.89 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.66 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -98.93 125.32 44.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.889 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 120.846 0.355 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -138.12 -10.95 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.779 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.8 p -107.73 149.44 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.57 156.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.44 ' ND2' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.52 127.96 54.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.509 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.33 111.02 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.726 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 125.0 35.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.82 161.57 24.53 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.118 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.82 -0.53 7.09 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.326 2.017 . . . . 0.0 111.92 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.38 -18.23 24.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.3 52.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.495 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -109.34 140.91 42.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.094 0.473 . . . . 0.0 110.874 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -108.4 151.92 25.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.035 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.72 149.89 52.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.8 122.75 48.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tp -131.88 151.52 51.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.084 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.84 120.8 41.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.98 170.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.964 0.412 . . . . 0.0 111.519 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 p -135.63 164.87 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.36 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.11 -12.5 35.74 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.875 2.383 . . . . 0.0 112.592 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -89.2 -6.1 57.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.878 0.371 . . . . 0.0 110.879 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' O ' HD13 ' A' ' 57' ' ' LEU . 1.5 m-85 -80.91 139.82 35.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -91.0 169.29 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.77 -33.86 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.035 0.445 . . . . 0.0 110.169 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -70.96 -32.71 69.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.829 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.576 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.6 tt0 -72.62 -51.23 20.47 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.709 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.88 -36.18 72.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.09 70.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.92 -24.6 61.66 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -48.01 26.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.854 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.73 -33.27 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.543 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.11 65.76 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.24 -33.37 75.6 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.85 -21.1 34.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.776 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.72 -18.17 18.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.252 . . . . 0.0 111.436 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.63 9.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.105 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.97 177.82 7.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.203 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 42' ' ' ILE . 3.2 p -106.04 126.24 31.1 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.593 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 32.5 Cg_exo -59.18 -18.05 42.29 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.393 2.729 . . . . 0.0 114.017 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.04 -14.7 60.62 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -109.12 -20.65 12.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.535 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.72 141.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -133.31 148.79 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 111.121 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.01 135.47 44.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.25 124.31 43.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -134.5 117.96 16.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.55 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 65.28 25.1 12.2 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.532 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.73 -16.47 60.14 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.824 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.26 146.77 25.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -95.26 149.43 21.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.06 135.82 44.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.01 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.79 141.79 24.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.015 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.9 -22.08 56.45 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.196 2.598 . . . . 0.0 113.548 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 m -76.12 -24.69 54.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.83 -174.63 4.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.4 0.619 . . . . 0.0 111.93 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.4 p -115.62 157.12 24.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.265 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 22' ' ' PHE . 12.8 mt -73.33 -31.6 64.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.776 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.78 -17.21 60.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.7 tt0 -82.75 -19.96 36.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -90.34 -20.06 23.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.144 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.52 45.34 5.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.614 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.35 135.53 44.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -125.64 155.65 72.02 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.631 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -69.74 139.35 40.08 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.655 2.237 . . . . 0.0 112.031 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.92 -6.13 30.9 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.436 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -94.66 165.16 12.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.557 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.44 HG23 ' ND2' ' A' ' 5' ' ' ASN . 8.2 p -91.0 125.83 35.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.41 145.33 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.41 116.9 31.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.39 140.71 39.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.43 144.19 50.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.06 136.12 58.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.628 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -98.61 132.9 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 31.2 tttm -108.47 -53.0 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 96.5 mttt 72.09 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.191 0.932 . . . . 0.0 111.878 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.78 -141.87 3.71 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 154.11 149.6 5.26 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.288 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.76 128.99 53.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.875 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.559 0.219 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.65 -18.07 1.44 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.197 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.3 p -108.95 152.34 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.036 0.446 . . . . 0.0 111.697 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.05 158.93 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -103.07 153.67 20.04 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -136.91 122.58 27.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.07 112.3 25.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 111.312 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -96.26 164.15 19.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.188 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 9.7 Cg_endo -54.35 -23.25 29.88 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.136 2.557 . . . . 0.0 113.583 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.27 -24.67 65.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.703 0.287 . . . . 0.0 110.541 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -6.17 52.88 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.441 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -94.35 167.62 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.552 0.676 . . . . 0.0 110.231 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.3 p -117.84 151.03 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.733 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.43 150.08 49.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.225 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.25 123.0 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.26 164.72 21.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.686 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -99.93 137.76 37.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.623 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.02 150.0 23.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.872 0.368 . . . . 0.0 111.547 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 p -138.73 156.87 72.73 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.344 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.98 -6.86 19.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.705 2.27 . . . . 0.0 112.564 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.23 -12.0 22.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.25 140.1 31.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.4 p -93.24 169.36 10.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.576 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -67.86 -30.35 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 110.239 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -71.56 -39.9 70.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.149 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.01 -48.72 51.49 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.27 -32.34 71.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.247 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.92 -37.27 70.08 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.8 pt-20 -71.16 -24.82 62.32 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -51.32 23.86 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-O 120.786 0.326 . . . . 0.0 110.695 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.9 -32.76 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.936 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -28.41 66.67 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -69.07 -33.36 73.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -25.97 45.78 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.9 -17.98 21.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.39 41.61 9.94 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.235 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.94 178.12 7.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' HG13 ' A' ' 42' ' ' ILE . 21.7 m -97.98 133.3 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.61 -21.19 46.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.975 2.45 . . . . 0.0 113.961 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -75.66 -14.76 60.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.65 -29.44 13.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.311 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.69 124.11 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.305 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -114.04 133.93 55.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.489 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.31 134.48 34.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.205 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.21 125.21 44.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -134.86 122.92 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.67 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 t30 63.65 25.92 14.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.803 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.04 -19.83 46.71 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.341 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.99 150.43 21.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.947 0.404 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 p -95.63 155.89 16.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.082 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.54 135.97 41.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.067 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.42 133.49 36.38 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.33 -22.21 60.38 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.051 2.501 . . . . 0.0 113.358 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 -27.97 32.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.62 -174.53 4.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.307 0.575 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 43.7 p -108.83 161.28 15.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 62' ' ' ILE . 9.3 mt -73.32 -30.06 63.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.764 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.21 -7.01 59.61 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.5 tm-20 -82.77 -26.92 31.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -83.13 -19.46 36.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.72 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 45.64 5.82 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 57' ' ' LEU . 2.1 mt -103.4 143.72 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -121.98 153.79 60.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.071 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 156.57 58.98 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.775 2.317 . . . . 0.0 112.491 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.91 2.14 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.505 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -104.12 156.1 18.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.99 0.424 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 p -88.92 125.87 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.464 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.28 138.11 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.351 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 131.93 56.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.341 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.5 161.07 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -139.24 151.77 46.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.64 137.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.212 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -98.22 131.64 44.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -133.37 -42.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -98.54 147.31 24.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.827 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.1 -73.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.287 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.05 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.457 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.72 109.73 22.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.672 0.272 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.131 -0.937 . . . . 0.0 111.674 179.421 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.669 0.271 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -136.85 -11.99 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.009 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -108.02 148.9 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.841 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -134.41 156.86 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.65 153.64 19.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.682 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -138.97 118.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.979 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 116.41 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.14 0.495 . . . . 0.0 111.115 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.28 166.85 12.57 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.844 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -54.54 -21.86 25.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.979 2.453 . . . . 0.0 113.617 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.45 -25.06 64.82 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.876 0.37 . . . . 0.0 110.377 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -8.55 55.1 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.375 -0.917 . . . . 0.0 114.386 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -92.22 163.34 13.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.533 0.666 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.1 p -115.96 156.31 26.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.33 150.15 52.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.14 122.41 46.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.77 149.13 47.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.72 117.84 33.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.746 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 179.17 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.227 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 p -135.26 165.1 39.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.266 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.2 -13.75 39.76 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 112.703 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.23 -7.3 58.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.04 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.3 m-85 -80.59 138.59 36.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.993 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -87.89 170.93 10.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.403 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.6 -32.25 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.044 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -72.11 -32.71 67.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.834 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.6 tt0 -72.25 -48.04 45.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.11 -34.61 75.22 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.786 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.72 -36.11 70.41 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -72.47 -24.91 61.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.619 0.247 . . . . 0.0 111.236 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.22 -50.34 28.25 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.831 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 tp -68.73 -33.05 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.876 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.32 66.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -70.45 -33.52 71.39 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -79.62 -26.63 41.11 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 -18.17 21.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.561 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.21 39.42 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.032 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.0 178.26 6.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.059 0.457 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.1 t -99.22 136.73 20.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.528 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.94 -17.27 51.39 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 123.164 2.576 . . . . 0.0 113.653 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.34 -21.73 58.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.668 0.27 . . . . 0.0 111.46 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.21 -28.28 16.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 38' ' ' SER . 1.2 mt -90.07 121.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.359 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -112.22 142.9 44.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.593 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.63 132.25 40.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.28 124.2 41.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 111.296 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -131.73 117.89 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.8 24.99 12.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.712 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.41 69.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.857 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.46 143.3 29.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 p -94.26 151.68 19.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.142 0.496 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.84 135.94 46.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.235 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.28 138.42 27.18 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.4 Cg_exo -63.78 -22.15 69.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.928 2.419 . . . . 0.0 113.759 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.6 p -78.83 -26.25 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -82.3 -174.59 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.334 0.587 . . . . 0.0 111.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -118.11 158.53 24.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.6 mt -73.21 -30.65 63.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.847 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.15 60.01 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.85 -27.95 30.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.427 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -83.23 -20.01 35.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.57 45.71 6.01 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.786 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -101.13 140.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.859 0.362 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -124.16 154.44 68.44 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.989 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.19 149.11 57.26 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.772 2.315 . . . . 0.0 112.339 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.46 6.59 54.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.408 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.2 t -106.45 161.6 14.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.898 0.38 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 p -93.17 121.22 34.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.34 126.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.032 0.444 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.13 143.76 32.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.669 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -117.61 161.81 19.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 111.054 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -136.26 132.2 35.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.337 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 73' ' ' LYS . 3.2 tp -106.15 149.15 9.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.768 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' N ' HG13 ' A' ' 72' ' ' ILE . 96.7 mttt -105.12 114.11 28.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.38 135.58 48.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -130.14 143.91 51.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.42 -87.97 0.74 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.628 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 154.11 80.88 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.149 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mp -103.52 131.94 50.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.049 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.948 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -136.88 -4.82 1.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.2 p -111.67 150.39 30.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -129.96 160.35 41.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.684 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.43 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.36 129.29 56.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.11 0.481 . . . . 0.0 110.13 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.96 112.28 37.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.683 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.48 133.7 33.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.93 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.76 162.8 20.42 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.977 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.06 -1.11 9.02 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.221 1.947 . . . . 0.0 111.969 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.69 -16.86 27.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.75 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.95 50.89 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.286 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -106.03 149.02 27.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.138 0.494 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -105.31 153.88 21.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.668 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.92 149.86 51.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 125.24 50.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.003 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -127.96 147.01 50.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.51 115.57 30.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.6 174.8 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 12.7 p -137.74 166.12 28.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.55 -14.6 40.58 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.791 2.328 . . . . 0.0 112.65 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -85.38 -7.6 58.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.836 0.351 . . . . 0.0 111.19 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' THR . 3.3 m-85 -81.32 141.37 34.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 p -88.43 167.39 13.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.22 -33.96 67.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.069 0.461 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -71.44 -31.99 67.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.846 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 4.5 tt0 -72.91 -45.83 55.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.61 -36.5 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.395 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.34 67.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -73.74 -26.06 60.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.78 -45.9 48.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.118 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 tp -70.2 -32.79 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.712 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.7 77.35 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.634 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -65.73 -33.35 75.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -75.46 -25.75 57.67 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.06 -18.25 22.02 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.594 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.29 -5.69 83.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.544 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -98.83 176.54 5.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.223 0.512 . . . . 0.0 110.888 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 54.0 m -89.16 151.06 46.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.318 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 12.7 Cg_exo -69.04 -16.84 40.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.392 2.728 . . . . 0.0 113.051 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.12 -14.99 62.91 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.679 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.64 -20.88 18.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.36 148.03 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.999 0.428 . . . . 0.0 111.606 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -137.76 128.18 26.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.341 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.85 121.41 31.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.43 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.08 127.52 55.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.127 0.489 . . . . 0.0 111.384 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -138.35 120.03 15.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.339 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 65.01 24.93 12.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.789 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -19.42 50.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.906 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.45 149.9 22.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -94.49 150.13 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.07 135.84 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.23 137.55 29.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.66 -22.08 64.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.013 2.475 . . . . 0.0 113.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -77.36 -27.69 52.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.65 -174.02 4.38 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.337 0.589 . . . . 0.0 111.904 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 71.7 p -113.6 157.84 21.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.376 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.32 -30.16 63.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.06 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 -7.63 59.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -83.13 -32.0 26.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.522 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.92 -19.68 34.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.776 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.03 45.64 3.82 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.011 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.58 136.16 39.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.81 0.305 . . . . 0.0 111.056 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.38 157.71 58.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 138.52 37.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.6 7.71 33.77 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -98.93 170.05 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 110.75 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.43 HG21 ' ND2' ' A' ' 5' ' ' ASN . 10.0 p -95.58 122.4 38.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.18 129.83 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.4 126.98 55.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.513 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.5 161.01 14.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.75 145.89 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -127.64 131.7 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.363 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -99.22 129.67 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.236 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -134.38 136.09 43.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -101.65 142.3 33.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.21 68.43 0.01 OUTLIER Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.628 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.34 80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.926 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -130.92 126.72 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.455 0.169 . . . . 0.0 111.065 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.25 1.105 0 O-C-N 123.872 0.733 . . . . 0.0 111.604 179.291 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -134.79 -18.55 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -110.38 151.97 26.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.74 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pt -131.18 156.12 42.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.519 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.92 112.69 36.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.73 133.93 33.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.94 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.73 162.44 21.14 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.817 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.46 -2.05 10.68 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.384 2.056 . . . . 0.0 111.801 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -91.17 -15.67 28.96 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.02 52.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.253 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -106.8 143.83 34.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 p -104.04 156.93 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.608 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.42 150.03 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.539 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.986 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 154.88 49.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.687 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.0 120.51 39.57 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.14 170.58 19.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.78 0.324 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.6 p -136.72 162.57 55.24 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.411 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.16 -14.92 44.95 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.741 2.294 . . . . 0.0 112.526 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.17 -3.64 59.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.898 0.38 . . . . 0.0 111.023 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.08 142.2 32.5 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.887 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.1 p -90.95 169.24 11.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 t -66.71 -33.55 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.94 0.4 . . . . 0.0 110.112 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.79 -34.3 69.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.803 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.21 -47.6 49.36 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.29 -35.55 77.62 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.759 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.02 69.87 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.95 -24.92 61.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.484 0.183 . . . . 0.0 111.444 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.81 -47.78 28.77 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -70.19 -32.71 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.9 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.84 -34.88 76.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.21 -33.59 75.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -88.11 -9.48 53.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.518 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.32 -18.12 20.21 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.209 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.84 82.7 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.13 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.8 164.39 16.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.47 0.635 . . . . 0.0 111.539 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -76.77 148.52 79.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.713 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.39 -16.77 53.81 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.368 2.712 . . . . 0.0 113.24 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.5 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.38 -27.04 14.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.388 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.13 128.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.77 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -121.9 141.88 50.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.31 126.51 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.59 127.08 55.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.99 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -136.83 121.23 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t30 64.39 26.5 13.56 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.68 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.47 -19.87 44.71 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.323 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -101.09 151.76 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.881 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 p -92.4 150.68 20.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.228 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.72 135.59 38.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.67 135.79 28.72 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.41 -22.16 59.88 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.019 2.479 . . . . 0.0 113.871 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.2 m -78.42 -27.84 46.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -88.89 -174.39 4.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.428 0.632 . . . . 0.0 112.041 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 42.1 p -110.05 155.85 21.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.466 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.34 -37.32 66.14 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.977 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.81 -14.42 62.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.96 -22.14 33.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.971 0.415 . . . . 0.0 110.822 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.68 -20.17 23.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.416 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.74 45.38 3.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.046 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.78 139.39 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.9 157.06 64.54 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.34 137.53 31.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.626 2.217 . . . . 0.0 112.135 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.98 14.91 29.94 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.118 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 t -99.74 169.85 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -95.21 123.21 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.694 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.75 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.33 125.6 54.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.45 161.22 14.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.63 152.8 44.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.468 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.32 136.11 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -125.66 149.34 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.16 153.69 45.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.91 132.69 44.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.79 89.92 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.653 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.6 73.62 0.03 OUTLIER Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.392 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -120.57 -43.62 2.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.203 -0.904 . . . . 0.0 110.694 179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.18 -2.42 2.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 p -110.4 149.7 29.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.019 0.438 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.73 155.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.961 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -102.57 153.69 19.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -135.94 120.77 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.02 122.49 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.13 161.78 24.31 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.168 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 -1.03 7.75 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.358 2.039 . . . . 0.0 111.744 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.46 -19.51 23.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.81 51.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.413 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -106.22 146.05 30.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.066 0.46 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -105.14 152.19 23.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 149.87 52.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -114.79 126.73 55.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.874 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.3 tp -125.82 148.48 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.775 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.41 117.77 35.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 178.08 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 16.0 p -132.38 164.57 42.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.208 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.43 -14.39 43.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.742 2.295 . . . . 0.0 112.918 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.4 -10.85 53.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -75.27 136.33 40.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.17 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.8 p -88.21 172.14 9.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.156 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.64 -33.07 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 110.13 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -70.64 -35.17 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.719 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -71.58 -48.6 47.2 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.18 -40.16 89.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.952 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -30.17 67.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -70.62 -26.22 63.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.77 -49.51 25.1 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.78 -32.89 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.853 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.07 -28.17 66.28 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.701 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -72.56 -33.37 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.39 -34.28 58.86 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.66 -18.17 21.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.23 51.07 5.89 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.116 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -130.02 178.07 6.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.126 0.489 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 42' ' ' ILE . 11.9 t -105.57 141.98 23.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.438 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.71 -17.41 58.87 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.86 2.374 . . . . 0.0 113.568 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.19 -21.51 58.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.303 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.69 -27.68 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.527 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 38' ' ' SER . 2.0 mt -87.07 134.67 27.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.957 0.408 . . . . 0.0 111.329 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -128.01 128.99 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -95.43 132.69 40.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.48 141.3 51.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.064 0.459 . . . . 0.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -145.12 106.47 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 67.17 25.22 9.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.71 74.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.943 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -102.27 139.68 37.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -93.25 145.69 24.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.54 135.89 36.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.308 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.22 138.98 22.9 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.92 -22.5 73.86 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.15 2.567 . . . . 0.0 114.019 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.2 p -81.85 -25.44 35.11 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -174.72 5.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.273 0.559 . . . . 0.0 111.752 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.9 p -117.19 161.89 18.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 22' ' ' PHE . 9.9 mt -73.0 -32.78 65.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.749 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.49 -11.56 59.96 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.61 -20.73 35.81 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.997 0.427 . . . . 0.0 110.626 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.04 -19.87 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.176 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 45.5 4.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.71 137.97 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.18 157.19 65.02 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.904 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.75 144.67 54.84 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.762 2.308 . . . . 0.0 112.071 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.79 1.03 34.37 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.587 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -107.74 159.0 16.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 p -88.58 123.93 33.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.83 148.55 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.92 135.82 48.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.064 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.35 140.12 52.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.499 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -132.6 131.65 41.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 143.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.771 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.34 143.89 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -108.5 155.46 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.575 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.08 4.87 47.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.347 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.03 151.89 21.12 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -155.05 68.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.227 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.7 mt -102.3 132.93 47.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.833 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.779 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.7 mmm . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.646 0.26 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -139.22 -14.93 1.13 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.003 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -109.72 153.12 24.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.0 111.669 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.04 162.43 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.57 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.31 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.88 112.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.184 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 122.68 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.977 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 163.29 21.19 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.999 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.78 -1.68 9.71 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.239 1.96 . . . . 0.0 112.059 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -89.86 -19.54 24.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.8 51.07 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.474 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -102.44 150.02 23.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.73 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 p -111.76 152.22 28.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.736 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.82 150.07 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.471 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.37 121.95 46.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.126 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -132.34 159.47 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.604 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.17 134.01 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.754 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.24 147.23 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 111.436 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 p -138.76 157.28 72.12 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.32 -6.09 18.25 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -98.29 -12.46 21.53 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.244 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.36 142.43 31.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.312 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 p -96.42 170.67 9.07 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.42 -33.09 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 110.267 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -72.21 -37.14 69.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.36 -47.83 46.48 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.679 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.11 -31.57 71.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.03 69.88 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.823 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -71.14 -24.91 62.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.49 0.186 . . . . 0.0 111.35 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.12 -51.0 42.93 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.76 -33.95 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.764 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.23 -28.58 66.48 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -67.1 -33.56 75.73 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.9 -16.33 38.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.704 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -100.46 -18.35 16.73 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.579 0.228 . . . . 0.0 111.48 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.18 39.72 12.44 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.011 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -131.5 178.19 6.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.225 0.536 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 42' ' ' ILE . 9.5 t -105.22 142.26 24.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.599 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.77 -18.95 59.21 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.06 2.507 . . . . 0.0 113.408 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.29 -20.34 59.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.639 0.257 . . . . 0.0 111.622 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -94.8 -30.24 14.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.7 123.04 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.652 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -115.21 138.85 50.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.443 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.94 131.07 38.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.24 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.5 125.32 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.977 0.417 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -134.17 121.98 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 62.45 26.84 15.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.669 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.64 -17.76 55.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.366 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.77 149.31 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.829 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -97.11 153.83 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.119 0.485 . . . . 0.0 111.108 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.52 136.11 42.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.214 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -90.03 138.16 27.72 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.3 Cg_exo -65.01 -22.1 62.83 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.433 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -78.51 -24.98 45.54 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.58 -175.12 5.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.267 0.556 . . . . 0.0 111.673 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.9 p -115.32 161.86 17.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.312 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.35 -29.73 62.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.12 -8.35 59.65 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.88 -31.16 28.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.088 0.471 . . . . 0.0 110.572 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -81.75 -19.95 40.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.736 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 45.61 6.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.651 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -98.19 139.53 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 0.0 111.606 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -124.28 156.56 66.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.916 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.54 146.38 55.23 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.614 2.21 . . . . 0.0 112.25 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.5 6.59 50.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.573 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -102.89 162.27 13.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.1 p -90.03 122.16 32.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.06 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.3 mm -112.57 119.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.977 0.418 . . . . 0.0 110.761 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.23 123.44 48.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.71 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -96.63 159.29 15.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.132 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.346 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.85 141.75 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.697 0.284 . . . . 0.0 110.614 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -121.93 137.54 54.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.098 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -116.09 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -129.17 135.3 48.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.68 62.58 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.706 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.89 149.53 5.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -102.03 133.17 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 110.871 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.857 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mmm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.52 -11.31 1.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.058 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -111.15 152.05 27.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.21 153.82 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.22 135.06 43.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mm -111.92 111.71 37.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.68 119.66 34.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.5 161.44 24.53 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.19 -0.88 8.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.266 1.977 . . . . 0.0 111.759 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.96 -18.78 24.11 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.48 6.13 50.92 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.335 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -107.36 145.87 32.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.863 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 17.5 p -112.68 146.22 39.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.504 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.2 150.51 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.33 121.15 41.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.685 0.278 . . . . 0.0 110.881 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.04 142.24 49.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -101.77 133.1 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.75 176.58 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.631 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 p -135.98 165.58 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.185 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.44 -12.47 30.91 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 113.018 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.44 -14.36 43.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' O ' HD11 ' A' ' 57' ' ' LEU . 3.2 m-85 -75.62 135.62 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 p -85.44 170.75 12.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.288 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.4 -33.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.059 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -72.11 -32.3 66.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.703 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.1 tt0 -72.0 -47.84 49.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.722 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.31 -36.18 79.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.703 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.0 70.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.301 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -72.26 -24.78 61.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.485 0.183 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.06 -49.67 27.35 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.877 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.83 -34.25 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.727 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.1 -27.88 65.99 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.825 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -69.35 -33.48 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -30.37 47.09 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.23 -18.15 20.26 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.47 49.3 5.88 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.073 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.61 178.24 6.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.429 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.0 t -105.33 142.03 23.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.563 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.85 -17.33 55.74 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.833 2.355 . . . . 0.0 113.377 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.33 -18.62 59.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.77 -29.78 12.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -89.48 126.23 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 0.0 111.441 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -121.89 135.29 54.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.794 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.18 133.85 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.67 129.52 47.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.294 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -130.38 125.22 34.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.399 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.94 32.39 1.83 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.95 . . . . 0.0 113.188 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.81 22.95 37.34 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.945 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -134.39 140.27 46.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.013 0.407 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -93.56 147.24 23.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.01 135.82 42.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.123 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 -91.27 138.08 25.87 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.2 Cg_exo -64.25 -22.36 66.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.1 2.533 . . . . 0.0 113.503 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.2 t -79.94 -28.11 39.73 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.42 -174.85 5.52 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 112.061 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 68.4 p -116.66 157.76 24.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.121 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 22' ' ' PHE . 10.1 mt -73.05 -31.18 64.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.08 -15.04 59.72 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.68 -20.2 36.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.053 0.454 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -89.14 -20.26 24.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.57 45.46 4.61 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -111.61 137.67 43.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.932 0.396 . . . . 0.0 111.453 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.34 158.16 62.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.576 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.27 141.02 46.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.484 2.122 . . . . 0.0 112.002 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.09 3.16 36.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -100.45 165.35 11.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -88.12 126.31 35.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.5 mm -104.52 149.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.678 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.63 115.34 25.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.124 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.37 127.34 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.99 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.07 131.04 38.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.21 144.5 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.446 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -100.04 129.57 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 110.646 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -102.29 150.86 22.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.583 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -110.48 142.95 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.785 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.36 5.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.852 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.62 -154.51 16.7 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.573 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 tt -106.99 127.94 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.72 179.79 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.577 0.227 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -142.53 -7.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -109.68 152.15 25.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.469 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -130.13 156.69 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -98.49 153.75 18.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.88 0.372 . . . . 0.0 111.333 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.06 117.15 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.524 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 119.91 38.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.407 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 163.14 23.21 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 -1.0 9.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.268 1.978 . . . . 0.0 112.236 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -89.41 -18.21 27.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 5.75 51.56 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -105.47 146.41 29.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -108.85 154.78 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.383 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.74 149.99 46.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.317 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 126.01 52.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.069 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.5 tp -120.05 148.56 43.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.93 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.97 116.37 32.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 -179.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.2 p -137.92 165.12 36.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.241 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.3 -13.05 35.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.537 2.158 . . . . 0.0 112.676 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.08 -6.49 58.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.081 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 m-85 -81.22 144.95 31.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.072 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -91.43 168.47 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -67.54 -32.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.417 . . . . 0.0 110.251 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -71.72 -34.38 69.53 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -71.59 -47.97 51.3 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.19 -36.21 77.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.841 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.26 -37.59 71.93 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.9 pt-20 -71.2 -24.95 62.32 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.45 -50.63 20.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.595 0.236 . . . . 0.0 110.836 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 tp -69.6 -35.5 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -28.24 66.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -68.03 -33.57 74.83 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.38 -18.65 33.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.68 -18.21 18.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.594 0.235 . . . . 0.0 111.417 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.46 41.19 16.96 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.131 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.53 178.0 6.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 32.7 m -98.3 131.43 26.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.828 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 23.0 Cg_exo -63.18 -25.24 72.57 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.02 2.48 . . . . 0.0 113.542 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.24 -15.65 60.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.42 -28.11 14.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.439 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -88.79 123.66 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.85 0.357 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -110.73 137.68 48.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.33 133.51 35.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 128.9 46.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.069 0.462 . . . . 0.0 111.445 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -130.56 124.73 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.49 1.96 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.024 0.93 . . . . 0.0 113.399 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.9 22.92 37.13 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.839 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -132.31 135.41 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 p -89.25 149.35 23.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 136.11 54.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.04 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.03 145.31 29.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.92 -22.19 56.19 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.206 2.604 . . . . 0.0 113.958 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m -74.02 -26.92 60.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -174.41 5.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.244 0.545 . . . . 0.0 111.848 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -114.33 157.51 22.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.257 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.0 mt -73.04 -32.17 64.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.06 -11.52 59.96 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.88 -28.77 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -84.74 -19.79 32.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.59 45.67 6.35 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.008 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.9 142.95 13.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.851 0.358 . . . . 0.0 111.505 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.0 p -124.32 155.55 68.27 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.72 146.6 54.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.616 2.211 . . . . 0.0 112.3 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.16 10.95 53.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.0 p -106.7 157.68 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.011 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -90.97 122.16 33.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.94 127.49 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.72 137.69 39.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.292 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.17 161.22 15.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.955 0.407 . . . . 0.0 111.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -138.97 134.33 32.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.281 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.92 144.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.407 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -113.3 146.17 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -115.37 147.77 40.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.777 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -129.39 152.64 48.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.7 -60.82 0.53 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.616 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.7 47.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.23 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 mt -131.9 127.66 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.697 179.911 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.57 0.224 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 p -107.93 150.95 26.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 111.429 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -126.43 162.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.811 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 136.63 53.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.995 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.67 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -126.12 116.35 45.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.005 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 119.26 32.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.541 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -99.41 163.18 19.09 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.828 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 11.4 Cg_endo -55.76 -21.07 30.85 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.946 2.431 . . . . 0.0 113.702 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.31 -22.01 63.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.34 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.84 -18.55 49.7 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.609 -0.805 . . . . 0.0 114.093 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -84.34 173.22 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.53 0.665 . . . . 0.0 110.082 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -129.82 150.41 51.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.954 0.407 . . . . 0.0 111.488 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -119.77 149.84 41.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.797 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.76 123.28 49.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -136.36 159.95 40.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.05 139.25 34.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.712 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.9 148.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.748 0.309 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 p -139.25 157.23 71.32 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.32 -6.7 19.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.648 2.232 . . . . 0.0 112.577 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -97.48 -12.11 23.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.325 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.22 144.99 28.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 p -97.56 169.55 9.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.93 -33.04 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 110.05 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -72.43 -37.98 68.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.6 tt0 -71.18 -49.11 47.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.09 -34.96 74.19 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.349 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.17 70.79 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -70.66 -24.83 62.77 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -51.52 18.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 tp -69.33 -32.33 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.959 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.13 66.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.662 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -65.96 -33.35 75.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.874 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -80.3 -22.98 41.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.676 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 -18.22 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.682 0.277 . . . . 0.0 111.073 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.65 42.15 9.31 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.818 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -129.57 178.08 6.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.7 p -108.15 145.15 30.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.85 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.39 -23.25 44.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.896 2.398 . . . . 0.0 114.078 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -75.51 -9.03 58.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.83 -27.72 10.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.509 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -91.11 132.46 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -123.52 134.94 53.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.14 132.8 35.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.215 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.61 125.79 43.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.056 0.455 . . . . 0.0 111.247 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -135.38 122.87 22.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 m120 64.04 24.98 13.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.08 -14.95 62.15 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.115 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.33 148.83 23.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.897 0.379 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -96.98 154.98 16.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.8 135.84 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -93.43 141.15 23.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.3 Cg_exo -66.13 -22.01 54.92 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.221 2.614 . . . . 0.0 113.503 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -75.46 -25.16 57.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.55 -174.5 4.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.343 0.592 . . . . 0.0 111.752 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -115.27 164.4 14.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.254 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.31 -30.05 63.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.01 -9.09 59.67 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.94 -31.64 27.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 0.0 110.469 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -82.17 -19.72 39.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.654 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.71 45.65 5.99 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.53 141.32 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.375 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -123.21 155.09 65.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.969 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.26 143.29 48.0 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.613 2.208 . . . . 0.0 112.112 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.49 47.12 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.728 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.8 m -99.44 164.98 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.408 . . . . 0.0 110.69 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -96.15 125.45 40.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.848 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.55 138.26 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.882 0.372 . . . . 0.0 111.22 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.13 130.34 55.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -103.55 161.48 13.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.56 147.74 36.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.786 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.372 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.9 0.381 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -113.65 149.74 34.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -130.81 159.17 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.775 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.24 129.25 55.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.0 109.97 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.674 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -118.87 111.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 132.5 33.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.858 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 162.98 20.98 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.992 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -0.88 9.68 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.247 1.965 . . . . 0.0 112.152 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.02 -14.68 30.93 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.37 52.2 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.231 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -107.47 147.47 30.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.099 0.476 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 p -102.59 157.21 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 149.95 51.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.522 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.21 128.29 54.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.832 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 tp -128.83 152.04 48.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 106.18 17.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.336 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.1 174.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 7.4 p -141.17 161.31 53.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.311 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 19' ' ' THR . 19.3 Cg_endo -61.55 -15.29 40.49 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.653 2.235 . . . . 0.0 112.732 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -82.5 -9.93 59.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.749 0.309 . . . . 0.0 111.256 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.98 160.59 21.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.0 p -93.76 166.43 12.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.566 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -69.9 -31.35 47.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.018 0.437 . . . . 0.0 110.213 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -68.41 -36.67 79.44 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -70.58 -47.34 60.72 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.043 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -59.77 -39.13 83.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.07 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.68 70.94 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.2 pt-20 -74.14 -24.67 59.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -74.08 -46.7 41.36 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.7 -33.34 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.563 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.07 -28.12 66.23 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.788 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.56 -33.53 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -77.31 -31.48 54.71 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -97.26 -18.21 19.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.89 47.76 6.09 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.773 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.8 mt -131.69 178.6 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 42' ' ' ILE . 64.1 m -104.15 147.54 34.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.669 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.7 Cg_exo -66.06 -23.35 53.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.991 2.461 . . . . 0.0 113.215 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.26 -15.41 60.53 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 111.59 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -96.38 -32.28 12.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.252 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.23 117.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.293 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -109.6 133.11 53.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.93 125.42 39.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 126.06 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.083 0.468 . . . . 0.0 111.365 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -134.47 117.78 16.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 65.02 25.18 12.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.687 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.4 -15.11 63.04 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.023 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.93 144.0 29.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.41 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.42 150.78 19.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.9 135.68 40.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 137.22 22.59 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -62.79 -22.41 73.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.02 2.48 . . . . 0.0 113.655 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -78.34 -27.04 46.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.9 -174.34 5.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.573 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 70.8 p -113.87 158.76 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.94 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.86 -31.79 64.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.865 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.17 -9.52 59.58 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.9 tp10 -82.73 -20.76 35.37 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.03 0.443 . . . . 0.0 110.55 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.2 -19.92 23.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.332 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.81 45.42 5.45 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.848 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.42 141.87 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 111.382 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.5 p -122.97 158.88 56.15 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.88 138.48 53.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.538 2.159 . . . . 0.0 112.014 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.02 3.44 26.37 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.632 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 p -98.86 172.26 7.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 p -95.84 120.44 36.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 126.07 74.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.72 128.73 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -97.67 161.5 13.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.041 0.448 . . . . 0.0 111.124 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -140.49 144.34 35.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.218 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.845 0.355 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -111.15 152.13 27.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -126.37 161.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.676 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.46 129.58 56.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.78 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.679 HG22 HD23 ' A' ' 70' ' ' LEU . 1.3 mp -119.42 111.95 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.741 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.98 132.13 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.668 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.4 161.42 25.33 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.16 -0.51 9.23 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.087 1.858 . . . . 0.0 112.097 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -91.61 -14.61 29.91 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.58 5.48 51.49 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.2 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -111.34 144.68 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -104.76 155.42 18.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.844 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.58 150.0 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.28 122.09 43.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -134.25 161.84 33.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.185 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -96.44 146.89 24.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 110.799 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.77 148.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -140.36 157.03 69.42 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.03 -6.51 19.11 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.727 2.285 . . . . 0.0 112.55 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.29 -11.99 22.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.73 143.69 29.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.385 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.8 p -97.33 170.38 9.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.33 -31.91 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.244 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 57.8 tttt -72.3 -39.97 67.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.878 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.8 tt0 -70.37 -47.13 62.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.798 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.68 -31.23 71.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -34.48 68.73 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.972 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -73.39 -24.88 60.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.618 0.247 . . . . 0.0 110.824 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.55 -49.68 52.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -69.43 -32.68 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.93 -28.36 66.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.887 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -70.94 -33.28 70.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -76.24 -29.2 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.92 -18.06 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.13 45.17 6.72 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.018 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 6.3 mt -132.07 178.55 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.1 p -105.13 147.44 34.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.644 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.1 Cg_exo -67.43 -17.72 49.17 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.049 2.499 . . . . 0.0 113.627 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.17 -20.32 59.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.53 -29.49 13.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.63 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.74 121.5 43.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -114.68 135.14 54.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.39 122.16 35.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.55 54.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.395 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.66 116.3 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.306 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 64.37 24.86 13.33 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.627 0.579 . . . . 0.0 111.774 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.04 76.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.867 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.54 142.12 33.38 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -92.98 151.03 20.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.203 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -100.22 135.97 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.425 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -85.78 130.97 48.7 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.248 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.2 Cg_exo -66.13 -22.14 54.74 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.061 2.508 . . . . 0.0 113.508 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -80.32 -27.96 38.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.27 -174.56 4.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.411 0.624 . . . . 0.0 111.922 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.6 p -107.3 157.96 17.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.365 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.4 -32.3 64.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.829 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.98 -15.52 60.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.7 tt0 -82.79 -19.78 37.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.887 0.375 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.87 -19.7 24.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.387 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.34 45.44 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.986 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.13 136.79 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -123.84 155.99 66.04 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.142 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.54 145.56 52.97 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.766 2.31 . . . . 0.0 112.173 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.01 10.56 48.79 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.633 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 m -100.86 164.6 11.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 p -96.86 119.69 35.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.94 138.85 48.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.353 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 126.51 52.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.05 161.52 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.288 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.84 134.38 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.626 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.632 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.718 0.294 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -111.75 148.88 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -129.58 154.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 136.08 48.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.715 HG22 HD23 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -130.53 113.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 123.1 32.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.461 . . . . 0.0 111.657 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.3 166.09 13.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.793 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.03 -23.3 34.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.957 2.438 . . . . 0.0 113.684 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.35 -24.53 65.72 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.438 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.4 -8.84 55.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.405 -0.902 . . . . 0.0 114.208 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -90.13 166.74 13.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.502 0.651 . . . . 0.0 110.16 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.7 p -106.61 148.23 28.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 150.17 40.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.191 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 124.96 44.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.923 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -129.58 146.06 51.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 115.19 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.76 176.76 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.0 p -136.31 165.47 35.29 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.07 -15.12 47.53 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.622 2.215 . . . . 0.0 112.651 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.75 -5.75 59.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -80.13 139.78 36.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.223 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 11.7 p -86.93 167.53 14.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 t -66.9 -34.13 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.352 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -70.91 -31.9 68.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.69 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.9 -48.93 32.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.31 -34.34 72.2 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -35.94 69.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.311 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -74.17 -24.6 59.41 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -44.74 35.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.997 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 tp -71.13 -34.26 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.405 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.31 80.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -68.76 -33.39 73.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.36 61.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.16 -17.89 24.27 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.89 34.95 11.98 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.81 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.0 178.55 6.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.703 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 59.4 m -98.57 146.71 32.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.924 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.1 Cg_exo -68.28 -20.62 42.68 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.95 2.433 . . . . 0.0 113.054 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -75.08 -15.13 60.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.587 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -96.96 -37.11 10.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.69 121.72 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -115.94 137.75 51.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mt -93.47 133.29 36.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.1 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.64 128.63 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 111.412 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -128.52 126.38 40.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.364 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.06 32.46 1.94 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 113.227 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.61 22.96 41.16 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.06 -0.591 . . . . 0.0 114.046 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.0 141.33 44.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 p -89.99 149.25 22.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.42 136.04 39.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.384 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -88.62 127.52 56.12 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.212 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -64.36 -23.01 65.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.341 2.694 . . . . 0.0 113.864 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.9 m -79.05 -27.28 43.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.33 -174.0 4.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.334 0.587 . . . . 0.0 111.859 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 49.4 p -109.56 155.93 20.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 22' ' ' PHE . 11.1 mt -73.22 -34.39 65.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.81 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.38 -16.04 61.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.91 -20.27 35.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -90.18 -19.52 24.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.208 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.7 45.38 4.28 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.84 137.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.76 157.13 63.83 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.43 137.96 37.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.391 2.061 . . . . 0.0 111.964 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.52 13.94 31.35 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.346 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.6 t -103.64 161.94 13.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -88.16 121.91 31.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.94 128.38 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.727 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 130.67 54.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.715 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -101.72 160.99 13.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.028 0.442 . . . . 0.0 111.166 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -141.13 143.25 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.559 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 179.639 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.575 0.226 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -108.26 154.8 21.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.412 . . . . 0.0 111.3 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.47 160.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.44 131.28 53.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.077 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 13' ' ' THR . 5.3 mm -105.37 108.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.069 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -95.14 113.22 24.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 162.64 22.53 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.319 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.31 -0.46 9.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.7 -18.34 26.61 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 5.88 52.53 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.387 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -109.06 147.32 32.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 20.4 p -114.82 144.85 42.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.79 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -122.59 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.498 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.86 120.78 41.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.74 155.98 48.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.51 135.98 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.07 149.0 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 111.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -137.55 156.71 74.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.308 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.09 -6.38 18.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.761 2.307 . . . . 0.0 112.694 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.64 -9.76 22.78 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.733 0.302 . . . . 0.0 111.414 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.57 138.02 32.97 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.407 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -93.87 169.75 10.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.7 t -66.98 -32.6 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.306 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -71.9 -36.05 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.646 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.7 tt0 -72.57 -49.46 32.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.17 -32.23 70.87 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -36.6 69.67 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.925 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.2 -24.87 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.289 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.18 -51.2 40.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.31 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 tp -70.58 -32.65 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.802 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.17 -29.82 67.9 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.808 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -67.22 -33.41 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.939 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -85.45 -17.3 36.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.789 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.6 mt -98.12 -18.05 18.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 111.421 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.67 33.29 22.29 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.009 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.3 mt -132.43 178.45 6.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.014 0.435 . . . . 0.0 110.997 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 42' ' ' ILE . 48.8 m -103.84 140.93 21.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.67 -18.45 58.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.179 2.586 . . . . 0.0 113.686 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.43 -21.67 57.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 111.719 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.03 -28.9 15.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.536 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.76 128.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.461 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -109.84 134.17 52.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.69 129.08 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.182 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 132.27 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -133.58 125.2 28.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.285 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p30 47.42 31.57 1.95 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.094 0.958 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.31 23.46 37.23 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.991 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -136.29 139.48 42.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.941 0.371 . . . . 0.0 110.805 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 p -92.51 145.65 24.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.18 135.98 41.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.42 138.11 27.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.6 Cg_exo -64.44 -22.26 65.81 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.747 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 p -78.55 -28.38 46.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.71 -175.46 5.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 112.036 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.5 p -115.74 162.4 17.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.239 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.3 -30.25 63.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.869 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.54 -8.74 59.76 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.91 -31.03 28.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.097 0.475 . . . . 0.0 110.521 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -82.08 -19.79 39.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.691 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.64 5.65 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.705 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.52 136.6 30.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.4 p -123.74 156.67 64.68 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.859 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -69.74 136.33 32.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.627 2.218 . . . . 0.0 112.136 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.11 25.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.696 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.5 p -98.06 161.53 13.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.936 0.398 . . . . 0.0 110.763 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -93.47 123.24 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.62 146.7 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.267 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 110.3 16.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 137.45 34.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.279 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.11 131.76 42.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.579 -179.662 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -111.05 152.08 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.208 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pt -128.48 156.94 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.148 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -99.32 154.42 18.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.296 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -136.44 114.64 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.704 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.03 122.07 39.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 111.786 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.32 163.86 19.71 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.11 -1.56 9.76 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.235 1.957 . . . . 0.0 111.895 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.87 -17.76 25.95 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.62 6.03 50.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -106.9 142.47 36.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.079 0.466 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.3 p -111.17 153.86 25.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.367 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.43 150.16 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.573 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.29 128.33 55.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -125.28 145.39 50.03 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 120.65 40.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.069 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.25 -179.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.037 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.8 p -133.84 164.98 40.13 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.81 -15.41 50.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.593 2.195 . . . . 0.0 112.584 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -86.09 -4.75 59.23 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.4 m-85 -80.75 137.34 36.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -90.18 170.26 10.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.68 -33.04 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -71.24 -34.38 70.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.924 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.7 -48.73 36.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.763 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.23 -36.13 77.01 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.906 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.76 -36.63 70.44 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.306 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.84 -25.17 61.87 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.93 -46.46 24.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.654 0.264 . . . . 0.0 111.176 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -72.01 -36.32 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.911 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.23 79.07 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.364 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 23.4 ttt180 -70.94 -33.41 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -26.96 61.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.452 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 mt -99.56 -18.22 17.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.62 47.66 5.29 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.15 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.28 177.93 7.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.994 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 42' ' ' ILE . 51.1 m -100.82 125.66 37.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.802 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.99 -20.21 71.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.133 2.555 . . . . 0.0 113.606 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.12 -19.96 59.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.39 -25.09 15.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.91 126.25 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.421 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -118.68 135.67 54.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.15 126.99 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.02 125.04 44.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 111.467 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -132.43 119.42 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 65.01 24.87 12.64 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.586 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -15.5 62.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.15 143.79 29.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.36 152.47 18.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 136.12 40.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.16 139.95 24.39 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.822 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.2 Cg_exo -63.7 -22.22 69.87 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.862 2.375 . . . . 0.0 113.408 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -82.26 -26.18 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.05 -174.72 5.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 111.659 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.5 p -115.25 160.73 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.868 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.14 -32.76 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.825 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.05 59.64 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.488 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.69 -19.84 37.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.073 0.463 . . . . 0.0 110.715 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -89.38 -19.57 25.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.52 4.84 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.649 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.17 142.28 27.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.01 0.433 . . . . 0.0 111.469 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -118.2 157.33 49.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.739 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.09 148.08 68.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.767 2.311 . . . . 0.0 112.495 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.93 6.3 52.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.695 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 p -101.01 158.37 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 110.66 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p -88.51 122.62 32.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.57 132.99 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.239 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.45 134.84 48.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -106.84 161.21 14.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.78 0.324 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -137.44 138.65 40.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.679 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.734 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -112.07 153.69 26.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.402 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' THR . 3.3 pt -120.98 160.72 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.056 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -97.71 151.87 19.69 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.181 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' THR . 16.4 mm -126.6 116.24 44.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.413 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.21 115.18 29.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 111.44 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.78 163.64 21.79 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.92 -2.27 11.25 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.295 1.997 . . . . 0.0 111.832 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.12 -18.22 26.23 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.42 5.53 51.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.168 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -104.23 145.07 30.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.195 0.521 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.7 p -113.73 151.51 31.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.286 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.08 145.04 45.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.354 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -108.08 123.13 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 111.479 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -124.59 153.38 42.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.05 131.8 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.748 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.28 147.55 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.985 0.421 . . . . 0.0 111.429 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -140.07 157.78 68.48 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.235 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.48 -6.28 18.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.695 2.263 . . . . 0.0 112.527 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -97.33 -14.93 20.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.349 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.8 140.64 32.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -94.17 171.05 9.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.3 -32.92 57.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -71.73 -37.45 70.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.993 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tt0 -72.23 -47.83 47.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.716 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.76 -32.4 72.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.598 0.237 . . . . 0.0 111.126 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.75 -37.87 70.49 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.677 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -69.96 -24.67 63.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.39 0.138 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.57 -53.05 25.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 110.765 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.45 -32.67 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.84 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.7 -27.82 66.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.772 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.49 -33.28 74.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -75.62 -31.35 59.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.79 -18.27 19.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.49 48.29 5.99 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.085 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.66 178.22 6.8 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.097 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 42' ' ' ILE . 37.9 m -106.25 143.89 27.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.6 Cg_exo -66.87 -21.99 49.63 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.957 2.438 . . . . 0.0 113.305 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.26 -17.17 60.37 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 111.774 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -95.97 -30.29 13.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.367 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.37 122.54 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.437 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -110.53 129.3 55.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.27 130.1 39.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.163 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.36 127.19 49.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.01 0.433 . . . . 0.0 111.294 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -133.03 117.48 17.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 64.7 24.91 12.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.658 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.93 -13.89 66.55 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.744 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -100.18 140.79 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -91.96 151.56 20.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.128 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.47 136.04 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.301 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.8 t70 -95.38 138.02 21.97 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -63.89 -22.28 68.81 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.05 2.5 . . . . 0.0 113.444 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -80.35 -27.12 38.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.56 -174.32 4.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.539 0.685 . . . . 0.0 111.548 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.6 p -115.55 166.48 11.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.092 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.12 -30.57 63.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 -7.7 59.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.84 -22.39 34.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.062 0.458 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.34 -19.41 24.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.739 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.54 45.78 6.33 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.81 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.08 142.63 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -122.86 148.43 53.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.077 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.13 149.88 71.38 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.76 2.307 . . . . 0.0 112.572 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.51 1.76 35.06 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.631 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.0 m -107.88 159.44 16.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.846 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 p -89.1 127.0 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.77 121.08 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.853 0.358 . . . . 0.0 111.066 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.27 135.22 42.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -114.6 161.44 18.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.646 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -141.94 133.61 26.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.441 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.959 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -109.31 153.54 23.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.76 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.34 162.12 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.556 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 129.35 56.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.926 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -119.83 113.13 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 135.08 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.968 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -101.14 162.35 20.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.25 -1.89 10.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.22 1.947 . . . . 0.0 111.696 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.01 -15.98 28.71 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.22 51.76 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -108.17 148.89 29.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -113.26 155.24 25.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.429 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -131.75 150.09 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.88 126.11 52.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.259 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.3 160.75 36.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.3 136.88 38.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.783 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.67 146.75 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.599 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.9 p -139.01 157.69 70.99 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.057 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.5 -6.03 18.08 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.78 2.32 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.18 -11.12 20.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.682 0.277 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.13 140.71 32.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.813 0.339 . . . . 0.0 110.363 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -94.88 171.92 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 t -68.22 -33.27 59.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.964 0.411 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.876 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.2 -47.86 54.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.14 -39.01 88.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.401 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.47 63.27 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.99 -27.16 63.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.995 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.41 -50.87 23.25 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -66.14 -32.58 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.878 0.371 . . . . 0.0 111.442 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.37 -28.03 65.85 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.85 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -69.71 -33.59 72.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -76.66 -31.16 57.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.77 -18.01 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.84 5.5 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.961 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 mt -132.25 178.53 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.4 p -109.61 147.53 36.29 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.2 Cg_exo -67.84 -17.69 47.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.131 2.554 . . . . 0.0 113.605 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.22 -19.95 59.51 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.01 -28.15 13.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.585 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.25 124.97 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 111.386 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -117.75 132.29 56.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.468 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -92.03 132.21 36.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.49 125.27 44.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -135.51 123.74 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.6 t30 64.61 25.14 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.853 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.87 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.771 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -100.66 150.04 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.067 0.46 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 p -93.38 158.41 15.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.333 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.37 135.8 43.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.016 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -88.96 135.19 32.11 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.011 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.8 Cg_exo -65.08 -22.28 62.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.072 2.515 . . . . 0.0 113.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 m -80.27 -27.45 38.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.34 -174.91 5.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.365 0.602 . . . . 0.0 111.862 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.2 p -113.29 158.94 19.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.0 mt -73.39 -31.29 63.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.77 -21.33 34.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.995 0.426 . . . . 0.0 110.909 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -88.28 -19.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 45.6 5.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.708 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.36 137.91 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.976 0.417 . . . . 0.0 111.514 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -123.34 156.95 62.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.925 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.81 146.14 52.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.722 2.282 . . . . 0.0 112.395 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.78 45.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.522 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.7 p -98.98 165.94 11.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -96.53 124.89 40.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.36 136.05 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.12 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.43 126.34 51.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.709 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -93.6 160.86 14.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.878 0.37 . . . . 0.0 111.252 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.47 149.51 45.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.473 179.66 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.771 0.319 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -107.91 151.37 25.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.093 0.473 . . . . 0.0 111.424 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.47 161.97 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.632 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.09 131.77 54.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.803 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.583 HG22 HD23 ' A' ' 70' ' ' LEU . 1.7 mp -120.08 113.48 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.298 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 132.96 35.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.935 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.78 161.8 22.69 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.884 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.02 -1.78 10.54 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.34 2.027 . . . . 0.0 111.812 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.25 -16.71 27.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.5 5.57 51.6 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.295 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -108.07 141.18 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.6 p -102.68 155.32 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -128.77 150.0 50.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.503 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.51 121.25 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.53 161.97 33.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.92 139.03 35.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.832 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.76 149.3 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.539 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 p -139.13 149.72 62.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.95 -9.57 26.34 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.635 2.223 . . . . 0.0 112.64 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -94.3 -9.34 36.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.94 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.55 145.85 26.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.4 p -96.43 169.36 9.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.53 -30.54 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.402 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.3 -39.48 68.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.022 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.63 -47.95 51.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.949 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.73 -33.37 72.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.224 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.96 69.61 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.7 pt-20 -72.26 -25.15 61.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -51.06 26.27 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.531 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 tp -67.45 -32.78 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.873 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.08 69.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -68.31 -33.48 74.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -84.87 -13.86 49.65 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -100.83 -18.09 16.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.612 0.244 . . . . 0.0 111.362 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.86 32.76 20.45 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.963 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.22 178.09 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.019 0.437 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.4 p -103.04 139.98 20.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.667 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.06 -17.04 45.82 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.015 2.476 . . . . 0.0 113.801 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.48 -21.5 58.01 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.37 -27.56 14.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.568 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 38' ' ' SER . 1.7 mt -87.52 123.4 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.432 . . . . 0.0 111.491 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.82 137.62 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.84 130.98 37.51 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.211 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.55 125.98 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -135.16 122.64 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.0 t30 62.87 26.56 15.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.793 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.8 -19.63 47.29 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.275 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -97.19 149.7 21.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -96.04 155.52 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.139 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 135.75 43.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.188 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -89.8 137.43 28.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 19.8 Cg_exo -65.1 -22.26 62.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.111 2.54 . . . . 0.0 113.388 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -77.7 -26.14 49.96 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.42 -174.88 5.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.2 p -115.25 163.89 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.356 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -73.37 -30.92 63.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.872 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.36 -7.77 59.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -82.9 -31.85 27.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.658 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -81.63 -19.89 40.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.663 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.71 5.37 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.23 141.53 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.786 0.327 . . . . 0.0 111.365 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.7 p -124.81 156.66 68.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.24 137.86 38.04 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.42 12.06 31.89 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t -101.71 160.1 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.9 p -87.52 124.38 33.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.181 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.02 127.63 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.983 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.25 125.44 53.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.583 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.93 161.06 14.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -139.73 144.42 37.48 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.477 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.743 0.306 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 p -110.45 151.98 26.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.513 . . . . 0.0 111.382 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.66 157.66 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -101.7 153.92 19.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.79 113.1 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.266 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.31 121.69 38.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.935 0.398 . . . . 0.0 111.553 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 163.67 19.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.58 -1.27 10.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.321 2.014 . . . . 0.0 112.032 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.44 -17.93 26.3 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.64 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.31 5.49 52.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.385 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -104.43 146.42 28.87 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 110.717 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p -109.86 156.5 20.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.567 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 150.25 46.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.292 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 125.14 50.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.283 . . . . 0.0 111.329 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.1 165.53 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.95 143.15 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.86 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.42 148.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.381 . . . . 0.0 111.641 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 p -139.43 157.38 70.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.079 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.41 -5.99 18.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.691 2.26 . . . . 0.0 112.675 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -99.69 -13.94 19.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.375 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.53 141.36 32.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.759 0.314 . . . . 0.0 110.33 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 p -94.92 171.79 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.89 -32.57 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.045 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -71.83 -39.18 69.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.113 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 5.1 tt0 -72.15 -45.04 62.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.71 -31.15 72.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 110.648 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.74 69.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.832 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -70.16 -26.19 63.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.408 0.147 . . . . 0.0 111.107 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.43 -53.35 29.81 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.94 -32.85 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.612 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.97 65.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -68.54 -33.46 74.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -77.33 -28.52 53.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.897 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.32 -18.11 18.52 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.31 47.82 5.59 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.108 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.12 178.29 6.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 111.313 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.6 t -107.2 141.99 24.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.58 -23.23 64.24 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.94 2.426 . . . . 0.0 113.495 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.4 -15.71 60.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.69 -31.87 12.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.62 124.28 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.628 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -113.0 131.7 55.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.384 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.64 124.24 34.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 127.21 52.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.708 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.87 115.84 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.379 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.04 24.96 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.06 -7.54 78.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.743 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -102.44 138.74 38.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -91.06 151.2 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.321 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 136.12 42.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.321 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -87.29 132.71 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.236 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 16.8 Cg_exo -66.0 -22.31 55.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.09 2.527 . . . . 0.0 113.543 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.1 m -78.84 -26.26 44.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.96 -174.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.435 0.636 . . . . 0.0 111.663 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.4 p -108.93 160.71 15.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.261 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.16 -32.02 64.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.661 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -9.63 59.65 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.62 -23.76 34.16 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 110.787 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.66 -19.75 23.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.631 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.27 5.53 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.862 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.34 136.71 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -123.37 155.48 65.21 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.59 155.72 62.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.88 2.387 . . . . 0.0 112.5 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.19 57.36 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.4 m -107.85 153.3 23.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 0.0 110.732 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -88.61 127.08 35.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.642 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -110.91 129.52 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 135.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.514 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -107.57 161.05 15.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.935 0.397 . . . . 0.0 111.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -140.07 135.43 32.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.351 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.667 -179.851 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 p -110.02 154.33 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -130.32 161.62 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.17 130.03 56.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.099 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.619 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -119.68 113.53 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.663 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.5 132.91 34.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.873 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.0 161.28 24.78 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.75 -1.08 9.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.162 1.908 . . . . 0.0 111.736 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.07 -15.33 29.68 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.43 6.02 51.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.442 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -109.6 151.82 26.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 110.878 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -112.95 146.43 39.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.708 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.1 mm? -116.03 150.08 37.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.526 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.27 123.39 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 111.071 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.39 161.09 37.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.599 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.24 134.56 40.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.644 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.49 148.5 17.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.817 0.342 . . . . 0.0 111.647 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 p -139.39 157.19 71.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.213 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.4 -6.26 18.51 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.696 2.264 . . . . 0.0 112.58 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.31 -9.72 22.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.43 142.73 29.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.4 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.7 p -95.52 171.57 8.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -68.8 -32.78 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 0.0 110.076 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -72.49 -36.62 68.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.914 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.1 tt0 -71.32 -48.12 52.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.82 -33.82 74.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.145 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.41 69.47 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.077 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.4 pt-20 -70.24 -24.93 63.16 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.02 -50.18 30.72 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.807 0.337 . . . . 0.0 110.356 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tp -70.12 -32.95 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -67.98 -33.02 73.85 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -62.38 -33.47 74.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.817 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -87.56 -10.54 51.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.753 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.12 -18.84 19.84 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.314 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.22 -6.32 78.47 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.263 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.453 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -119.74 164.13 16.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 110.998 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -83.59 154.7 65.61 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.396 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.69 -16.34 53.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.715 2.943 . . . . 0.0 113.245 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.32 -23.84 66.01 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.08 -24.58 14.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.711 0.291 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -92.07 127.18 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -123.64 140.23 53.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.025 0.44 . . . . 0.0 110.516 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.7 135.39 36.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.413 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.54 126.12 35.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.679 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -137.23 127.05 25.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 63.98 25.02 13.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.609 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 -18.76 44.1 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.868 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -96.04 149.96 21.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.775 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.6 p -96.0 156.87 16.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.16 135.15 48.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.076 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -92.37 137.99 24.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.761 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.3 Cg_exo -63.96 -22.13 68.46 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.899 2.399 . . . . 0.0 113.525 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -79.51 -27.97 41.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -83.64 -175.06 5.63 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.283 0.564 . . . . 0.0 111.951 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.8 p -116.05 163.28 16.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.119 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -73.23 -31.01 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.63 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.05 59.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.84 -24.54 33.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.973 0.416 . . . . 0.0 110.72 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.5 -20.2 26.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.498 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.98 45.29 5.73 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 141.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 111.549 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.6 t -122.5 144.49 42.33 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.569 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.6 Cg_exo -67.32 137.55 43.81 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.406 2.071 . . . . 0.0 112.097 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.96 4.65 27.61 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 t -99.4 168.54 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 122.61 36.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.12 134.75 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 128.41 55.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.619 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -101.12 159.42 15.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.137 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -139.73 148.71 42.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.102 179.556 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.834 0.35 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.8 p -107.73 149.44 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.57 156.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.52 127.96 54.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.509 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.33 111.02 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.726 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 125.0 35.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.82 161.57 24.53 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.118 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.82 -0.53 7.09 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.326 2.017 . . . . 0.0 111.92 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.38 -18.23 24.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.3 52.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.495 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -109.34 140.91 42.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.094 0.473 . . . . 0.0 110.874 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -108.4 151.92 25.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.035 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.72 149.89 52.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.8 122.75 48.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tp -131.88 151.52 51.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.084 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.84 120.8 41.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 27' ' ' LEU . 10.5 m -131.98 170.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.964 0.412 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 p -135.63 164.87 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.36 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.11 -12.5 35.74 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.875 2.383 . . . . 0.0 112.592 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -89.2 -6.1 57.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.878 0.371 . . . . 0.0 110.879 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 m-85 -80.91 139.82 35.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -91.0 169.29 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.77 -33.86 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.035 0.445 . . . . 0.0 110.169 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -70.96 -32.71 69.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.829 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.6 tt0 -72.62 -51.23 20.47 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.709 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 18' ' ' VAL . 6.4 tt -57.88 -36.18 72.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.817 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.09 70.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.92 -24.6 61.66 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -48.01 26.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.854 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.73 -33.27 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.543 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.11 65.76 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.24 -33.37 75.6 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.85 -21.1 34.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.776 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.72 -18.17 18.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.252 . . . . 0.0 111.436 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.63 9.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.105 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.97 177.82 7.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.203 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG13 ' A' ' 42' ' ' ILE . 3.2 p -106.04 126.24 31.1 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.593 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 32.5 Cg_exo -59.18 -18.05 42.29 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.393 2.729 . . . . 0.0 114.017 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.04 -14.7 60.62 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -109.12 -20.65 12.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.535 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.72 141.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -133.31 148.79 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 111.121 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.01 135.47 44.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.25 124.31 43.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -134.5 117.96 16.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.55 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 65.28 25.1 12.2 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.532 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.73 -16.47 60.14 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.824 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.26 146.77 25.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -95.26 149.43 21.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.06 135.82 44.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.01 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.79 141.79 24.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.015 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.9 -22.08 56.45 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.196 2.598 . . . . 0.0 113.548 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 m -76.12 -24.69 54.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.83 -174.63 4.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.4 0.619 . . . . 0.0 111.93 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.4 p -115.62 157.12 24.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.265 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.8 mt -73.33 -31.6 64.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.776 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.78 -17.21 60.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.431 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.7 tt0 -82.75 -19.96 36.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -90.34 -20.06 23.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.144 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.52 45.34 5.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.614 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.35 135.53 44.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -125.64 155.65 72.02 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.631 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -69.74 139.35 40.08 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.655 2.237 . . . . 0.0 112.031 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.92 -6.13 30.9 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.436 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -94.66 165.16 12.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.557 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 p -91.0 125.83 35.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.41 145.33 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.41 116.9 31.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.39 140.71 39.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.43 144.19 50.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.628 179.599 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.726 0.298 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.3 p -108.95 152.34 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.036 0.446 . . . . 0.0 111.697 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.05 158.93 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -103.07 153.67 20.04 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -136.91 122.58 27.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.07 112.3 25.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 111.312 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -96.26 164.15 19.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.188 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 9.7 Cg_endo -54.35 -23.25 29.88 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.136 2.557 . . . . 0.0 113.583 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HB2' HD12 ' A' ' 8' ' ' LEU . 2.8 m-20 -67.27 -24.67 65.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.703 0.287 . . . . 0.0 110.541 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -6.17 52.88 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.441 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -94.35 167.62 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.552 0.676 . . . . 0.0 110.231 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.3 p -117.84 151.03 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.733 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.43 150.08 49.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.225 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.25 123.0 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.26 164.72 21.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.686 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -99.93 137.76 37.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.623 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.02 150.0 23.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.872 0.368 . . . . 0.0 111.547 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 p -138.73 156.87 72.73 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.344 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.98 -6.86 19.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.705 2.27 . . . . 0.0 112.564 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.23 -12.0 22.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.25 140.1 31.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.4 p -93.24 169.36 10.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.576 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -67.86 -30.35 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 110.239 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -71.56 -39.9 70.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.149 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.01 -48.72 51.49 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.27 -32.34 71.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.247 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.92 -37.27 70.08 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.8 pt-20 -71.16 -24.82 62.32 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -51.32 23.86 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-O 120.786 0.326 . . . . 0.0 110.695 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.9 -32.76 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.936 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -28.41 66.67 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -69.07 -33.36 73.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -25.97 45.78 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.9 -17.98 21.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.39 41.61 9.94 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.235 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.94 178.12 7.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 42' ' ' ILE . 21.7 m -97.98 133.3 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.61 -21.19 46.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.975 2.45 . . . . 0.0 113.961 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -75.66 -14.76 60.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.65 -29.44 13.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.311 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.69 124.11 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.305 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -114.04 133.93 55.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.489 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.31 134.48 34.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.205 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.21 125.21 44.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -134.86 122.92 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.67 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 t30 63.65 25.92 14.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.803 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.04 -19.83 46.71 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.341 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.99 150.43 21.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.947 0.404 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 p -95.63 155.89 16.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.082 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.54 135.97 41.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.067 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.2 t70 -88.42 133.49 36.38 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.5 Cg_exo -65.33 -22.21 60.38 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.051 2.501 . . . . 0.0 113.358 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 -27.97 32.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.62 -174.53 4.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.307 0.575 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 43.7 p -108.83 161.28 15.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 9.3 mt -73.32 -30.06 63.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.764 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.21 -7.01 59.61 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.416 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.5 tm-20 -82.77 -26.92 31.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -83.13 -19.46 36.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.72 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 45.64 5.82 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 57' ' ' LEU . 2.1 mt -103.4 143.72 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -121.98 153.79 60.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.071 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 156.57 58.98 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.775 2.317 . . . . 0.0 112.491 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.91 2.14 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.505 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -104.12 156.1 18.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.99 0.424 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 p -88.92 125.87 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.464 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.28 138.11 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.351 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 131.93 56.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.341 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.5 161.07 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -139.24 151.77 46.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.212 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.655 0.264 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -108.02 148.9 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.841 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -134.41 156.86 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.65 153.64 19.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.682 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -138.97 118.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.979 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 116.41 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.14 0.495 . . . . 0.0 111.115 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -98.28 166.85 12.57 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.844 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 58.7 Cg_exo -54.54 -21.86 25.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.979 2.453 . . . . 0.0 113.617 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.45 -25.06 64.82 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.876 0.37 . . . . 0.0 110.377 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -8.55 55.1 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.375 -0.917 . . . . 0.0 114.386 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -92.22 163.34 13.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.533 0.666 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.1 p -115.96 156.31 26.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.33 150.15 52.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.14 122.41 46.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.77 149.13 47.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.72 117.84 33.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.746 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 179.17 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.227 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 15.3 p -135.26 165.1 39.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.266 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.2 -13.75 39.76 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 112.703 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.23 -7.3 58.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.04 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.3 m-85 -80.59 138.59 36.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.993 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -87.89 170.93 10.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.403 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.6 -32.25 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.044 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -72.11 -32.71 67.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.834 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.6 tt0 -72.25 -48.04 45.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.11 -34.61 75.22 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.786 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.72 -36.11 70.41 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -72.47 -24.91 61.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.619 0.247 . . . . 0.0 111.236 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.22 -50.34 28.25 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.831 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 tp -68.73 -33.05 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.876 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.32 66.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -70.45 -33.52 71.39 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -79.62 -26.63 41.11 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 -18.17 21.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.561 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.21 39.42 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.032 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.0 178.26 6.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.059 0.457 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.1 t -99.22 136.73 20.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.528 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.94 -17.27 51.39 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 123.164 2.576 . . . . 0.0 113.653 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.34 -21.73 58.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.668 0.27 . . . . 0.0 111.46 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.21 -28.28 16.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' SER . 1.2 mt -90.07 121.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.359 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -112.22 142.9 44.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.593 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.63 132.25 40.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.28 124.2 41.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 111.296 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -131.73 117.89 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.8 24.99 12.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.712 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.41 69.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.857 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.46 143.3 29.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 p -94.26 151.68 19.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.142 0.496 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.84 135.94 46.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.235 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.28 138.42 27.18 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.4 Cg_exo -63.78 -22.15 69.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.928 2.419 . . . . 0.0 113.759 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.6 p -78.83 -26.25 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -82.3 -174.59 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.334 0.587 . . . . 0.0 111.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -118.11 158.53 24.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.6 mt -73.21 -30.65 63.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.847 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.15 60.01 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.85 -27.95 30.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.427 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -83.23 -20.01 35.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.57 45.71 6.01 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.786 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -101.13 140.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.859 0.362 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -124.16 154.44 68.44 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.989 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.19 149.11 57.26 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.772 2.315 . . . . 0.0 112.339 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.46 6.59 54.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.408 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.2 t -106.45 161.6 14.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.898 0.38 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 p -93.17 121.22 34.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.34 126.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.032 0.444 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.13 143.76 32.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.669 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -117.61 161.81 19.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 111.054 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -136.26 132.2 35.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.337 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.768 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.776 0.322 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.2 p -111.67 150.39 30.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -129.96 160.35 41.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.684 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 129.29 56.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.11 0.481 . . . . 0.0 110.13 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -117.96 112.28 37.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.683 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.48 133.7 33.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.93 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -98.76 162.8 20.42 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.977 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.06 -1.11 9.02 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.221 1.947 . . . . 0.0 111.969 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.69 -16.86 27.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.75 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.95 50.89 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.286 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -106.03 149.02 27.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.138 0.494 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -105.31 153.88 21.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.668 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.92 149.86 51.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 125.24 50.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.003 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -127.96 147.01 50.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.51 115.57 30.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.6 174.8 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 12.7 p -137.74 166.12 28.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.55 -14.6 40.58 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.791 2.328 . . . . 0.0 112.65 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -85.38 -7.6 58.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.836 0.351 . . . . 0.0 111.19 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 19' ' ' THR . 3.3 m-85 -81.32 141.37 34.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 p -88.43 167.39 13.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.22 -33.96 67.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.069 0.461 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -71.44 -31.99 67.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.846 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 4.5 tt0 -72.91 -45.83 55.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.61 -36.5 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.395 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.34 67.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -73.74 -26.06 60.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.78 -45.9 48.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.118 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 tp -70.2 -32.79 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.712 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.7 77.35 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.634 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -65.73 -33.35 75.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -75.46 -25.75 57.67 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.06 -18.25 22.02 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.594 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.29 -5.69 83.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.544 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.83 176.54 5.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.223 0.512 . . . . 0.0 110.888 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 54.0 m -89.16 151.06 46.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.318 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 12.7 Cg_exo -69.04 -16.84 40.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.392 2.728 . . . . 0.0 113.051 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.12 -14.99 62.91 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.679 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.64 -20.88 18.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.36 148.03 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.999 0.428 . . . . 0.0 111.606 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -137.76 128.18 26.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.341 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.85 121.41 31.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.43 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.08 127.52 55.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.127 0.489 . . . . 0.0 111.384 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -138.35 120.03 15.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.339 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 65.01 24.93 12.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.789 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -19.42 50.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.906 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.45 149.9 22.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -94.49 150.13 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.07 135.84 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.23 137.55 29.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.66 -22.08 64.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.013 2.475 . . . . 0.0 113.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -77.36 -27.69 52.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.65 -174.02 4.38 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.337 0.589 . . . . 0.0 111.904 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 71.7 p -113.6 157.84 21.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.376 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.32 -30.16 63.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.06 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 -7.63 59.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -83.13 -32.0 26.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.522 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.92 -19.68 34.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.776 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.03 45.64 3.82 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.011 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.58 136.16 39.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.81 0.305 . . . . 0.0 111.056 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.38 157.71 58.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 138.52 37.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.6 7.71 33.77 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -98.93 170.05 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 110.75 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 p -95.58 122.4 38.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.18 129.83 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.4 126.98 55.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.513 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.575 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.5 161.01 14.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.75 145.89 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.363 179.533 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -110.38 151.97 26.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.74 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pt -131.18 156.12 42.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.519 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.598 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -120.92 112.69 36.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.73 133.93 33.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.94 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.73 162.44 21.14 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.817 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.46 -2.05 10.68 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.384 2.056 . . . . 0.0 111.801 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -91.17 -15.67 28.96 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.02 52.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.253 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -106.8 143.83 34.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 p -104.04 156.93 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.608 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.42 150.03 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.539 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.986 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 154.88 49.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.687 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.0 120.51 39.57 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.14 170.58 19.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.78 0.324 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 18.6 p -136.72 162.57 55.24 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.411 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.16 -14.92 44.95 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.741 2.294 . . . . 0.0 112.526 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.17 -3.64 59.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.898 0.38 . . . . 0.0 111.023 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.08 142.2 32.5 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.887 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.1 p -90.95 169.24 11.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 t -66.71 -33.55 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.94 0.4 . . . . 0.0 110.112 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.79 -34.3 69.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.803 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.21 -47.6 49.36 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.29 -35.55 77.62 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.759 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.02 69.87 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.95 -24.92 61.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.484 0.183 . . . . 0.0 111.444 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.81 -47.78 28.77 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -70.19 -32.71 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.9 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.84 -34.88 76.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.21 -33.59 75.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -88.11 -9.48 53.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.518 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.32 -18.12 20.21 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.209 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.84 82.7 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.13 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -120.8 164.39 16.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.47 0.635 . . . . 0.0 111.539 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -76.77 148.52 79.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.713 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.39 -16.77 53.81 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.368 2.712 . . . . 0.0 113.24 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.5 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.38 -27.04 14.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.388 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.13 128.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.77 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -121.9 141.88 50.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.31 126.51 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.59 127.08 55.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.99 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -136.83 121.23 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t30 64.39 26.5 13.56 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.68 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.47 -19.87 44.71 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.323 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -101.09 151.76 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.881 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 p -92.4 150.68 20.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.228 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.72 135.59 38.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.67 135.79 28.72 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.41 -22.16 59.88 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.019 2.479 . . . . 0.0 113.871 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.2 m -78.42 -27.84 46.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -88.89 -174.39 4.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.428 0.632 . . . . 0.0 112.041 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 42.1 p -110.05 155.85 21.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.466 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.34 -37.32 66.14 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.977 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.81 -14.42 62.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.96 -22.14 33.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.971 0.415 . . . . 0.0 110.822 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.68 -20.17 23.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.416 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.74 45.38 3.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.046 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.78 139.39 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.9 157.06 64.54 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.34 137.53 31.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.626 2.217 . . . . 0.0 112.135 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.98 14.91 29.94 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.118 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 t -99.74 169.85 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -95.21 123.21 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.694 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.75 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.33 125.6 54.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.45 161.22 14.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.63 152.8 44.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.468 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 -179.743 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.717 0.294 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 p -110.4 149.7 29.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.019 0.438 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.73 155.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.961 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -102.57 153.69 19.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -135.94 120.77 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.02 122.49 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.13 161.78 24.31 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.168 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 -1.03 7.75 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.358 2.039 . . . . 0.0 111.744 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.46 -19.51 23.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.81 51.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.413 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -106.22 146.05 30.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.066 0.46 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -105.14 152.19 23.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 149.87 52.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -114.79 126.73 55.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.874 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.3 tp -125.82 148.48 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.775 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.41 117.77 35.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 178.08 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 16.0 p -132.38 164.57 42.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.208 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.43 -14.39 43.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.742 2.295 . . . . 0.0 112.918 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.4 -10.85 53.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -75.27 136.33 40.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.17 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.8 p -88.21 172.14 9.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.156 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.64 -33.07 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 110.13 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -70.64 -35.17 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.719 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -71.58 -48.6 47.2 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.18 -40.16 89.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.952 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -30.17 67.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -70.62 -26.22 63.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.77 -49.51 25.1 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.78 -32.89 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.853 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.07 -28.17 66.28 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.701 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -72.56 -33.37 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.39 -34.28 58.86 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.66 -18.17 21.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.23 51.07 5.89 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.116 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -130.02 178.07 6.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.126 0.489 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 42' ' ' ILE . 11.9 t -105.57 141.98 23.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.438 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 22.9 Cg_exo -62.71 -17.41 58.87 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.86 2.374 . . . . 0.0 113.568 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.19 -21.51 58.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.303 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.69 -27.68 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.527 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' SER . 2.0 mt -87.07 134.67 27.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.957 0.408 . . . . 0.0 111.329 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -128.01 128.99 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -95.43 132.69 40.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.48 141.3 51.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.064 0.459 . . . . 0.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -145.12 106.47 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 67.17 25.22 9.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.71 74.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.943 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -102.27 139.68 37.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -93.25 145.69 24.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.54 135.89 36.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.308 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.22 138.98 22.9 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.92 -22.5 73.86 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.15 2.567 . . . . 0.0 114.019 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.2 p -81.85 -25.44 35.11 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -174.72 5.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.273 0.559 . . . . 0.0 111.752 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.9 p -117.19 161.89 18.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 9.9 mt -73.0 -32.78 65.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.749 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.49 -11.56 59.96 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.61 -20.73 35.81 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.997 0.427 . . . . 0.0 110.626 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.04 -19.87 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.176 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 45.5 4.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.71 137.97 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.18 157.19 65.02 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.904 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.75 144.67 54.84 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.762 2.308 . . . . 0.0 112.071 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.79 1.03 34.37 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.587 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -107.74 159.0 16.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 p -88.58 123.93 33.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.83 148.55 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.92 135.82 48.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.064 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.35 140.12 52.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.499 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -132.6 131.65 41.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.771 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -109.72 153.12 24.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.0 111.669 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.04 162.43 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.57 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.31 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.88 112.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.184 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 122.68 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.977 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 163.29 21.19 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.999 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.78 -1.68 9.71 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.239 1.96 . . . . 0.0 112.059 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -89.86 -19.54 24.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.8 51.07 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.474 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -102.44 150.02 23.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.73 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 p -111.76 152.22 28.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.736 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.82 150.07 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.471 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.37 121.95 46.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.126 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -132.34 159.47 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.604 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.17 134.01 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.754 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.24 147.23 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 111.436 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 p -138.76 157.28 72.12 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.32 -6.09 18.25 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -98.29 -12.46 21.53 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.244 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.36 142.43 31.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.312 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 p -96.42 170.67 9.07 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.42 -33.09 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 110.267 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -72.21 -37.14 69.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.36 -47.83 46.48 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.679 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.11 -31.57 71.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.03 69.88 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.823 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -71.14 -24.91 62.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.49 0.186 . . . . 0.0 111.35 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.12 -51.0 42.93 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.76 -33.95 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.764 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.23 -28.58 66.48 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -67.1 -33.56 75.73 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.9 -16.33 38.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.704 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -100.46 -18.35 16.73 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.579 0.228 . . . . 0.0 111.48 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.18 39.72 12.44 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.011 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -131.5 178.19 6.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.225 0.536 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 9.5 t -105.22 142.26 24.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.599 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.77 -18.95 59.21 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.06 2.507 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.29 -20.34 59.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.639 0.257 . . . . 0.0 111.622 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -94.8 -30.24 14.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.7 123.04 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.652 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -115.21 138.85 50.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.443 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.94 131.07 38.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.24 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.5 125.32 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.977 0.417 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -134.17 121.98 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 62.45 26.84 15.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.669 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.64 -17.76 55.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.366 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.77 149.31 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.829 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -97.11 153.83 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.119 0.485 . . . . 0.0 111.108 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.52 136.11 42.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.214 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -90.03 138.16 27.72 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.3 Cg_exo -65.01 -22.1 62.83 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.433 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -78.51 -24.98 45.54 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.58 -175.12 5.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.267 0.556 . . . . 0.0 111.673 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.9 p -115.32 161.86 17.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.312 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.35 -29.73 62.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.12 -8.35 59.65 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.88 -31.16 28.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.088 0.471 . . . . 0.0 110.572 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -81.75 -19.95 40.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.736 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 45.61 6.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.651 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -98.19 139.53 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 0.0 111.606 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -124.28 156.56 66.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.916 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.54 146.38 55.23 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.614 2.21 . . . . 0.0 112.25 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.5 6.59 50.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.573 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -102.89 162.27 13.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.1 p -90.03 122.16 32.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.06 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.3 mm -112.57 119.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.977 0.418 . . . . 0.0 110.761 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.23 123.44 48.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.71 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -96.63 159.29 15.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.132 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.346 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.697 0.284 . . . . 0.0 110.614 -179.703 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.734 0.302 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -111.15 152.05 27.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.21 153.82 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.22 135.06 43.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mm -111.92 111.71 37.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.68 119.66 34.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.5 161.44 24.53 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.19 -0.88 8.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.266 1.977 . . . . 0.0 111.759 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.96 -18.78 24.11 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.48 6.13 50.92 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.335 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -107.36 145.87 32.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.863 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 17.5 p -112.68 146.22 39.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.504 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.2 150.51 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.33 121.15 41.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.685 0.278 . . . . 0.0 110.881 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.04 142.24 49.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -101.77 133.1 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.75 176.58 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.631 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 p -135.98 165.58 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.185 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.44 -12.47 30.91 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 113.018 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.44 -14.36 43.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.41 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 m-85 -75.62 135.62 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 p -85.44 170.75 12.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.288 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.4 -33.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.059 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -72.11 -32.3 66.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.703 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.1 tt0 -72.0 -47.84 49.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.722 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.31 -36.18 79.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.703 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.0 70.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.301 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -72.26 -24.78 61.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.485 0.183 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.06 -49.67 27.35 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.877 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.83 -34.25 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.727 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.1 -27.88 65.99 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.825 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -69.35 -33.48 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -30.37 47.09 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.23 -18.15 20.26 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.47 49.3 5.88 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.073 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.61 178.24 6.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.429 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.0 t -105.33 142.03 23.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.563 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.85 -17.33 55.74 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.833 2.355 . . . . 0.0 113.377 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.33 -18.62 59.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.77 -29.78 12.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -89.48 126.23 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 0.0 111.441 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -121.89 135.29 54.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.794 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.18 133.85 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.67 129.52 47.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.294 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -130.38 125.22 34.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.399 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p30 46.94 32.39 1.83 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.95 . . . . 0.0 113.188 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.81 22.95 37.34 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.945 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -134.39 140.27 46.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.013 0.407 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -93.56 147.24 23.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.01 135.82 42.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.123 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.27 138.08 25.87 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.25 -22.36 66.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.1 2.533 . . . . 0.0 113.503 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.2 t -79.94 -28.11 39.73 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.42 -174.85 5.52 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 112.061 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 68.4 p -116.66 157.76 24.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.121 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 10.1 mt -73.05 -31.18 64.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.08 -15.04 59.72 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.68 -20.2 36.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.053 0.454 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -89.14 -20.26 24.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.57 45.46 4.61 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -111.61 137.67 43.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.932 0.396 . . . . 0.0 111.453 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.34 158.16 62.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.576 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.27 141.02 46.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.484 2.122 . . . . 0.0 112.002 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.09 3.16 36.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -100.45 165.35 11.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -88.12 126.31 35.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.5 mm -104.52 149.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.678 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.63 115.34 25.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.124 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.37 127.34 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.99 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.07 131.04 38.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.446 -179.674 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -109.68 152.15 25.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.469 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -130.13 156.69 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -98.49 153.75 18.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.88 0.372 . . . . 0.0 111.333 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.06 117.15 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.524 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 119.91 38.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.407 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 163.14 23.21 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 -1.0 9.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.268 1.978 . . . . 0.0 112.236 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -89.41 -18.21 27.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 5.75 51.56 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -105.47 146.41 29.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -108.85 154.78 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.383 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.74 149.99 46.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.317 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 126.01 52.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.069 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.5 tp -120.05 148.56 43.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.93 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.97 116.37 32.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 -179.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.2 p -137.92 165.12 36.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.241 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.3 -13.05 35.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.537 2.158 . . . . 0.0 112.676 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.08 -6.49 58.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.081 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 m-85 -81.22 144.95 31.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.072 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -91.43 168.47 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -67.54 -32.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.417 . . . . 0.0 110.251 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -71.72 -34.38 69.53 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -71.59 -47.97 51.3 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.19 -36.21 77.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.841 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.26 -37.59 71.93 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.9 pt-20 -71.2 -24.95 62.32 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.45 -50.63 20.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.595 0.236 . . . . 0.0 110.836 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 tp -69.6 -35.5 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -28.24 66.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -68.03 -33.57 74.83 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.38 -18.65 33.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.68 -18.21 18.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.594 0.235 . . . . 0.0 111.417 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.46 41.19 16.96 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.131 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.53 178.0 6.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.487 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 32.7 m -98.3 131.43 26.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.828 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 23.0 Cg_exo -63.18 -25.24 72.57 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.02 2.48 . . . . 0.0 113.542 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.24 -15.65 60.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.42 -28.11 14.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.439 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -88.79 123.66 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.85 0.357 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -110.73 137.68 48.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.33 133.51 35.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 128.9 46.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.069 0.462 . . . . 0.0 111.445 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -130.56 124.73 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.06 32.49 1.96 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.024 0.93 . . . . 0.0 113.399 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.9 22.92 37.13 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.839 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -132.31 135.41 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 p -89.25 149.35 23.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 136.11 54.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.04 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -95.03 145.31 29.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.725 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.92 -22.19 56.19 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.206 2.604 . . . . 0.0 113.958 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m -74.02 -26.92 60.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -174.41 5.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.244 0.545 . . . . 0.0 111.848 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -114.33 157.51 22.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.257 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.0 mt -73.04 -32.17 64.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.06 -11.52 59.96 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.88 -28.77 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -84.74 -19.79 32.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.59 45.67 6.35 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.008 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.9 142.95 13.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.851 0.358 . . . . 0.0 111.505 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.0 p -124.32 155.55 68.27 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.72 146.6 54.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.616 2.211 . . . . 0.0 112.3 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.16 10.95 53.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.0 p -106.7 157.68 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.011 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -90.97 122.16 33.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.94 127.49 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.72 137.69 39.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.292 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.17 161.22 15.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.955 0.407 . . . . 0.0 111.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -138.97 134.33 32.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.281 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.407 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 65.1 mtt . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -139.08 -8.14 1.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.18 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 p -107.93 150.95 26.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 111.429 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -126.43 162.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.811 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.34 136.63 53.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.995 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.67 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -126.12 116.35 45.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.005 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 119.26 32.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.541 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -99.41 163.18 19.09 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.828 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 11.4 Cg_endo -55.76 -21.07 30.85 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.946 2.431 . . . . 0.0 113.702 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.31 -22.01 63.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.34 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.84 -18.55 49.7 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.609 -0.805 . . . . 0.0 114.093 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -84.34 173.22 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.53 0.665 . . . . 0.0 110.082 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -129.82 150.41 51.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.954 0.407 . . . . 0.0 111.488 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -119.77 149.84 41.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.797 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.76 123.28 49.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -136.36 159.95 40.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.05 139.25 34.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.712 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.9 148.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.748 0.309 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 p -139.25 157.23 71.32 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.32 -6.7 19.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.648 2.232 . . . . 0.0 112.577 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -97.48 -12.11 23.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.325 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.22 144.99 28.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 p -97.56 169.55 9.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.93 -33.04 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 110.05 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -72.43 -37.98 68.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.6 tt0 -71.18 -49.11 47.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.09 -34.96 74.19 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.349 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.17 70.79 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -70.66 -24.83 62.77 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -51.52 18.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 tp -69.33 -32.33 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.959 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.13 66.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.662 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -65.96 -33.35 75.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.874 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -80.3 -22.98 41.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.676 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 -18.22 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.682 0.277 . . . . 0.0 111.073 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.65 42.15 9.31 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.818 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -129.57 178.08 6.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.7 p -108.15 145.15 30.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.85 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.39 -23.25 44.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.896 2.398 . . . . 0.0 114.078 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -75.51 -9.03 58.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.83 -27.72 10.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.509 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -91.11 132.46 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -123.52 134.94 53.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.14 132.8 35.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.215 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.61 125.79 43.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.056 0.455 . . . . 0.0 111.247 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -135.38 122.87 22.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 m120 64.04 24.98 13.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.08 -14.95 62.15 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.115 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.33 148.83 23.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.897 0.379 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -96.98 154.98 16.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.8 135.84 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -93.43 141.15 23.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.3 Cg_exo -66.13 -22.01 54.92 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.221 2.614 . . . . 0.0 113.503 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -75.46 -25.16 57.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.55 -174.5 4.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.343 0.592 . . . . 0.0 111.752 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -115.27 164.4 14.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.254 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.31 -30.05 63.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.01 -9.09 59.67 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.94 -31.64 27.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 0.0 110.469 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -82.17 -19.72 39.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.654 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.71 45.65 5.99 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.53 141.32 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.375 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -123.21 155.09 65.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.969 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.26 143.29 48.0 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.613 2.208 . . . . 0.0 112.112 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 98.67 11.49 47.12 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.728 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.8 m -99.44 164.98 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.408 . . . . 0.0 110.69 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -96.15 125.45 40.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.848 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.55 138.26 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.882 0.372 . . . . 0.0 111.22 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.13 130.34 55.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -103.55 161.48 13.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.56 147.74 36.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.786 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.3 145.58 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.372 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -102.2 128.58 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.529 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.62 149.75 36.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.61 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -128.36 135.1 49.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.643 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.33 -69.1 0.77 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.342 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.58 -139.3 3.29 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 78' ' ' LEU . 3.3 mm? -98.44 -46.82 5.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.4 . . . . 0.0 110.52 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.418 179.72 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.52 -6.74 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -113.65 149.74 34.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -130.81 159.17 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.775 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.24 129.25 55.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.0 109.97 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.674 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -118.87 111.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 132.5 33.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.858 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 162.98 20.98 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.992 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -0.88 9.68 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.247 1.965 . . . . 0.0 112.152 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.02 -14.68 30.93 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.37 52.2 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.231 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -107.47 147.47 30.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.099 0.476 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 p -102.59 157.21 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 149.95 51.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.522 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.21 128.29 54.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.832 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 tp -128.83 152.04 48.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 106.18 17.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.336 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.1 174.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 7.4 p -141.17 161.31 53.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.311 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 19' ' ' THR . 19.3 Cg_endo -61.55 -15.29 40.49 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.653 2.235 . . . . 0.0 112.732 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -82.5 -9.93 59.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.749 0.309 . . . . 0.0 111.256 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.98 160.59 21.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.0 p -93.76 166.43 12.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.566 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -69.9 -31.35 47.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.018 0.437 . . . . 0.0 110.213 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -68.41 -36.67 79.44 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -70.58 -47.34 60.72 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.043 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -59.77 -39.13 83.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.07 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.68 70.94 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.2 pt-20 -74.14 -24.67 59.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -74.08 -46.7 41.36 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.7 -33.34 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.563 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.07 -28.12 66.23 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.788 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.56 -33.53 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -77.31 -31.48 54.71 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -97.26 -18.21 19.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.89 47.76 6.09 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.773 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.8 mt -131.69 178.6 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 42' ' ' ILE . 64.1 m -104.15 147.54 34.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.669 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.7 Cg_exo -66.06 -23.35 53.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.991 2.461 . . . . 0.0 113.215 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.26 -15.41 60.53 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 111.59 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -96.38 -32.28 12.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.252 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.23 117.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.293 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -109.6 133.11 53.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.93 125.42 39.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 126.06 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.083 0.468 . . . . 0.0 111.365 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -134.47 117.78 16.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 65.02 25.18 12.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.687 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.4 -15.11 63.04 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.023 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.93 144.0 29.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.41 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.42 150.78 19.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.9 135.68 40.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 137.22 22.59 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -62.79 -22.41 73.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.02 2.48 . . . . 0.0 113.655 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -78.34 -27.04 46.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.9 -174.34 5.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.573 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 70.8 p -113.87 158.76 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.94 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.86 -31.79 64.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.865 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.17 -9.52 59.58 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.9 tp10 -82.73 -20.76 35.37 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.03 0.443 . . . . 0.0 110.55 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.2 -19.92 23.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.332 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.81 45.42 5.45 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.848 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.42 141.87 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 111.382 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.5 p -122.97 158.88 56.15 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.88 138.48 53.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.538 2.159 . . . . 0.0 112.014 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.02 3.44 26.37 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.632 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 p -98.86 172.26 7.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 p -95.84 120.44 36.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 126.07 74.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.72 128.73 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -97.67 161.5 13.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.041 0.448 . . . . 0.0 111.124 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -140.49 144.34 35.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.76 146.58 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.218 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -98.91 127.85 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -116.9 146.1 43.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.68 142.98 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.6 -91.59 0.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.671 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 78' ' ' LEU . . . 119.64 -116.7 3.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 16.8 mt 71.43 116.7 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.413 0.625 . . . . 0.0 111.85 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.154 -179.414 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.735 0.302 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.67 -9.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -111.15 152.13 27.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -126.37 161.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.676 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.46 129.58 56.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.78 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.679 HG22 HD23 ' A' ' 70' ' ' LEU . 1.3 mp -119.42 111.95 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.741 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.98 132.13 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.668 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.4 161.42 25.33 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.16 -0.51 9.23 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.087 1.858 . . . . 0.0 112.097 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -91.61 -14.61 29.91 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.58 5.48 51.49 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.2 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -111.34 144.68 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -104.76 155.42 18.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.844 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.58 150.0 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.28 122.09 43.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -134.25 161.84 33.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.185 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -96.44 146.89 24.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 110.799 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.77 148.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -140.36 157.03 69.42 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.03 -6.51 19.11 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.727 2.285 . . . . 0.0 112.55 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.29 -11.99 22.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.73 143.69 29.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.385 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.8 p -97.33 170.38 9.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.33 -31.91 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.244 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 57.8 tttt -72.3 -39.97 67.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.878 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.8 tt0 -70.37 -47.13 62.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.798 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.68 -31.23 71.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -34.48 68.73 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.972 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -73.39 -24.88 60.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.618 0.247 . . . . 0.0 110.824 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.55 -49.68 52.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -69.43 -32.68 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.93 -28.36 66.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.887 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -70.94 -33.28 70.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -76.24 -29.2 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.92 -18.06 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.13 45.17 6.72 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.018 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 6.3 mt -132.07 178.55 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.1 p -105.13 147.44 34.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.644 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.1 Cg_exo -67.43 -17.72 49.17 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.049 2.499 . . . . 0.0 113.627 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.17 -20.32 59.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.53 -29.49 13.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.63 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.74 121.5 43.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -114.68 135.14 54.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.39 122.16 35.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.55 54.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.395 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.66 116.3 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.306 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 64.37 24.86 13.33 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.627 0.579 . . . . 0.0 111.774 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.04 76.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.867 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.54 142.12 33.38 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -92.98 151.03 20.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.203 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -100.22 135.97 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.425 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -85.78 130.97 48.7 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.248 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.2 Cg_exo -66.13 -22.14 54.74 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.061 2.508 . . . . 0.0 113.508 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -80.32 -27.96 38.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.27 -174.56 4.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.411 0.624 . . . . 0.0 111.922 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.6 p -107.3 157.96 17.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.365 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.4 -32.3 64.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.829 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.98 -15.52 60.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.7 tt0 -82.79 -19.78 37.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.887 0.375 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.87 -19.7 24.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.387 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.34 45.44 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.986 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.13 136.79 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -123.84 155.99 66.04 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.142 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.54 145.56 52.97 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.766 2.31 . . . . 0.0 112.173 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.01 10.56 48.79 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.633 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 m -100.86 164.6 11.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 p -96.86 119.69 35.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.94 138.85 48.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.353 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 126.51 52.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.05 161.52 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.288 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.84 134.38 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.626 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.26 142.69 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.632 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.5 119.97 25.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -133.43 135.98 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.954 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -132.49 130.51 40.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.54 151.59 23.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.781 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 159.3 62.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.182 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.86 129.87 44.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.574 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.879 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.89 -6.28 2.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.126 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -111.75 148.88 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -129.58 154.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 136.08 48.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.715 HG22 HD23 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -130.53 113.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 123.1 32.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.461 . . . . 0.0 111.657 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.3 166.09 13.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.793 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.03 -23.3 34.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.957 2.438 . . . . 0.0 113.684 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.35 -24.53 65.72 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.438 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.4 -8.84 55.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.405 -0.902 . . . . 0.0 114.208 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -90.13 166.74 13.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.502 0.651 . . . . 0.0 110.16 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.7 p -106.61 148.23 28.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 150.17 40.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.191 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 124.96 44.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.923 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -129.58 146.06 51.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 115.19 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.76 176.76 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.0 p -136.31 165.47 35.29 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.07 -15.12 47.53 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.622 2.215 . . . . 0.0 112.651 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.75 -5.75 59.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -80.13 139.78 36.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.223 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 11.7 p -86.93 167.53 14.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 t -66.9 -34.13 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.352 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -70.91 -31.9 68.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.69 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.9 -48.93 32.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.31 -34.34 72.2 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -35.94 69.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.311 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -74.17 -24.6 59.41 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -44.74 35.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.997 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 tp -71.13 -34.26 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.405 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.31 80.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -68.76 -33.39 73.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.36 61.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.16 -17.89 24.27 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.89 34.95 11.98 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.81 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.0 178.55 6.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.703 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 59.4 m -98.57 146.71 32.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.924 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.1 Cg_exo -68.28 -20.62 42.68 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.95 2.433 . . . . 0.0 113.054 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -75.08 -15.13 60.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.587 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -96.96 -37.11 10.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.69 121.72 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -115.94 137.75 51.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mt -93.47 133.29 36.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.1 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.64 128.63 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 111.412 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -128.52 126.38 40.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.364 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.06 32.46 1.94 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 113.227 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.61 22.96 41.16 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.06 -0.591 . . . . 0.0 114.046 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.0 141.33 44.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 p -89.99 149.25 22.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.42 136.04 39.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.384 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -88.62 127.52 56.12 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.212 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -64.36 -23.01 65.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.341 2.694 . . . . 0.0 113.864 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.9 m -79.05 -27.28 43.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.33 -174.0 4.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.334 0.587 . . . . 0.0 111.859 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 49.4 p -109.56 155.93 20.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 22' ' ' PHE . 11.1 mt -73.22 -34.39 65.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.81 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.38 -16.04 61.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.91 -20.27 35.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -90.18 -19.52 24.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.208 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.7 45.38 4.28 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.84 137.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.76 157.13 63.83 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.43 137.96 37.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.391 2.061 . . . . 0.0 111.964 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.52 13.94 31.35 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.346 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.6 t -103.64 161.94 13.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -88.16 121.91 31.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.157 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.94 128.38 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.727 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 130.67 54.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.715 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -101.72 160.99 13.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.028 0.442 . . . . 0.0 111.166 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -141.13 143.25 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.559 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.01 145.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.91 148.58 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.97 155.38 17.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -101.32 144.16 30.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.523 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.71 -114.05 1.91 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.8 -93.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.468 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.97 -43.37 6.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.412 179.813 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.0 -13.22 1.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.968 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -108.26 154.8 21.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.412 . . . . 0.0 111.3 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.47 160.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.44 131.28 53.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.077 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 13' ' ' THR . 5.3 mm -105.37 108.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.069 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -95.14 113.22 24.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 162.64 22.53 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.319 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.31 -0.46 9.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.7 -18.34 26.61 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 5.88 52.53 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.387 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -109.06 147.32 32.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 20.4 p -114.82 144.85 42.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.79 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -122.59 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.498 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.86 120.78 41.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.74 155.98 48.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.51 135.98 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.07 149.0 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 111.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -137.55 156.71 74.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.308 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.09 -6.38 18.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.761 2.307 . . . . 0.0 112.694 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.64 -9.76 22.78 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.733 0.302 . . . . 0.0 111.414 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.57 138.02 32.97 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.407 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -93.87 169.75 10.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.7 t -66.98 -32.6 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.306 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -71.9 -36.05 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.646 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.7 tt0 -72.57 -49.46 32.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.17 -32.23 70.87 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -36.6 69.67 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.925 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.2 -24.87 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.289 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.18 -51.2 40.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.31 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 tp -70.58 -32.65 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.802 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.17 -29.82 67.9 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.808 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -67.22 -33.41 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.939 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -85.45 -17.3 36.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.789 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.6 mt -98.12 -18.05 18.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 111.421 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.67 33.29 22.29 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.009 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.3 mt -132.43 178.45 6.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.014 0.435 . . . . 0.0 110.997 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 42' ' ' ILE . 48.8 m -103.84 140.93 21.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.67 -18.45 58.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.179 2.586 . . . . 0.0 113.686 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.43 -21.67 57.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 111.719 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.03 -28.9 15.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.536 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.76 128.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.461 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -109.84 134.17 52.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.69 129.08 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.182 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 132.27 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -133.58 125.2 28.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.285 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p30 47.42 31.57 1.95 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.094 0.958 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.31 23.46 37.23 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.991 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -136.29 139.48 42.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.941 0.371 . . . . 0.0 110.805 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 p -92.51 145.65 24.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.18 135.98 41.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.42 138.11 27.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.6 Cg_exo -64.44 -22.26 65.81 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.747 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 p -78.55 -28.38 46.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.71 -175.46 5.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 112.036 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.5 p -115.74 162.4 17.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.239 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.3 -30.25 63.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.869 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.54 -8.74 59.76 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.91 -31.03 28.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.097 0.475 . . . . 0.0 110.521 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -82.08 -19.79 39.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.691 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.64 5.65 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.705 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.52 136.6 30.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.4 p -123.74 156.67 64.68 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.859 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -69.74 136.33 32.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.627 2.218 . . . . 0.0 112.136 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.11 25.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.696 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.5 p -98.06 161.53 13.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.936 0.398 . . . . 0.0 110.763 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -93.47 123.24 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.62 146.7 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.267 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 110.3 16.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 137.45 34.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.279 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.11 131.76 42.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.55 138.57 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.579 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -116.84 122.34 44.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.849 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -136.96 148.62 47.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -121.92 132.4 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.33 144.41 4.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.77 99.74 0.47 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.683 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 tt -107.42 128.44 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.484 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.818 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 63.1 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.746 0.307 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -134.06 -2.62 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -111.05 152.08 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.208 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pt -128.48 156.94 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.148 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -99.32 154.42 18.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.296 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -136.44 114.64 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.704 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.03 122.07 39.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 111.786 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.32 163.86 19.71 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.11 -1.56 9.76 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.235 1.957 . . . . 0.0 111.895 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.87 -17.76 25.95 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.62 6.03 50.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -106.9 142.47 36.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.079 0.466 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.3 p -111.17 153.86 25.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.367 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.43 150.16 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.573 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.29 128.33 55.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -125.28 145.39 50.03 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 120.65 40.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.069 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.25 -179.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.037 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.8 p -133.84 164.98 40.13 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.81 -15.41 50.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.593 2.195 . . . . 0.0 112.584 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -86.09 -4.75 59.23 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.4 m-85 -80.75 137.34 36.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -90.18 170.26 10.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.68 -33.04 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -71.24 -34.38 70.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.924 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.7 -48.73 36.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.763 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.23 -36.13 77.01 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.906 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.76 -36.63 70.44 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.306 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.84 -25.17 61.87 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.93 -46.46 24.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.654 0.264 . . . . 0.0 111.176 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -72.01 -36.32 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.911 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.23 79.07 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.364 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 23.4 ttt180 -70.94 -33.41 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -26.96 61.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.452 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 mt -99.56 -18.22 17.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.62 47.66 5.29 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.15 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.28 177.93 7.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.994 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 42' ' ' ILE . 51.1 m -100.82 125.66 37.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.802 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.99 -20.21 71.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.133 2.555 . . . . 0.0 113.606 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.12 -19.96 59.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.39 -25.09 15.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.91 126.25 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.421 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -118.68 135.67 54.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.15 126.99 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.02 125.04 44.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 111.467 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -132.43 119.42 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 65.01 24.87 12.64 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.586 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -15.5 62.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.15 143.79 29.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.36 152.47 18.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 136.12 40.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.16 139.95 24.39 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.822 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.2 Cg_exo -63.7 -22.22 69.87 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.862 2.375 . . . . 0.0 113.408 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -82.26 -26.18 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.05 -174.72 5.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 111.659 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.5 p -115.25 160.73 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.868 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.14 -32.76 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.825 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.05 59.64 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.488 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.69 -19.84 37.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.073 0.463 . . . . 0.0 110.715 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -89.38 -19.57 25.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.52 4.84 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.649 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.17 142.28 27.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.01 0.433 . . . . 0.0 111.469 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -118.2 157.33 49.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.739 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.09 148.08 68.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.767 2.311 . . . . 0.0 112.495 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 100.93 6.3 52.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.695 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 p -101.01 158.37 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 110.66 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p -88.51 122.62 32.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.57 132.99 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.239 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.45 134.84 48.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -106.84 161.21 14.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.78 0.324 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -137.44 138.65 40.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.679 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mt -122.68 145.02 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.734 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.21 145.83 26.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.032 0.444 . . . . 0.0 111.073 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.98 146.85 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.822 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.63 152.58 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.858 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -102.68 -109.96 3.38 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -112.16 87.84 0.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.34 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.01 -43.77 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.711 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -133.99 -11.67 2.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -112.07 153.69 26.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.402 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' THR . 3.3 pt -120.98 160.72 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.056 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -97.71 151.87 19.69 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.181 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' THR . 16.4 mm -126.6 116.24 44.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.413 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.21 115.18 29.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 111.44 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.78 163.64 21.79 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.92 -2.27 11.25 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.295 1.997 . . . . 0.0 111.832 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.12 -18.22 26.23 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.42 5.53 51.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.168 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -104.23 145.07 30.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.195 0.521 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.7 p -113.73 151.51 31.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.286 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.08 145.04 45.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.354 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -108.08 123.13 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 111.479 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -124.59 153.38 42.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.05 131.8 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.748 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.28 147.55 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.985 0.421 . . . . 0.0 111.429 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -140.07 157.78 68.48 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.235 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.48 -6.28 18.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.695 2.263 . . . . 0.0 112.527 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -97.33 -14.93 20.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.349 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.8 140.64 32.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -94.17 171.05 9.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.3 -32.92 57.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -71.73 -37.45 70.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.993 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tt0 -72.23 -47.83 47.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.716 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.76 -32.4 72.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.598 0.237 . . . . 0.0 111.126 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.75 -37.87 70.49 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.677 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -69.96 -24.67 63.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.39 0.138 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.57 -53.05 25.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 110.765 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.45 -32.67 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.84 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.7 -27.82 66.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.772 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.49 -33.28 74.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -75.62 -31.35 59.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.79 -18.27 19.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.49 48.29 5.99 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.085 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.66 178.22 6.8 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.097 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 42' ' ' ILE . 37.9 m -106.25 143.89 27.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.6 Cg_exo -66.87 -21.99 49.63 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.957 2.438 . . . . 0.0 113.305 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.26 -17.17 60.37 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 111.774 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -95.97 -30.29 13.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.367 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.37 122.54 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.437 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -110.53 129.3 55.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.27 130.1 39.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.163 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.36 127.19 49.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.01 0.433 . . . . 0.0 111.294 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -133.03 117.48 17.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 64.7 24.91 12.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.658 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.93 -13.89 66.55 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.744 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -100.18 140.79 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -91.96 151.56 20.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.128 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.47 136.04 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.301 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.8 t70 -95.38 138.02 21.97 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -63.89 -22.28 68.81 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.05 2.5 . . . . 0.0 113.444 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -80.35 -27.12 38.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.56 -174.32 4.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.539 0.685 . . . . 0.0 111.548 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.6 p -115.55 166.48 11.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.092 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.12 -30.57 63.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 -7.7 59.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.84 -22.39 34.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.062 0.458 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.34 -19.41 24.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.739 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.54 45.78 6.33 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.81 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.08 142.63 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -122.86 148.43 53.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.077 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.13 149.88 71.38 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.76 2.307 . . . . 0.0 112.572 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.51 1.76 35.06 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.631 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.0 m -107.88 159.44 16.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.846 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 p -89.1 127.0 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.77 121.08 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.853 0.358 . . . . 0.0 111.066 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.27 135.22 42.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -114.6 161.44 18.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.646 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -141.94 133.61 26.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.441 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.66 140.42 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.959 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -101.27 132.79 46.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.41 149.47 40.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.767 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -114.12 147.1 39.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.44 131.93 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.485 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.97 -112.35 0.91 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.7 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -99.53 -42.94 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.584 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.656 0.265 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -137.51 -19.35 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.98 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -109.31 153.54 23.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.76 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.34 162.12 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.556 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 129.35 56.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.926 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -119.83 113.13 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 135.08 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.968 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -101.14 162.35 20.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.25 -1.89 10.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.22 1.947 . . . . 0.0 111.696 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.01 -15.98 28.71 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.22 51.76 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -108.17 148.89 29.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -113.26 155.24 25.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.429 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -131.75 150.09 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.88 126.11 52.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.259 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.3 160.75 36.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.3 136.88 38.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.783 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.67 146.75 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.599 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.9 p -139.01 157.69 70.99 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.057 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.5 -6.03 18.08 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.78 2.32 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.18 -11.12 20.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.682 0.277 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.13 140.71 32.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.813 0.339 . . . . 0.0 110.363 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -94.88 171.92 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 t -68.22 -33.27 59.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.964 0.411 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.876 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.2 -47.86 54.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.14 -39.01 88.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.401 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.47 63.27 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.99 -27.16 63.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.995 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.41 -50.87 23.25 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -66.14 -32.58 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.878 0.371 . . . . 0.0 111.442 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.37 -28.03 65.85 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.85 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -69.71 -33.59 72.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -76.66 -31.16 57.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.77 -18.01 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.84 5.5 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.961 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 mt -132.25 178.53 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.4 p -109.61 147.53 36.29 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.2 Cg_exo -67.84 -17.69 47.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.131 2.554 . . . . 0.0 113.605 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.22 -19.95 59.51 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.01 -28.15 13.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.585 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.25 124.97 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 111.386 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -117.75 132.29 56.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.468 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -92.03 132.21 36.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.49 125.27 44.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -135.51 123.74 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.6 t30 64.61 25.14 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.853 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.87 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.771 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -100.66 150.04 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.067 0.46 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 p -93.38 158.41 15.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.333 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.37 135.8 43.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.016 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -88.96 135.19 32.11 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.011 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.8 Cg_exo -65.08 -22.28 62.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.072 2.515 . . . . 0.0 113.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 m -80.27 -27.45 38.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.34 -174.91 5.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.365 0.602 . . . . 0.0 111.862 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.2 p -113.29 158.94 19.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.0 mt -73.39 -31.29 63.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.77 -21.33 34.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.995 0.426 . . . . 0.0 110.909 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -88.28 -19.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 45.6 5.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.708 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.36 137.91 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.976 0.417 . . . . 0.0 111.514 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -123.34 156.95 62.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.925 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.81 146.14 52.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.722 2.282 . . . . 0.0 112.395 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.78 45.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.522 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.7 p -98.98 165.94 11.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -96.53 124.89 40.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.36 136.05 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.12 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.43 126.34 51.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.709 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -93.6 160.86 14.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.878 0.37 . . . . 0.0 111.252 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.47 149.51 45.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.39 145.3 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.473 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -123.58 137.77 54.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -107.75 148.65 29.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -125.89 146.27 49.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.79 76.32 1.07 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.784 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' LEU . . . 118.39 149.41 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.312 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 15.0 mt 76.61 -54.54 0.58 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.43 0.692 . . . . 0.0 111.673 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.624 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 65.8 mtt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.756 0.312 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.89 -11.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -107.91 151.37 25.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.093 0.473 . . . . 0.0 111.424 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.47 161.97 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.632 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.09 131.77 54.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.803 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.583 HG22 HD23 ' A' ' 70' ' ' LEU . 1.7 mp -120.08 113.48 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.298 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 132.96 35.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.935 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.78 161.8 22.69 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.884 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.02 -1.78 10.54 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.34 2.027 . . . . 0.0 111.812 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.25 -16.71 27.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.5 5.57 51.6 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.295 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -108.07 141.18 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.6 p -102.68 155.32 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -128.77 150.0 50.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.503 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.51 121.25 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.53 161.97 33.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.92 139.03 35.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.832 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.76 149.3 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.539 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 p -139.13 149.72 62.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.95 -9.57 26.34 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.635 2.223 . . . . 0.0 112.64 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -94.3 -9.34 36.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.94 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.55 145.85 26.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.4 p -96.43 169.36 9.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.53 -30.54 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.402 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.3 -39.48 68.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.022 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.63 -47.95 51.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.949 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.73 -33.37 72.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.224 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.96 69.61 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.7 pt-20 -72.26 -25.15 61.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -51.06 26.27 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.531 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 tp -67.45 -32.78 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.873 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.08 69.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -68.31 -33.48 74.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -84.87 -13.86 49.65 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -100.83 -18.09 16.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.612 0.244 . . . . 0.0 111.362 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.86 32.76 20.45 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.963 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.22 178.09 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.019 0.437 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.4 p -103.04 139.98 20.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.667 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.06 -17.04 45.82 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.015 2.476 . . . . 0.0 113.801 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.48 -21.5 58.01 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.37 -27.56 14.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.568 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 38' ' ' SER . 1.7 mt -87.52 123.4 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.432 . . . . 0.0 111.491 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.82 137.62 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.84 130.98 37.51 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.211 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.55 125.98 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -135.16 122.64 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.0 t30 62.87 26.56 15.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.793 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.8 -19.63 47.29 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.275 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -97.19 149.7 21.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -96.04 155.52 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.139 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 135.75 43.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.188 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -89.8 137.43 28.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 19.8 Cg_exo -65.1 -22.26 62.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.111 2.54 . . . . 0.0 113.388 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -77.7 -26.14 49.96 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.42 -174.88 5.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.2 p -115.25 163.89 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.356 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -73.37 -30.92 63.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.872 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.36 -7.77 59.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -82.9 -31.85 27.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.658 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -81.63 -19.89 40.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.663 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.71 5.37 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.23 141.53 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.786 0.327 . . . . 0.0 111.365 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.7 p -124.81 156.66 68.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.24 137.86 38.04 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 103.42 12.06 31.89 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.459 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t -101.71 160.1 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.9 p -87.52 124.38 33.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.181 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.02 127.63 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.983 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.25 125.44 53.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.583 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.93 161.06 14.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -139.73 144.42 37.48 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -127.0 148.46 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.477 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -122.4 120.02 32.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.749 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -134.49 151.38 51.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -129.8 137.88 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.44 140.99 3.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.801 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 142.97 142.2 3.96 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.602 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -101.29 130.79 47.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.378 . . . . 0.0 110.723 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.945 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -137.17 -1.2 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 p -110.45 151.98 26.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.513 . . . . 0.0 111.382 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.66 157.66 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -101.7 153.92 19.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.79 113.1 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.266 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.31 121.69 38.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.935 0.398 . . . . 0.0 111.553 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 163.67 19.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.58 -1.27 10.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.321 2.014 . . . . 0.0 112.032 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.44 -17.93 26.3 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.64 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.31 5.49 52.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.385 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -104.43 146.42 28.87 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 110.717 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p -109.86 156.5 20.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.567 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 150.25 46.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.292 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 125.14 50.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.283 . . . . 0.0 111.329 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.1 165.53 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.95 143.15 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.86 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.42 148.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.381 . . . . 0.0 111.641 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 p -139.43 157.38 70.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.079 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.41 -5.99 18.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.691 2.26 . . . . 0.0 112.675 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -99.69 -13.94 19.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.375 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.53 141.36 32.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.759 0.314 . . . . 0.0 110.33 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 p -94.92 171.79 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.89 -32.57 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.045 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -71.83 -39.18 69.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.113 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 5.1 tt0 -72.15 -45.04 62.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.71 -31.15 72.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 110.648 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.74 69.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.832 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -70.16 -26.19 63.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.408 0.147 . . . . 0.0 111.107 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.43 -53.35 29.81 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.94 -32.85 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.612 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.97 65.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -68.54 -33.46 74.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -77.33 -28.52 53.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.897 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.32 -18.11 18.52 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.31 47.82 5.59 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.108 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.12 178.29 6.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 111.313 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.6 t -107.2 141.99 24.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.58 -23.23 64.24 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.94 2.426 . . . . 0.0 113.495 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.4 -15.71 60.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.69 -31.87 12.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.62 124.28 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.628 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -113.0 131.7 55.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.384 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.64 124.24 34.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 127.21 52.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.708 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.87 115.84 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.379 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.04 24.96 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.06 -7.54 78.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.743 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -102.44 138.74 38.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -91.06 151.2 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.321 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 136.12 42.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.321 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -87.29 132.71 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.236 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 16.8 Cg_exo -66.0 -22.31 55.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.09 2.527 . . . . 0.0 113.543 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.1 m -78.84 -26.26 44.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.96 -174.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.435 0.636 . . . . 0.0 111.663 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.4 p -108.93 160.71 15.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.261 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.16 -32.02 64.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.661 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -9.63 59.65 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.62 -23.76 34.16 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 110.787 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.66 -19.75 23.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.631 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.27 5.53 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.862 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.34 136.71 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -123.37 155.48 65.21 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.59 155.72 62.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.88 2.387 . . . . 0.0 112.5 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.19 57.36 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.4 m -107.85 153.3 23.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 0.0 110.732 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -88.61 127.08 35.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.642 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -110.91 129.52 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 135.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.514 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -107.57 161.05 15.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.935 0.397 . . . . 0.0 111.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -140.07 135.43 32.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.351 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.82 144.2 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.667 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.83 149.27 22.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -129.98 -44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.96 148.19 37.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.1 -88.16 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.276 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.38 -98.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.331 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 mt -124.1 -43.52 2.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.903 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.694 0.283 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -141.23 -26.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 p -110.02 154.33 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -130.32 161.62 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.17 130.03 56.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.099 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.619 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -119.68 113.53 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.663 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.5 132.91 34.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.873 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.0 161.28 24.78 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.75 -1.08 9.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.162 1.908 . . . . 0.0 111.736 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.07 -15.33 29.68 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.43 6.02 51.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.442 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -109.6 151.82 26.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 110.878 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -112.95 146.43 39.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.708 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.1 mm? -116.03 150.08 37.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.526 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.27 123.39 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 111.071 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.39 161.09 37.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.599 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.24 134.56 40.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.644 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.49 148.5 17.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.817 0.342 . . . . 0.0 111.647 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 p -139.39 157.19 71.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.213 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.4 -6.26 18.51 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.696 2.264 . . . . 0.0 112.58 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.31 -9.72 22.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.43 142.73 29.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.4 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.7 p -95.52 171.57 8.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -68.8 -32.78 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 0.0 110.076 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -72.49 -36.62 68.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.914 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.1 tt0 -71.32 -48.12 52.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.82 -33.82 74.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.145 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.41 69.47 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.077 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.4 pt-20 -70.24 -24.93 63.16 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.02 -50.18 30.72 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.807 0.337 . . . . 0.0 110.356 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tp -70.12 -32.95 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -67.98 -33.02 73.85 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -62.38 -33.47 74.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.817 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -87.56 -10.54 51.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.753 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.12 -18.84 19.84 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.314 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.22 -6.32 78.47 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.263 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.453 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -119.74 164.13 16.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 110.998 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -83.59 154.7 65.61 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.396 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.69 -16.34 53.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.715 2.943 . . . . 0.0 113.245 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.32 -23.84 66.01 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.08 -24.58 14.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.711 0.291 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -92.07 127.18 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -123.64 140.23 53.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.025 0.44 . . . . 0.0 110.516 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.7 135.39 36.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.413 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.54 126.12 35.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.679 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -137.23 127.05 25.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 63.98 25.02 13.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.609 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 -18.76 44.1 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.868 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -96.04 149.96 21.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.775 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.6 p -96.0 156.87 16.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.16 135.15 48.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.076 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -92.37 137.99 24.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.761 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.3 Cg_exo -63.96 -22.13 68.46 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.899 2.399 . . . . 0.0 113.525 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -79.51 -27.97 41.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -83.64 -175.06 5.63 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.283 0.564 . . . . 0.0 111.951 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.8 p -116.05 163.28 16.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.119 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -73.23 -31.01 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.63 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.05 59.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.84 -24.54 33.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.973 0.416 . . . . 0.0 110.72 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.5 -20.2 26.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.498 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.98 45.29 5.73 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 141.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 111.549 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.6 t -122.5 144.49 42.33 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.569 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.6 Cg_exo -67.32 137.55 43.81 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.406 2.071 . . . . 0.0 112.097 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.96 4.65 27.61 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 t -99.4 168.54 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 122.61 36.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.12 134.75 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 128.41 55.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.619 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -101.12 159.42 15.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.137 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -139.73 148.71 42.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.28 143.0 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.102 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -103.59 147.56 27.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -124.51 -46.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.73 133.43 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.14 -51.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.503 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.86 -46.6 1.89 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.66 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -98.93 125.32 44.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.889 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 120.846 0.355 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -138.12 -10.95 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.779 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.8 p -107.73 149.44 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.57 156.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.52 127.96 54.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.509 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.33 111.02 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.726 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 125.0 35.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.82 161.57 24.53 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.118 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.82 -0.53 7.09 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.326 2.017 . . . . 0.0 111.92 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.38 -18.23 24.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.3 52.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.495 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -109.34 140.91 42.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.094 0.473 . . . . 0.0 110.874 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -108.4 151.92 25.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.035 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.72 149.89 52.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.8 122.75 48.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tp -131.88 151.52 51.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.084 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.84 120.8 41.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 27' ' ' LEU . 10.5 m -131.98 170.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.964 0.412 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 p -135.63 164.87 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.36 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.11 -12.5 35.74 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.875 2.383 . . . . 0.0 112.592 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -89.2 -6.1 57.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.878 0.371 . . . . 0.0 110.879 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 m-85 -80.91 139.82 35.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -91.0 169.29 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.77 -33.86 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.035 0.445 . . . . 0.0 110.169 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -70.96 -32.71 69.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.829 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.6 tt0 -72.62 -51.23 20.47 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.709 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 18' ' ' VAL . 6.4 tt -57.88 -36.18 72.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.817 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.09 70.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.92 -24.6 61.66 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -48.01 26.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.854 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.73 -33.27 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.543 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.11 65.76 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.24 -33.37 75.6 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.85 -21.1 34.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.776 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.72 -18.17 18.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.252 . . . . 0.0 111.436 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.63 9.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.105 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.97 177.82 7.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.203 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG13 ' A' ' 42' ' ' ILE . 3.2 p -106.04 126.24 31.1 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.593 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 32.5 Cg_exo -59.18 -18.05 42.29 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.393 2.729 . . . . 0.0 114.017 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.04 -14.7 60.62 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -109.12 -20.65 12.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.535 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.72 141.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -133.31 148.79 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 111.121 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.01 135.47 44.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.25 124.31 43.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -134.5 117.96 16.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.55 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 65.28 25.1 12.2 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.532 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.73 -16.47 60.14 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.824 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.26 146.77 25.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -95.26 149.43 21.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.06 135.82 44.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.01 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.79 141.79 24.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.015 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.9 -22.08 56.45 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.196 2.598 . . . . 0.0 113.548 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 m -76.12 -24.69 54.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.83 -174.63 4.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.4 0.619 . . . . 0.0 111.93 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.4 p -115.62 157.12 24.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.265 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.8 mt -73.33 -31.6 64.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.776 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.78 -17.21 60.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.431 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.7 tt0 -82.75 -19.96 36.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -90.34 -20.06 23.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.144 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.52 45.34 5.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.614 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.35 135.53 44.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -125.64 155.65 72.02 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.631 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -69.74 139.35 40.08 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.655 2.237 . . . . 0.0 112.031 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.92 -6.13 30.9 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.436 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -94.66 165.16 12.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.557 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 p -91.0 125.83 35.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.41 145.33 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.41 116.9 31.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.39 140.71 39.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.43 144.19 50.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.06 136.12 58.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.628 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -98.61 132.9 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 31.2 tttm -108.47 -53.0 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 96.5 mttt 72.09 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.191 0.932 . . . . 0.0 111.878 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.78 -141.87 3.71 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 154.11 149.6 5.26 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.288 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.76 128.99 53.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.875 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.559 0.219 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.65 -18.07 1.44 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.197 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.3 p -108.95 152.34 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.036 0.446 . . . . 0.0 111.697 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.05 158.93 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -103.07 153.67 20.04 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -136.91 122.58 27.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.07 112.3 25.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 111.312 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -96.26 164.15 19.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.188 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 9.7 Cg_endo -54.35 -23.25 29.88 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.136 2.557 . . . . 0.0 113.583 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HB2' HD12 ' A' ' 8' ' ' LEU . 2.8 m-20 -67.27 -24.67 65.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.703 0.287 . . . . 0.0 110.541 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -6.17 52.88 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.441 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -94.35 167.62 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.552 0.676 . . . . 0.0 110.231 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.3 p -117.84 151.03 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.733 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.43 150.08 49.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.225 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.25 123.0 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.26 164.72 21.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.686 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -99.93 137.76 37.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.623 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.02 150.0 23.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.872 0.368 . . . . 0.0 111.547 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 p -138.73 156.87 72.73 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.344 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.98 -6.86 19.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.705 2.27 . . . . 0.0 112.564 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.23 -12.0 22.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.25 140.1 31.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.4 p -93.24 169.36 10.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.576 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -67.86 -30.35 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 110.239 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -71.56 -39.9 70.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.149 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.01 -48.72 51.49 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.27 -32.34 71.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.247 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.92 -37.27 70.08 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.8 pt-20 -71.16 -24.82 62.32 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -51.32 23.86 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-O 120.786 0.326 . . . . 0.0 110.695 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.9 -32.76 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.936 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -28.41 66.67 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -69.07 -33.36 73.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -25.97 45.78 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.9 -17.98 21.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.39 41.61 9.94 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.235 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.94 178.12 7.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 42' ' ' ILE . 21.7 m -97.98 133.3 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.61 -21.19 46.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.975 2.45 . . . . 0.0 113.961 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -75.66 -14.76 60.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.65 -29.44 13.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.311 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.69 124.11 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.305 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -114.04 133.93 55.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.489 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.31 134.48 34.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.205 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.21 125.21 44.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -134.86 122.92 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.67 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 t30 63.65 25.92 14.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.803 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.04 -19.83 46.71 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.341 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.99 150.43 21.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.947 0.404 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 p -95.63 155.89 16.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.082 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.54 135.97 41.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.067 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.2 t70 -88.42 133.49 36.38 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.5 Cg_exo -65.33 -22.21 60.38 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.051 2.501 . . . . 0.0 113.358 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 -27.97 32.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.62 -174.53 4.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.307 0.575 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 43.7 p -108.83 161.28 15.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 9.3 mt -73.32 -30.06 63.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.764 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.21 -7.01 59.61 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.5 tm-20 -82.77 -26.92 31.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -83.13 -19.46 36.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.72 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 45.64 5.82 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 57' ' ' LEU . 2.1 mt -103.4 143.72 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -121.98 153.79 60.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.071 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 156.57 58.98 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.775 2.317 . . . . 0.0 112.491 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.91 2.14 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.505 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -104.12 156.1 18.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.99 0.424 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 p -88.92 125.87 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.464 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.28 138.11 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.351 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 131.93 56.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.341 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.5 161.07 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -139.24 151.77 46.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.64 137.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.212 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -98.22 131.64 44.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -133.37 -42.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -98.54 147.31 24.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.827 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.1 -73.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.287 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.05 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.457 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.72 109.73 22.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.672 0.272 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.131 -0.937 . . . . 0.0 111.674 179.421 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.669 0.271 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -136.85 -11.99 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.009 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -108.02 148.9 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.841 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -134.41 156.86 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.65 153.64 19.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.682 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -138.97 118.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.979 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 116.41 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.14 0.495 . . . . 0.0 111.115 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -98.28 166.85 12.57 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.844 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 58.7 Cg_exo -54.54 -21.86 25.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.979 2.453 . . . . 0.0 113.617 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.45 -25.06 64.82 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.876 0.37 . . . . 0.0 110.377 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -8.55 55.1 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.375 -0.917 . . . . 0.0 114.386 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -92.22 163.34 13.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.533 0.666 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.1 p -115.96 156.31 26.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.33 150.15 52.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.14 122.41 46.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.77 149.13 47.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.72 117.84 33.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.746 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 179.17 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.227 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 15.3 p -135.26 165.1 39.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.266 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.2 -13.75 39.76 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 112.703 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.23 -7.3 58.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.04 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.3 m-85 -80.59 138.59 36.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.993 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -87.89 170.93 10.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.403 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.6 -32.25 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.044 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -72.11 -32.71 67.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.834 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.6 tt0 -72.25 -48.04 45.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.11 -34.61 75.22 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.786 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.72 -36.11 70.41 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -72.47 -24.91 61.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.619 0.247 . . . . 0.0 111.236 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.22 -50.34 28.25 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.831 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 tp -68.73 -33.05 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.876 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.32 66.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -70.45 -33.52 71.39 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -79.62 -26.63 41.11 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 -18.17 21.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.561 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.21 39.42 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.032 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.0 178.26 6.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.059 0.457 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.1 t -99.22 136.73 20.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.528 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.94 -17.27 51.39 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 123.164 2.576 . . . . 0.0 113.653 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.34 -21.73 58.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.668 0.27 . . . . 0.0 111.46 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.21 -28.28 16.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' SER . 1.2 mt -90.07 121.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.359 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -112.22 142.9 44.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.593 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.63 132.25 40.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.28 124.2 41.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 111.296 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -131.73 117.89 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.8 24.99 12.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.712 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.41 69.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.857 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.46 143.3 29.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 p -94.26 151.68 19.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.142 0.496 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.84 135.94 46.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.235 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.28 138.42 27.18 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.4 Cg_exo -63.78 -22.15 69.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.928 2.419 . . . . 0.0 113.759 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.6 p -78.83 -26.25 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -82.3 -174.59 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.334 0.587 . . . . 0.0 111.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -118.11 158.53 24.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.6 mt -73.21 -30.65 63.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.847 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.15 60.01 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.85 -27.95 30.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.427 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -83.23 -20.01 35.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.57 45.71 6.01 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.786 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -101.13 140.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.859 0.362 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -124.16 154.44 68.44 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.989 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.19 149.11 57.26 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.772 2.315 . . . . 0.0 112.339 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.46 6.59 54.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.408 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.2 t -106.45 161.6 14.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.898 0.38 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 p -93.17 121.22 34.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.34 126.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.032 0.444 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.13 143.76 32.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.669 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -117.61 161.81 19.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 111.054 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -136.26 132.2 35.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.337 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 73' ' ' LYS . 3.2 tp -106.15 149.15 9.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.768 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' N ' HG13 ' A' ' 72' ' ' ILE . 96.7 mttt -105.12 114.11 28.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.38 135.58 48.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -130.14 143.91 51.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.42 -87.97 0.74 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.628 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 154.11 80.88 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.149 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mp -103.52 131.94 50.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.049 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.948 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 63.8 mtt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -136.88 -4.82 1.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.2 p -111.67 150.39 30.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -129.96 160.35 41.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.684 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 129.29 56.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.11 0.481 . . . . 0.0 110.13 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -117.96 112.28 37.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.683 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.48 133.7 33.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.93 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -98.76 162.8 20.42 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.977 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.06 -1.11 9.02 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.221 1.947 . . . . 0.0 111.969 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.69 -16.86 27.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.75 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.95 50.89 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.286 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -106.03 149.02 27.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.138 0.494 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -105.31 153.88 21.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.668 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.92 149.86 51.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 125.24 50.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.003 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -127.96 147.01 50.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.51 115.57 30.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.6 174.8 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 12.7 p -137.74 166.12 28.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.55 -14.6 40.58 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.791 2.328 . . . . 0.0 112.65 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -85.38 -7.6 58.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.836 0.351 . . . . 0.0 111.19 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 19' ' ' THR . 3.3 m-85 -81.32 141.37 34.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 p -88.43 167.39 13.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.22 -33.96 67.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.069 0.461 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -71.44 -31.99 67.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.846 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 4.5 tt0 -72.91 -45.83 55.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.61 -36.5 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.395 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.34 67.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -73.74 -26.06 60.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.78 -45.9 48.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.118 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 tp -70.2 -32.79 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.712 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.7 77.35 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.634 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -65.73 -33.35 75.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -75.46 -25.75 57.67 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.06 -18.25 22.02 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.594 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.29 -5.69 83.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.544 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.83 176.54 5.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.223 0.512 . . . . 0.0 110.888 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 54.0 m -89.16 151.06 46.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.318 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 12.7 Cg_exo -69.04 -16.84 40.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.392 2.728 . . . . 0.0 113.051 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.12 -14.99 62.91 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.679 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.64 -20.88 18.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.36 148.03 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.999 0.428 . . . . 0.0 111.606 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -137.76 128.18 26.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.341 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.85 121.41 31.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.43 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.08 127.52 55.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.127 0.489 . . . . 0.0 111.384 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -138.35 120.03 15.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.339 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 65.01 24.93 12.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.789 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -19.42 50.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.906 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.45 149.9 22.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -94.49 150.13 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.07 135.84 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.23 137.55 29.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.66 -22.08 64.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.013 2.475 . . . . 0.0 113.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -77.36 -27.69 52.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.65 -174.02 4.38 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.337 0.589 . . . . 0.0 111.904 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 71.7 p -113.6 157.84 21.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.376 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.32 -30.16 63.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.06 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 -7.63 59.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -83.13 -32.0 26.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.522 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.92 -19.68 34.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.776 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.03 45.64 3.82 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.011 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.58 136.16 39.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.81 0.305 . . . . 0.0 111.056 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.38 157.71 58.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 138.52 37.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 106.6 7.71 33.77 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -98.93 170.05 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 110.75 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 p -95.58 122.4 38.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.18 129.83 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.4 126.98 55.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.513 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.575 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.5 161.01 14.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.75 145.89 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -127.64 131.7 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.363 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -99.22 129.67 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.236 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -134.38 136.09 43.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -101.65 142.3 33.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.21 68.43 0.01 OUTLIER Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.628 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.34 80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.926 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -130.92 126.72 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.455 0.169 . . . . 0.0 111.065 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.25 1.105 0 O-C-N 123.872 0.733 . . . . 0.0 111.604 179.291 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -134.79 -18.55 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -110.38 151.97 26.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.74 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pt -131.18 156.12 42.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.519 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.598 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -120.92 112.69 36.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.73 133.93 33.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.94 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.73 162.44 21.14 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.817 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.46 -2.05 10.68 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.384 2.056 . . . . 0.0 111.801 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -91.17 -15.67 28.96 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.02 52.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.253 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -106.8 143.83 34.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 p -104.04 156.93 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.608 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.42 150.03 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.539 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.986 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 154.88 49.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.687 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.0 120.51 39.57 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.14 170.58 19.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.78 0.324 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 18.6 p -136.72 162.57 55.24 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.411 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.16 -14.92 44.95 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.741 2.294 . . . . 0.0 112.526 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.17 -3.64 59.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.898 0.38 . . . . 0.0 111.023 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.08 142.2 32.5 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.887 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.1 p -90.95 169.24 11.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 t -66.71 -33.55 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.94 0.4 . . . . 0.0 110.112 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.79 -34.3 69.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.803 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.21 -47.6 49.36 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.29 -35.55 77.62 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.759 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.02 69.87 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.95 -24.92 61.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.484 0.183 . . . . 0.0 111.444 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.81 -47.78 28.77 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -70.19 -32.71 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.9 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.84 -34.88 76.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.21 -33.59 75.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -88.11 -9.48 53.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.518 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.32 -18.12 20.21 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.209 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.84 82.7 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.13 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -120.8 164.39 16.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.47 0.635 . . . . 0.0 111.539 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -76.77 148.52 79.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.713 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.39 -16.77 53.81 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.368 2.712 . . . . 0.0 113.24 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.5 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.38 -27.04 14.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.388 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.13 128.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.77 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -121.9 141.88 50.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.31 126.51 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.59 127.08 55.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.99 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -136.83 121.23 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t30 64.39 26.5 13.56 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.68 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.47 -19.87 44.71 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.323 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -101.09 151.76 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.881 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 p -92.4 150.68 20.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.228 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.72 135.59 38.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.67 135.79 28.72 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.41 -22.16 59.88 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.019 2.479 . . . . 0.0 113.871 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.2 m -78.42 -27.84 46.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -88.89 -174.39 4.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.428 0.632 . . . . 0.0 112.041 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 42.1 p -110.05 155.85 21.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.466 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.34 -37.32 66.14 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.977 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.81 -14.42 62.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.96 -22.14 33.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.971 0.415 . . . . 0.0 110.822 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.68 -20.17 23.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.416 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.74 45.38 3.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.046 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.78 139.39 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.9 157.06 64.54 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.34 137.53 31.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.626 2.217 . . . . 0.0 112.135 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.98 14.91 29.94 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.118 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 t -99.74 169.85 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -95.21 123.21 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.694 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.75 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.33 125.6 54.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.45 161.22 14.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.63 152.8 44.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.468 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.32 136.11 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -125.66 149.34 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.16 153.69 45.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.91 132.69 44.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.79 89.92 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.653 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.6 73.62 0.03 OUTLIER Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.392 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -120.57 -43.62 2.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.203 -0.904 . . . . 0.0 110.694 179.831 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.18 -2.42 2.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 p -110.4 149.7 29.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.019 0.438 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.73 155.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.961 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -102.57 153.69 19.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -135.94 120.77 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.02 122.49 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.13 161.78 24.31 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.168 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 -1.03 7.75 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.358 2.039 . . . . 0.0 111.744 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.46 -19.51 23.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.81 51.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.413 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -106.22 146.05 30.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.066 0.46 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -105.14 152.19 23.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 149.87 52.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -114.79 126.73 55.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.874 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.3 tp -125.82 148.48 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.775 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.41 117.77 35.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 178.08 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 16.0 p -132.38 164.57 42.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.208 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.43 -14.39 43.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.742 2.295 . . . . 0.0 112.918 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.4 -10.85 53.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -75.27 136.33 40.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.17 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.8 p -88.21 172.14 9.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.156 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.64 -33.07 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 110.13 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -70.64 -35.17 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.719 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -71.58 -48.6 47.2 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.18 -40.16 89.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.952 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -30.17 67.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -70.62 -26.22 63.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.77 -49.51 25.1 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.78 -32.89 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.853 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.07 -28.17 66.28 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.701 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -72.56 -33.37 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.39 -34.28 58.86 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.66 -18.17 21.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.23 51.07 5.89 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.116 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -130.02 178.07 6.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.126 0.489 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 42' ' ' ILE . 11.9 t -105.57 141.98 23.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.438 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 22.9 Cg_exo -62.71 -17.41 58.87 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.86 2.374 . . . . 0.0 113.568 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.19 -21.51 58.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.303 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.69 -27.68 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.527 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' SER . 2.0 mt -87.07 134.67 27.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.957 0.408 . . . . 0.0 111.329 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -128.01 128.99 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -95.43 132.69 40.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.48 141.3 51.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.064 0.459 . . . . 0.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -145.12 106.47 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 67.17 25.22 9.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.71 74.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.943 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -102.27 139.68 37.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -93.25 145.69 24.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.54 135.89 36.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.308 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.22 138.98 22.9 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.92 -22.5 73.86 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.15 2.567 . . . . 0.0 114.019 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.2 p -81.85 -25.44 35.11 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -174.72 5.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.273 0.559 . . . . 0.0 111.752 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.9 p -117.19 161.89 18.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 9.9 mt -73.0 -32.78 65.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.749 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.49 -11.56 59.96 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.61 -20.73 35.81 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.997 0.427 . . . . 0.0 110.626 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.04 -19.87 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.176 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 45.5 4.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.71 137.97 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.18 157.19 65.02 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.904 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.75 144.67 54.84 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.762 2.308 . . . . 0.0 112.071 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.79 1.03 34.37 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.587 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -107.74 159.0 16.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 p -88.58 123.93 33.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.83 148.55 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.92 135.82 48.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.064 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.35 140.12 52.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.499 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -132.6 131.65 41.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 143.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.771 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.34 143.89 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -108.5 155.46 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.575 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.08 4.87 47.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.347 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.03 151.89 21.12 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -155.05 68.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.227 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.7 mt -102.3 132.93 47.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.833 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.779 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.7 mmm . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.646 0.26 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -139.22 -14.93 1.13 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.003 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -109.72 153.12 24.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.0 111.669 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.04 162.43 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.57 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.31 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.88 112.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.184 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 122.68 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.977 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 163.29 21.19 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.999 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.78 -1.68 9.71 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.239 1.96 . . . . 0.0 112.059 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -89.86 -19.54 24.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.8 51.07 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.474 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -102.44 150.02 23.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.73 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 p -111.76 152.22 28.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.736 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.82 150.07 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.471 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.37 121.95 46.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.126 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -132.34 159.47 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.604 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.17 134.01 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.754 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.24 147.23 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 111.436 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 p -138.76 157.28 72.12 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.32 -6.09 18.25 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -98.29 -12.46 21.53 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.244 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.36 142.43 31.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.312 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 p -96.42 170.67 9.07 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.42 -33.09 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 110.267 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -72.21 -37.14 69.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.36 -47.83 46.48 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.679 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.11 -31.57 71.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.03 69.88 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.823 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -71.14 -24.91 62.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.49 0.186 . . . . 0.0 111.35 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.12 -51.0 42.93 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.76 -33.95 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.764 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.23 -28.58 66.48 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -67.1 -33.56 75.73 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.9 -16.33 38.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.704 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -100.46 -18.35 16.73 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.579 0.228 . . . . 0.0 111.48 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.18 39.72 12.44 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.011 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -131.5 178.19 6.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.225 0.536 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 9.5 t -105.22 142.26 24.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.599 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.77 -18.95 59.21 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.06 2.507 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.29 -20.34 59.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.639 0.257 . . . . 0.0 111.622 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -94.8 -30.24 14.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.7 123.04 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.652 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -115.21 138.85 50.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.443 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.94 131.07 38.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.24 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.5 125.32 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.977 0.417 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -134.17 121.98 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 62.45 26.84 15.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.669 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.64 -17.76 55.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.366 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.77 149.31 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.829 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -97.11 153.83 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.119 0.485 . . . . 0.0 111.108 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.52 136.11 42.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.214 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -90.03 138.16 27.72 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.3 Cg_exo -65.01 -22.1 62.83 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.433 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -78.51 -24.98 45.54 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.58 -175.12 5.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.267 0.556 . . . . 0.0 111.673 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.9 p -115.32 161.86 17.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.312 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.35 -29.73 62.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.12 -8.35 59.65 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.88 -31.16 28.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.088 0.471 . . . . 0.0 110.572 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -81.75 -19.95 40.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.736 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 45.61 6.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.651 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -98.19 139.53 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 0.0 111.606 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -124.28 156.56 66.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.916 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.54 146.38 55.23 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.614 2.21 . . . . 0.0 112.25 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.5 6.59 50.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.573 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -102.89 162.27 13.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.1 p -90.03 122.16 32.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.06 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.3 mm -112.57 119.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.977 0.418 . . . . 0.0 110.761 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.23 123.44 48.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.71 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -96.63 159.29 15.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.132 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.346 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.85 141.75 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.697 0.284 . . . . 0.0 110.614 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -121.93 137.54 54.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.098 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -116.09 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -129.17 135.3 48.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.68 62.58 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.706 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.89 149.53 5.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -102.03 133.17 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 110.871 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.857 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mmm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.52 -11.31 1.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.058 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -111.15 152.05 27.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.21 153.82 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.22 135.06 43.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mm -111.92 111.71 37.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.68 119.66 34.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.5 161.44 24.53 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.19 -0.88 8.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.266 1.977 . . . . 0.0 111.759 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.96 -18.78 24.11 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.48 6.13 50.92 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.335 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -107.36 145.87 32.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.863 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 17.5 p -112.68 146.22 39.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.504 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.2 150.51 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.33 121.15 41.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.685 0.278 . . . . 0.0 110.881 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.04 142.24 49.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -101.77 133.1 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.75 176.58 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.631 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 p -135.98 165.58 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.185 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.44 -12.47 30.91 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 113.018 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.44 -14.36 43.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 m-85 -75.62 135.62 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 p -85.44 170.75 12.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.288 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.4 -33.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.059 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -72.11 -32.3 66.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.703 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.1 tt0 -72.0 -47.84 49.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.722 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.31 -36.18 79.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.703 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.0 70.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.301 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -72.26 -24.78 61.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.485 0.183 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.06 -49.67 27.35 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.877 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.83 -34.25 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.727 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.1 -27.88 65.99 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.825 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -69.35 -33.48 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -30.37 47.09 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.23 -18.15 20.26 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.47 49.3 5.88 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.073 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.61 178.24 6.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.429 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.0 t -105.33 142.03 23.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.563 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.85 -17.33 55.74 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.833 2.355 . . . . 0.0 113.377 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.33 -18.62 59.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.77 -29.78 12.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -89.48 126.23 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 0.0 111.441 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -121.89 135.29 54.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.794 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.18 133.85 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.67 129.52 47.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.294 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -130.38 125.22 34.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.399 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p30 46.94 32.39 1.83 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.95 . . . . 0.0 113.188 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.81 22.95 37.34 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.945 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -134.39 140.27 46.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.013 0.407 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -93.56 147.24 23.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.01 135.82 42.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.123 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.27 138.08 25.87 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.25 -22.36 66.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.1 2.533 . . . . 0.0 113.503 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.2 t -79.94 -28.11 39.73 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.42 -174.85 5.52 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 112.061 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 68.4 p -116.66 157.76 24.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.121 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 10.1 mt -73.05 -31.18 64.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.08 -15.04 59.72 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.68 -20.2 36.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.053 0.454 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -89.14 -20.26 24.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.57 45.46 4.61 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -111.61 137.67 43.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.932 0.396 . . . . 0.0 111.453 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.34 158.16 62.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.576 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.27 141.02 46.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.484 2.122 . . . . 0.0 112.002 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.09 3.16 36.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -100.45 165.35 11.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -88.12 126.31 35.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.5 mm -104.52 149.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.678 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.63 115.34 25.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.124 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.37 127.34 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.99 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.07 131.04 38.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.21 144.5 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.446 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -100.04 129.57 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 110.646 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -102.29 150.86 22.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.583 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -110.48 142.95 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.785 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.36 5.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.852 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.62 -154.51 16.7 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.573 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 tt -106.99 127.94 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.72 179.79 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.577 0.227 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -142.53 -7.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -109.68 152.15 25.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.469 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -130.13 156.69 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -98.49 153.75 18.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.88 0.372 . . . . 0.0 111.333 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.06 117.15 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.524 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 119.91 38.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.407 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 163.14 23.21 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 -1.0 9.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.268 1.978 . . . . 0.0 112.236 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -89.41 -18.21 27.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 5.75 51.56 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -105.47 146.41 29.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -108.85 154.78 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.383 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.74 149.99 46.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.317 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 126.01 52.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.069 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.5 tp -120.05 148.56 43.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.93 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.97 116.37 32.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 -179.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.2 p -137.92 165.12 36.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.241 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.3 -13.05 35.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.537 2.158 . . . . 0.0 112.676 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.08 -6.49 58.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.081 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 m-85 -81.22 144.95 31.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.072 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -91.43 168.47 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -67.54 -32.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.417 . . . . 0.0 110.251 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -71.72 -34.38 69.53 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -71.59 -47.97 51.3 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.19 -36.21 77.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.841 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.26 -37.59 71.93 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.9 pt-20 -71.2 -24.95 62.32 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.45 -50.63 20.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.595 0.236 . . . . 0.0 110.836 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 tp -69.6 -35.5 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -28.24 66.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -68.03 -33.57 74.83 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.38 -18.65 33.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.68 -18.21 18.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.594 0.235 . . . . 0.0 111.417 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.46 41.19 16.96 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.131 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.53 178.0 6.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.487 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 32.7 m -98.3 131.43 26.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.828 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 23.0 Cg_exo -63.18 -25.24 72.57 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.02 2.48 . . . . 0.0 113.542 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.24 -15.65 60.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.42 -28.11 14.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.439 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -88.79 123.66 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.85 0.357 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -110.73 137.68 48.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.33 133.51 35.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 128.9 46.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.069 0.462 . . . . 0.0 111.445 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -130.56 124.73 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.06 32.49 1.96 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.024 0.93 . . . . 0.0 113.399 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.9 22.92 37.13 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.839 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -132.31 135.41 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 p -89.25 149.35 23.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 136.11 54.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.04 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -95.03 145.31 29.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.725 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.92 -22.19 56.19 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.206 2.604 . . . . 0.0 113.958 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m -74.02 -26.92 60.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -174.41 5.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.244 0.545 . . . . 0.0 111.848 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -114.33 157.51 22.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.257 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.0 mt -73.04 -32.17 64.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.06 -11.52 59.96 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.88 -28.77 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -84.74 -19.79 32.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.59 45.67 6.35 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.008 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.9 142.95 13.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.851 0.358 . . . . 0.0 111.505 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.0 p -124.32 155.55 68.27 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.72 146.6 54.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.616 2.211 . . . . 0.0 112.3 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.16 10.95 53.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.0 p -106.7 157.68 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.011 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -90.97 122.16 33.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.94 127.49 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.72 137.69 39.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.292 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.17 161.22 15.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.955 0.407 . . . . 0.0 111.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -138.97 134.33 32.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.281 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.92 144.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.407 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -113.3 146.17 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -115.37 147.77 40.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.777 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -129.39 152.64 48.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.7 -60.82 0.53 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.616 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.7 47.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.23 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 mt -131.9 127.66 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.697 179.911 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.57 0.224 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 p -107.93 150.95 26.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 111.429 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -126.43 162.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.811 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -117.34 136.63 53.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.995 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.67 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -126.12 116.35 45.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.005 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 119.26 32.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.541 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -99.41 163.18 19.09 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.828 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 11.4 Cg_endo -55.76 -21.07 30.85 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.946 2.431 . . . . 0.0 113.702 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.31 -22.01 63.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.34 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.84 -18.55 49.7 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.609 -0.805 . . . . 0.0 114.093 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -84.34 173.22 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.53 0.665 . . . . 0.0 110.082 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -129.82 150.41 51.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.954 0.407 . . . . 0.0 111.488 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -119.77 149.84 41.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.797 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.76 123.28 49.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -136.36 159.95 40.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.05 139.25 34.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.712 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.9 148.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.748 0.309 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 p -139.25 157.23 71.32 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.32 -6.7 19.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.648 2.232 . . . . 0.0 112.577 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -97.48 -12.11 23.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.325 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.22 144.99 28.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 p -97.56 169.55 9.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.93 -33.04 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 110.05 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -72.43 -37.98 68.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.6 tt0 -71.18 -49.11 47.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.09 -34.96 74.19 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.349 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.17 70.79 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -70.66 -24.83 62.77 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -51.52 18.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 tp -69.33 -32.33 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.959 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.13 66.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.662 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -65.96 -33.35 75.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.874 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -80.3 -22.98 41.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.676 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 -18.22 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.682 0.277 . . . . 0.0 111.073 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.65 42.15 9.31 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.818 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -129.57 178.08 6.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.7 p -108.15 145.15 30.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.85 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.39 -23.25 44.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.896 2.398 . . . . 0.0 114.078 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -75.51 -9.03 58.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.83 -27.72 10.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.509 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -91.11 132.46 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -123.52 134.94 53.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.14 132.8 35.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.215 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.61 125.79 43.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.056 0.455 . . . . 0.0 111.247 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -135.38 122.87 22.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 64.04 24.98 13.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.08 -14.95 62.15 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.115 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.33 148.83 23.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.897 0.379 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -96.98 154.98 16.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.8 135.84 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -93.43 141.15 23.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.3 Cg_exo -66.13 -22.01 54.92 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.221 2.614 . . . . 0.0 113.503 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -75.46 -25.16 57.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.55 -174.5 4.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.343 0.592 . . . . 0.0 111.752 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -115.27 164.4 14.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.254 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.31 -30.05 63.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.01 -9.09 59.67 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.94 -31.64 27.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 0.0 110.469 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -82.17 -19.72 39.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.654 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.71 45.65 5.99 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.53 141.32 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.375 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -123.21 155.09 65.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.969 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.26 143.29 48.0 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.613 2.208 . . . . 0.0 112.112 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.49 47.12 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.728 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.8 m -99.44 164.98 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.408 . . . . 0.0 110.69 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 16.2 p -96.15 125.45 40.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.848 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.55 138.26 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.882 0.372 . . . . 0.0 111.22 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.13 130.34 55.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -103.55 161.48 13.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.56 147.74 36.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.786 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.372 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.9 0.381 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -113.65 149.74 34.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -130.81 159.17 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.775 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.461 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -110.24 129.25 55.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.0 109.97 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.674 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -118.87 111.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 132.5 33.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.858 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 162.98 20.98 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.992 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -0.88 9.68 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.247 1.965 . . . . 0.0 112.152 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.02 -14.68 30.93 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.37 52.2 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.231 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -107.47 147.47 30.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.099 0.476 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 p -102.59 157.21 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 149.95 51.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.522 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.21 128.29 54.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.832 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 tp -128.83 152.04 48.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 106.18 17.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.336 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.1 174.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 7.4 p -141.17 161.31 53.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.311 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 19' ' ' THR . 19.3 Cg_endo -61.55 -15.29 40.49 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.653 2.235 . . . . 0.0 112.732 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -82.5 -9.93 59.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.749 0.309 . . . . 0.0 111.256 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.98 160.59 21.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.0 p -93.76 166.43 12.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.566 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -69.9 -31.35 47.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.018 0.437 . . . . 0.0 110.213 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -68.41 -36.67 79.44 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -70.58 -47.34 60.72 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.043 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -59.77 -39.13 83.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.07 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.68 70.94 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.2 pt-20 -74.14 -24.67 59.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -74.08 -46.7 41.36 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.7 -33.34 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.563 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.07 -28.12 66.23 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.788 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.56 -33.53 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -77.31 -31.48 54.71 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -97.26 -18.21 19.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.89 47.76 6.09 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.773 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.8 mt -131.69 178.6 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 42' ' ' ILE . 64.1 m -104.15 147.54 34.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.669 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.7 Cg_exo -66.06 -23.35 53.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.991 2.461 . . . . 0.0 113.215 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.26 -15.41 60.53 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 111.59 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -96.38 -32.28 12.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.252 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.23 117.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.293 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -109.6 133.11 53.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.93 125.42 39.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 126.06 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.083 0.468 . . . . 0.0 111.365 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -134.47 117.78 16.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 65.02 25.18 12.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.687 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.4 -15.11 63.04 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.023 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.93 144.0 29.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.41 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.42 150.78 19.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.9 135.68 40.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 137.22 22.59 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -62.79 -22.41 73.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.02 2.48 . . . . 0.0 113.655 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -78.34 -27.04 46.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.9 -174.34 5.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.573 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 70.8 p -113.87 158.76 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.94 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.86 -31.79 64.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.865 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.17 -9.52 59.58 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.9 tp10 -82.73 -20.76 35.37 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.03 0.443 . . . . 0.0 110.55 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.2 -19.92 23.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.332 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.81 45.42 5.45 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.848 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.42 141.87 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 111.382 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.5 p -122.97 158.88 56.15 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.88 138.48 53.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.538 2.159 . . . . 0.0 112.014 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.02 3.44 26.37 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.632 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 p -98.86 172.26 7.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.461 HG22 ' ND2' ' A' ' 5' ' ' ASN . 11.8 p -95.84 120.44 36.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 126.07 74.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.72 128.73 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -97.67 161.5 13.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.041 0.448 . . . . 0.0 111.124 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -140.49 144.34 35.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.218 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.845 0.355 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -111.15 152.13 27.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -126.37 161.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.676 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.46 129.58 56.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.78 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.679 HG22 HD23 ' A' ' 70' ' ' LEU . 1.3 mp -119.42 111.95 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.741 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.98 132.13 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.668 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.4 161.42 25.33 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.16 -0.51 9.23 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.087 1.858 . . . . 0.0 112.097 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -91.61 -14.61 29.91 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.58 5.48 51.49 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.2 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -111.34 144.68 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -104.76 155.42 18.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.844 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.58 150.0 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.28 122.09 43.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -134.25 161.84 33.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.185 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -96.44 146.89 24.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 110.799 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.77 148.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -140.36 157.03 69.42 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.03 -6.51 19.11 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.727 2.285 . . . . 0.0 112.55 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.29 -11.99 22.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.73 143.69 29.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.385 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.8 p -97.33 170.38 9.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.33 -31.91 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.244 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 57.8 tttt -72.3 -39.97 67.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.878 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.8 tt0 -70.37 -47.13 62.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.798 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.68 -31.23 71.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -34.48 68.73 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.972 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -73.39 -24.88 60.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.618 0.247 . . . . 0.0 110.824 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.55 -49.68 52.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -69.43 -32.68 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.93 -28.36 66.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.887 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -70.94 -33.28 70.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -76.24 -29.2 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.92 -18.06 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.13 45.17 6.72 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.018 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 6.3 mt -132.07 178.55 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.1 p -105.13 147.44 34.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.644 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.1 Cg_exo -67.43 -17.72 49.17 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.049 2.499 . . . . 0.0 113.627 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.17 -20.32 59.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.53 -29.49 13.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.63 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.74 121.5 43.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -114.68 135.14 54.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.39 122.16 35.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.55 54.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.395 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.66 116.3 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.306 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 64.37 24.86 13.33 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.627 0.579 . . . . 0.0 111.774 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.04 76.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.867 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.54 142.12 33.38 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -92.98 151.03 20.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.203 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -100.22 135.97 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.425 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -85.78 130.97 48.7 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.248 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.2 Cg_exo -66.13 -22.14 54.74 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.061 2.508 . . . . 0.0 113.508 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -80.32 -27.96 38.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.27 -174.56 4.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.411 0.624 . . . . 0.0 111.922 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.6 p -107.3 157.96 17.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.365 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.4 -32.3 64.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.829 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.98 -15.52 60.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.7 tt0 -82.79 -19.78 37.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.887 0.375 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.87 -19.7 24.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.387 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.34 45.44 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.986 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.13 136.79 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -123.84 155.99 66.04 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.142 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.54 145.56 52.97 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.766 2.31 . . . . 0.0 112.173 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.01 10.56 48.79 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.633 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 m -100.86 164.6 11.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 HG22 ' ND2' ' A' ' 5' ' ' ASN . 9.8 p -96.86 119.69 35.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.94 138.85 48.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.353 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 126.51 52.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.05 161.52 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.288 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.84 134.38 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.626 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.632 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.718 0.294 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -111.75 148.88 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -129.58 154.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.416 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.8 136.08 48.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.715 HG22 HD23 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -130.53 113.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 123.1 32.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.461 . . . . 0.0 111.657 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.3 166.09 13.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.793 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.03 -23.3 34.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.957 2.438 . . . . 0.0 113.684 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.35 -24.53 65.72 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.438 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.4 -8.84 55.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.405 -0.902 . . . . 0.0 114.208 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -90.13 166.74 13.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.502 0.651 . . . . 0.0 110.16 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.7 p -106.61 148.23 28.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 150.17 40.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.191 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 124.96 44.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.923 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -129.58 146.06 51.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 115.19 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.76 176.76 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.0 p -136.31 165.47 35.29 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.07 -15.12 47.53 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.622 2.215 . . . . 0.0 112.651 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.75 -5.75 59.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -80.13 139.78 36.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.223 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 11.7 p -86.93 167.53 14.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 t -66.9 -34.13 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.352 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -70.91 -31.9 68.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.69 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.9 -48.93 32.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.31 -34.34 72.2 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -35.94 69.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.311 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -74.17 -24.6 59.41 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -44.74 35.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.997 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 tp -71.13 -34.26 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.405 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.31 80.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -68.76 -33.39 73.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.36 61.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.16 -17.89 24.27 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.89 34.95 11.98 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.81 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.0 178.55 6.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.703 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 59.4 m -98.57 146.71 32.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.924 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.1 Cg_exo -68.28 -20.62 42.68 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.95 2.433 . . . . 0.0 113.054 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -75.08 -15.13 60.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.587 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -96.96 -37.11 10.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.69 121.72 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -115.94 137.75 51.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mt -93.47 133.29 36.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.1 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.64 128.63 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 111.412 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -128.52 126.38 40.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.364 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.46 1.94 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 113.227 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.61 22.96 41.16 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.06 -0.591 . . . . 0.0 114.046 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.0 141.33 44.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 p -89.99 149.25 22.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.42 136.04 39.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.384 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -88.62 127.52 56.12 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.212 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -64.36 -23.01 65.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.341 2.694 . . . . 0.0 113.864 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.9 m -79.05 -27.28 43.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.33 -174.0 4.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.334 0.587 . . . . 0.0 111.859 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 49.4 p -109.56 155.93 20.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 22' ' ' PHE . 11.1 mt -73.22 -34.39 65.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.81 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.38 -16.04 61.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.91 -20.27 35.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -90.18 -19.52 24.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.208 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.7 45.38 4.28 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.84 137.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.76 157.13 63.83 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.43 137.96 37.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.391 2.061 . . . . 0.0 111.964 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.52 13.94 31.35 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.346 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.6 t -103.64 161.94 13.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.416 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.2 p -88.16 121.91 31.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.157 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.94 128.38 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.727 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 130.67 54.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.715 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -101.72 160.99 13.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.028 0.442 . . . . 0.0 111.166 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -141.13 143.25 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.559 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 179.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.575 0.226 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -108.26 154.8 21.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.412 . . . . 0.0 111.3 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.47 160.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.431 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -105.44 131.28 53.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.077 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 13' ' ' THR . 5.3 mm -105.37 108.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.069 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -95.14 113.22 24.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 162.64 22.53 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.319 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.31 -0.46 9.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.7 -18.34 26.61 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 5.88 52.53 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.387 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -109.06 147.32 32.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 20.4 p -114.82 144.85 42.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.79 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -122.59 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.498 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.86 120.78 41.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.74 155.98 48.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.51 135.98 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.07 149.0 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 111.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -137.55 156.71 74.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.308 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.09 -6.38 18.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.761 2.307 . . . . 0.0 112.694 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.64 -9.76 22.78 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.733 0.302 . . . . 0.0 111.414 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.57 138.02 32.97 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.407 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -93.87 169.75 10.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.7 t -66.98 -32.6 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.306 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -71.9 -36.05 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.646 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.7 tt0 -72.57 -49.46 32.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.17 -32.23 70.87 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -36.6 69.67 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.925 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.2 -24.87 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.289 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.18 -51.2 40.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.31 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 tp -70.58 -32.65 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.802 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.17 -29.82 67.9 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.808 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -67.22 -33.41 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.939 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -85.45 -17.3 36.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.789 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.6 mt -98.12 -18.05 18.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 111.421 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.67 33.29 22.29 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.009 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.3 mt -132.43 178.45 6.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.014 0.435 . . . . 0.0 110.997 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 42' ' ' ILE . 48.8 m -103.84 140.93 21.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.67 -18.45 58.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.179 2.586 . . . . 0.0 113.686 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.43 -21.67 57.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 111.719 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.03 -28.9 15.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.536 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.76 128.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.461 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -109.84 134.17 52.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.69 129.08 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.182 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 132.27 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -133.58 125.2 28.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.285 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.42 31.57 1.95 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.094 0.958 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.31 23.46 37.23 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.991 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -136.29 139.48 42.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.941 0.371 . . . . 0.0 110.805 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 p -92.51 145.65 24.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.18 135.98 41.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.42 138.11 27.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.6 Cg_exo -64.44 -22.26 65.81 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.747 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 p -78.55 -28.38 46.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.71 -175.46 5.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 112.036 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.5 p -115.74 162.4 17.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.239 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.3 -30.25 63.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.869 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.54 -8.74 59.76 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.91 -31.03 28.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.097 0.475 . . . . 0.0 110.521 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -82.08 -19.79 39.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.691 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.64 5.65 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.705 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.52 136.6 30.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.4 p -123.74 156.67 64.68 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.859 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -69.74 136.33 32.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.627 2.218 . . . . 0.0 112.136 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.11 25.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.696 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.5 p -98.06 161.53 13.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.936 0.398 . . . . 0.0 110.763 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.431 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -93.47 123.24 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.62 146.7 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.267 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 110.3 16.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 137.45 34.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.279 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.11 131.76 42.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.579 -179.662 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -111.05 152.08 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.208 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pt -128.48 156.94 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.148 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -99.32 154.42 18.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.296 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -136.44 114.64 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.704 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.03 122.07 39.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 111.786 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.32 163.86 19.71 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.11 -1.56 9.76 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.235 1.957 . . . . 0.0 111.895 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.87 -17.76 25.95 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.62 6.03 50.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -106.9 142.47 36.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.079 0.466 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.3 p -111.17 153.86 25.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.367 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.43 150.16 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.573 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.29 128.33 55.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -125.28 145.39 50.03 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 120.65 40.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.069 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.25 -179.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.037 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.8 p -133.84 164.98 40.13 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.81 -15.41 50.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.593 2.195 . . . . 0.0 112.584 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -86.09 -4.75 59.23 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.4 m-85 -80.75 137.34 36.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -90.18 170.26 10.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.68 -33.04 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -71.24 -34.38 70.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.924 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.7 -48.73 36.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.763 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.23 -36.13 77.01 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.906 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.76 -36.63 70.44 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.306 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.84 -25.17 61.87 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.93 -46.46 24.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.654 0.264 . . . . 0.0 111.176 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -72.01 -36.32 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.911 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.23 79.07 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.364 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 23.4 ttt180 -70.94 -33.41 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -26.96 61.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.452 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 mt -99.56 -18.22 17.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.62 47.66 5.29 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.15 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.28 177.93 7.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.994 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 42' ' ' ILE . 51.1 m -100.82 125.66 37.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.802 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.99 -20.21 71.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.133 2.555 . . . . 0.0 113.606 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.12 -19.96 59.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.39 -25.09 15.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.91 126.25 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.421 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -118.68 135.67 54.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.15 126.99 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.02 125.04 44.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 111.467 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -132.43 119.42 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 65.01 24.87 12.64 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.586 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -15.5 62.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.15 143.79 29.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.36 152.47 18.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 136.12 40.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.16 139.95 24.39 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.822 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.2 Cg_exo -63.7 -22.22 69.87 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.862 2.375 . . . . 0.0 113.408 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -82.26 -26.18 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.05 -174.72 5.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 111.659 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.5 p -115.25 160.73 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.868 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.14 -32.76 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.825 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.05 59.64 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.488 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.69 -19.84 37.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.073 0.463 . . . . 0.0 110.715 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -89.38 -19.57 25.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.52 4.84 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.649 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.17 142.28 27.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.01 0.433 . . . . 0.0 111.469 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -118.2 157.33 49.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.739 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.09 148.08 68.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.767 2.311 . . . . 0.0 112.495 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.93 6.3 52.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.695 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 p -101.01 158.37 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 110.66 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p -88.51 122.62 32.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.57 132.99 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.239 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.45 134.84 48.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -106.84 161.21 14.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.78 0.324 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -137.44 138.65 40.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.679 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.734 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.749 0.309 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -112.07 153.69 26.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.402 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' THR . 3.3 pt -120.98 160.72 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.056 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -97.71 151.87 19.69 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.181 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' THR . 16.4 mm -126.6 116.24 44.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.413 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.21 115.18 29.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 111.44 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.78 163.64 21.79 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.92 -2.27 11.25 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.295 1.997 . . . . 0.0 111.832 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.12 -18.22 26.23 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.42 5.53 51.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.168 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -104.23 145.07 30.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.195 0.521 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.7 p -113.73 151.51 31.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.286 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.08 145.04 45.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.354 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -108.08 123.13 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 111.479 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -124.59 153.38 42.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.05 131.8 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.748 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.28 147.55 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.985 0.421 . . . . 0.0 111.429 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -140.07 157.78 68.48 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.235 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.48 -6.28 18.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.695 2.263 . . . . 0.0 112.527 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -97.33 -14.93 20.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.349 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.8 140.64 32.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -94.17 171.05 9.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.3 -32.92 57.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -71.73 -37.45 70.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.993 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tt0 -72.23 -47.83 47.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.716 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.76 -32.4 72.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.598 0.237 . . . . 0.0 111.126 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.75 -37.87 70.49 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.677 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -69.96 -24.67 63.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.39 0.138 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.57 -53.05 25.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 110.765 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.45 -32.67 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.84 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.7 -27.82 66.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.772 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.49 -33.28 74.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -75.62 -31.35 59.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.79 -18.27 19.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.49 48.29 5.99 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.085 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.66 178.22 6.8 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.097 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 42' ' ' ILE . 37.9 m -106.25 143.89 27.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.6 Cg_exo -66.87 -21.99 49.63 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.957 2.438 . . . . 0.0 113.305 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.26 -17.17 60.37 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 111.774 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -95.97 -30.29 13.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.367 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.37 122.54 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.437 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -110.53 129.3 55.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.27 130.1 39.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.163 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.36 127.19 49.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.01 0.433 . . . . 0.0 111.294 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -133.03 117.48 17.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 64.7 24.91 12.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.658 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.93 -13.89 66.55 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.744 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -100.18 140.79 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -91.96 151.56 20.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.128 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.47 136.04 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.301 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.8 t70 -95.38 138.02 21.97 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -63.89 -22.28 68.81 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.05 2.5 . . . . 0.0 113.444 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -80.35 -27.12 38.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.56 -174.32 4.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.539 0.685 . . . . 0.0 111.548 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.6 p -115.55 166.48 11.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.092 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.12 -30.57 63.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 -7.7 59.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.84 -22.39 34.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.062 0.458 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.34 -19.41 24.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.739 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.54 45.78 6.33 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.81 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.08 142.63 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -122.86 148.43 53.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.077 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.13 149.88 71.38 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.76 2.307 . . . . 0.0 112.572 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.51 1.76 35.06 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.631 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.0 m -107.88 159.44 16.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.846 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 p -89.1 127.0 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.77 121.08 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.853 0.358 . . . . 0.0 111.066 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.27 135.22 42.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -114.6 161.44 18.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.646 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -141.94 133.61 26.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.441 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.959 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -109.31 153.54 23.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.76 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.34 162.12 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.556 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 129.35 56.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.926 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -119.83 113.13 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 135.08 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.968 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -101.14 162.35 20.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.25 -1.89 10.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.22 1.947 . . . . 0.0 111.696 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.01 -15.98 28.71 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.22 51.76 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -108.17 148.89 29.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -113.26 155.24 25.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.429 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -131.75 150.09 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.88 126.11 52.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.259 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.3 160.75 36.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.3 136.88 38.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.783 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.67 146.75 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.599 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.9 p -139.01 157.69 70.99 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.057 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.5 -6.03 18.08 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.78 2.32 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.18 -11.12 20.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.682 0.277 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.13 140.71 32.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.813 0.339 . . . . 0.0 110.363 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -94.88 171.92 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 t -68.22 -33.27 59.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.964 0.411 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.876 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.2 -47.86 54.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.14 -39.01 88.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.401 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.47 63.27 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.99 -27.16 63.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.995 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.41 -50.87 23.25 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -66.14 -32.58 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.878 0.371 . . . . 0.0 111.442 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.37 -28.03 65.85 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.85 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -69.71 -33.59 72.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -76.66 -31.16 57.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.77 -18.01 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.84 5.5 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.961 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 mt -132.25 178.53 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.4 p -109.61 147.53 36.29 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.2 Cg_exo -67.84 -17.69 47.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.131 2.554 . . . . 0.0 113.605 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.22 -19.95 59.51 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.01 -28.15 13.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.585 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.25 124.97 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 111.386 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -117.75 132.29 56.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.468 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -92.03 132.21 36.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.49 125.27 44.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -135.51 123.74 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.6 t30 64.61 25.14 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.853 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.87 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.771 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -100.66 150.04 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.067 0.46 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 p -93.38 158.41 15.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.333 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.37 135.8 43.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.016 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -88.96 135.19 32.11 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.011 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.8 Cg_exo -65.08 -22.28 62.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.072 2.515 . . . . 0.0 113.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 m -80.27 -27.45 38.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.34 -174.91 5.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.365 0.602 . . . . 0.0 111.862 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.2 p -113.29 158.94 19.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.0 mt -73.39 -31.29 63.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.77 -21.33 34.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.995 0.426 . . . . 0.0 110.909 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -88.28 -19.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 45.6 5.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.708 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.36 137.91 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.976 0.417 . . . . 0.0 111.514 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -123.34 156.95 62.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.925 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.81 146.14 52.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.722 2.282 . . . . 0.0 112.395 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.78 45.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.522 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.7 p -98.98 165.94 11.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -96.53 124.89 40.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.36 136.05 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.12 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.43 126.34 51.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.709 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -93.6 160.86 14.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.878 0.37 . . . . 0.0 111.252 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.47 149.51 45.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.473 179.66 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.771 0.319 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -107.91 151.37 25.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.093 0.473 . . . . 0.0 111.424 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.47 161.97 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.632 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.09 131.77 54.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.803 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.583 HG22 HD23 ' A' ' 70' ' ' LEU . 1.7 mp -120.08 113.48 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.298 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 132.96 35.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.935 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.78 161.8 22.69 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.884 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.02 -1.78 10.54 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.34 2.027 . . . . 0.0 111.812 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.25 -16.71 27.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.5 5.57 51.6 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.295 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -108.07 141.18 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.6 p -102.68 155.32 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -128.77 150.0 50.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.503 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.51 121.25 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.53 161.97 33.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.92 139.03 35.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.832 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.76 149.3 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.539 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 p -139.13 149.72 62.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.95 -9.57 26.34 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.635 2.223 . . . . 0.0 112.64 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -94.3 -9.34 36.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.94 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.55 145.85 26.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.4 p -96.43 169.36 9.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.53 -30.54 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.402 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.3 -39.48 68.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.022 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.63 -47.95 51.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.949 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.73 -33.37 72.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.224 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.96 69.61 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.7 pt-20 -72.26 -25.15 61.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -51.06 26.27 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.531 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 tp -67.45 -32.78 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.873 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.08 69.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -68.31 -33.48 74.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -84.87 -13.86 49.65 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -100.83 -18.09 16.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.612 0.244 . . . . 0.0 111.362 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.86 32.76 20.45 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.963 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.22 178.09 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.019 0.437 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.4 p -103.04 139.98 20.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.667 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.06 -17.04 45.82 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.015 2.476 . . . . 0.0 113.801 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.48 -21.5 58.01 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.37 -27.56 14.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.568 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 38' ' ' SER . 1.7 mt -87.52 123.4 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.432 . . . . 0.0 111.491 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.82 137.62 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.84 130.98 37.51 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.211 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.55 125.98 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -135.16 122.64 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.0 t30 62.87 26.56 15.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.793 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.8 -19.63 47.29 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.275 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -97.19 149.7 21.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -96.04 155.52 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.139 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 135.75 43.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.188 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -89.8 137.43 28.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 19.8 Cg_exo -65.1 -22.26 62.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.111 2.54 . . . . 0.0 113.388 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -77.7 -26.14 49.96 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.42 -174.88 5.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.2 p -115.25 163.89 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.356 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -73.37 -30.92 63.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.872 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.36 -7.77 59.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -82.9 -31.85 27.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.658 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -81.63 -19.89 40.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.663 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.71 5.37 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.23 141.53 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.786 0.327 . . . . 0.0 111.365 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.7 p -124.81 156.66 68.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.24 137.86 38.04 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.42 12.06 31.89 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.459 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t -101.71 160.1 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.9 p -87.52 124.38 33.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.181 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.02 127.63 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.983 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.25 125.44 53.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.583 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.93 161.06 14.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -139.73 144.42 37.48 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.477 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.743 0.306 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 p -110.45 151.98 26.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.513 . . . . 0.0 111.382 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.66 157.66 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -101.7 153.92 19.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.79 113.1 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.266 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.31 121.69 38.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.935 0.398 . . . . 0.0 111.553 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 163.67 19.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.58 -1.27 10.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.321 2.014 . . . . 0.0 112.032 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.44 -17.93 26.3 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.64 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.31 5.49 52.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.385 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -104.43 146.42 28.87 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 110.717 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p -109.86 156.5 20.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.567 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 150.25 46.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.292 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 125.14 50.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.283 . . . . 0.0 111.329 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.1 165.53 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.95 143.15 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.86 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.42 148.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.381 . . . . 0.0 111.641 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 p -139.43 157.38 70.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.079 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.41 -5.99 18.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.691 2.26 . . . . 0.0 112.675 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -99.69 -13.94 19.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.375 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.53 141.36 32.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.759 0.314 . . . . 0.0 110.33 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 p -94.92 171.79 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.89 -32.57 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.045 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -71.83 -39.18 69.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.113 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 5.1 tt0 -72.15 -45.04 62.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.71 -31.15 72.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 110.648 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.74 69.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.832 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -70.16 -26.19 63.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.408 0.147 . . . . 0.0 111.107 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.43 -53.35 29.81 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.94 -32.85 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.612 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.97 65.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -68.54 -33.46 74.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -77.33 -28.52 53.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.897 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.32 -18.11 18.52 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.31 47.82 5.59 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.108 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.12 178.29 6.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 111.313 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.6 t -107.2 141.99 24.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.58 -23.23 64.24 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.94 2.426 . . . . 0.0 113.495 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.4 -15.71 60.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.69 -31.87 12.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.62 124.28 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.628 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -113.0 131.7 55.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.384 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.64 124.24 34.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 127.21 52.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.708 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.87 115.84 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.379 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.04 24.96 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.06 -7.54 78.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.743 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -102.44 138.74 38.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -91.06 151.2 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.321 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 136.12 42.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.321 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -87.29 132.71 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.236 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 16.8 Cg_exo -66.0 -22.31 55.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.09 2.527 . . . . 0.0 113.543 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.1 m -78.84 -26.26 44.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.96 -174.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.435 0.636 . . . . 0.0 111.663 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.4 p -108.93 160.71 15.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.261 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.16 -32.02 64.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.661 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -9.63 59.65 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.62 -23.76 34.16 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 110.787 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.66 -19.75 23.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.631 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.27 5.53 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.862 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.34 136.71 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -123.37 155.48 65.21 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.59 155.72 62.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.88 2.387 . . . . 0.0 112.5 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.19 57.36 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.4 m -107.85 153.3 23.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 0.0 110.732 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -88.61 127.08 35.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.642 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -110.91 129.52 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 135.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.514 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -107.57 161.05 15.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.935 0.397 . . . . 0.0 111.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -140.07 135.43 32.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.351 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.667 -179.851 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.86 0.362 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 p -110.02 154.33 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -130.32 161.62 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.44 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.17 130.03 56.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.099 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.619 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -119.68 113.53 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.663 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.5 132.91 34.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.873 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.0 161.28 24.78 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.75 -1.08 9.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.162 1.908 . . . . 0.0 111.736 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.07 -15.33 29.68 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.43 6.02 51.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.442 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -109.6 151.82 26.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 110.878 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -112.95 146.43 39.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.708 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.1 mm? -116.03 150.08 37.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.526 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.27 123.39 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 111.071 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.39 161.09 37.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.599 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.24 134.56 40.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.644 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.49 148.5 17.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.817 0.342 . . . . 0.0 111.647 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 p -139.39 157.19 71.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.213 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.4 -6.26 18.51 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.696 2.264 . . . . 0.0 112.58 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.31 -9.72 22.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.43 142.73 29.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.4 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.7 p -95.52 171.57 8.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -68.8 -32.78 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 0.0 110.076 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -72.49 -36.62 68.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.914 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.1 tt0 -71.32 -48.12 52.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.82 -33.82 74.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.145 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.41 69.47 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.077 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.4 pt-20 -70.24 -24.93 63.16 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.02 -50.18 30.72 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.807 0.337 . . . . 0.0 110.356 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tp -70.12 -32.95 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -67.98 -33.02 73.85 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -62.38 -33.47 74.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.817 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -87.56 -10.54 51.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.753 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.12 -18.84 19.84 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.314 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.22 -6.32 78.47 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.263 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.453 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -119.74 164.13 16.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 110.998 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -83.59 154.7 65.61 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.396 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.69 -16.34 53.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.715 2.943 . . . . 0.0 113.245 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.32 -23.84 66.01 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.08 -24.58 14.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.711 0.291 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -92.07 127.18 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -123.64 140.23 53.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.025 0.44 . . . . 0.0 110.516 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.7 135.39 36.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.413 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.54 126.12 35.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.679 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -137.23 127.05 25.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 63.98 25.02 13.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.609 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 -18.76 44.1 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.868 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -96.04 149.96 21.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.775 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.6 p -96.0 156.87 16.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.16 135.15 48.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.076 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -92.37 137.99 24.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.761 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.3 Cg_exo -63.96 -22.13 68.46 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.899 2.399 . . . . 0.0 113.525 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -79.51 -27.97 41.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -83.64 -175.06 5.63 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.283 0.564 . . . . 0.0 111.951 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.8 p -116.05 163.28 16.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.119 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -73.23 -31.01 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.63 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.05 59.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.84 -24.54 33.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.973 0.416 . . . . 0.0 110.72 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.5 -20.2 26.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.498 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.98 45.29 5.73 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 141.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 111.549 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.6 t -122.5 144.49 42.33 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.569 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.6 Cg_exo -67.32 137.55 43.81 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.406 2.071 . . . . 0.0 112.097 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.96 4.65 27.61 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 t -99.4 168.54 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.44 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.5 p -93.75 122.61 36.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.12 134.75 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 128.41 55.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.619 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -101.12 159.42 15.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.137 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -139.73 148.71 42.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.102 179.556 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.834 0.35 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.8 p -107.73 149.44 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.57 156.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.439 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.52 127.96 54.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.509 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.33 111.02 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.726 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 125.0 35.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.82 161.57 24.53 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.118 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.82 -0.53 7.09 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.326 2.017 . . . . 0.0 111.92 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.38 -18.23 24.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.3 52.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.495 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -109.34 140.91 42.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.094 0.473 . . . . 0.0 110.874 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -108.4 151.92 25.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.035 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.72 149.89 52.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.8 122.75 48.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tp -131.88 151.52 51.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.084 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.84 120.8 41.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 27' ' ' LEU . 10.5 m -131.98 170.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.964 0.412 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 p -135.63 164.87 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.36 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.11 -12.5 35.74 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.875 2.383 . . . . 0.0 112.592 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -89.2 -6.1 57.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.878 0.371 . . . . 0.0 110.879 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 m-85 -80.91 139.82 35.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -91.0 169.29 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.77 -33.86 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.035 0.445 . . . . 0.0 110.169 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -70.96 -32.71 69.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.829 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.6 tt0 -72.62 -51.23 20.47 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.709 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 18' ' ' VAL . 6.4 tt -57.88 -36.18 72.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.817 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.09 70.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.92 -24.6 61.66 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -48.01 26.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.854 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.73 -33.27 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.543 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.11 65.76 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.24 -33.37 75.6 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.85 -21.1 34.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.776 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.72 -18.17 18.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.252 . . . . 0.0 111.436 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.63 9.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.105 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.97 177.82 7.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.203 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG13 ' A' ' 42' ' ' ILE . 3.2 p -106.04 126.24 31.1 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.593 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 32.5 Cg_exo -59.18 -18.05 42.29 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.393 2.729 . . . . 0.0 114.017 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.04 -14.7 60.62 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -109.12 -20.65 12.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.535 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.72 141.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -133.31 148.79 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 111.121 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.01 135.47 44.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.25 124.31 43.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -134.5 117.96 16.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.55 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 65.28 25.1 12.2 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.532 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.73 -16.47 60.14 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.824 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.26 146.77 25.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -95.26 149.43 21.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.06 135.82 44.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.01 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.79 141.79 24.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.015 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.9 -22.08 56.45 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.196 2.598 . . . . 0.0 113.548 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 m -76.12 -24.69 54.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.83 -174.63 4.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.4 0.619 . . . . 0.0 111.93 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.4 p -115.62 157.12 24.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.265 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.8 mt -73.33 -31.6 64.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.776 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.78 -17.21 60.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.431 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.7 tt0 -82.75 -19.96 36.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -90.34 -20.06 23.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.144 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.52 45.34 5.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.614 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.35 135.53 44.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -125.64 155.65 72.02 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.631 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -69.74 139.35 40.08 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.655 2.237 . . . . 0.0 112.031 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.92 -6.13 30.9 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.436 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -94.66 165.16 12.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.557 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.439 HG22 ' ND2' ' A' ' 5' ' ' ASN . 8.2 p -91.0 125.83 35.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.41 145.33 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.41 116.9 31.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.39 140.71 39.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.43 144.19 50.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.628 179.599 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.726 0.298 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.3 p -108.95 152.34 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.036 0.446 . . . . 0.0 111.697 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.05 158.93 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -103.07 153.67 20.04 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -136.91 122.58 27.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.07 112.3 25.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 111.312 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -96.26 164.15 19.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.188 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 9.7 Cg_endo -54.35 -23.25 29.88 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.136 2.557 . . . . 0.0 113.583 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HB2' HD12 ' A' ' 8' ' ' LEU . 2.8 m-20 -67.27 -24.67 65.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.703 0.287 . . . . 0.0 110.541 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -6.17 52.88 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.441 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -94.35 167.62 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.552 0.676 . . . . 0.0 110.231 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.3 p -117.84 151.03 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.733 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.43 150.08 49.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.225 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.25 123.0 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.26 164.72 21.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.686 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -99.93 137.76 37.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.623 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.02 150.0 23.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.872 0.368 . . . . 0.0 111.547 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 p -138.73 156.87 72.73 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.344 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.98 -6.86 19.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.705 2.27 . . . . 0.0 112.564 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.23 -12.0 22.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.25 140.1 31.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.4 p -93.24 169.36 10.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.576 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -67.86 -30.35 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 110.239 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -71.56 -39.9 70.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.149 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.01 -48.72 51.49 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.27 -32.34 71.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.247 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.92 -37.27 70.08 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.8 pt-20 -71.16 -24.82 62.32 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -51.32 23.86 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-O 120.786 0.326 . . . . 0.0 110.695 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.9 -32.76 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.936 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -28.41 66.67 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -69.07 -33.36 73.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -25.97 45.78 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.9 -17.98 21.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.39 41.61 9.94 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.235 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.94 178.12 7.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 42' ' ' ILE . 21.7 m -97.98 133.3 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.61 -21.19 46.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.975 2.45 . . . . 0.0 113.961 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -75.66 -14.76 60.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.65 -29.44 13.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.311 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.69 124.11 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.305 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -114.04 133.93 55.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.489 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.31 134.48 34.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.205 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.21 125.21 44.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -134.86 122.92 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.67 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 t30 63.65 25.92 14.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.803 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.04 -19.83 46.71 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.341 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.99 150.43 21.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.947 0.404 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 p -95.63 155.89 16.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.082 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.54 135.97 41.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.067 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.2 t70 -88.42 133.49 36.38 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.5 Cg_exo -65.33 -22.21 60.38 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.051 2.501 . . . . 0.0 113.358 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 -27.97 32.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.62 -174.53 4.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.307 0.575 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 43.7 p -108.83 161.28 15.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 9.3 mt -73.32 -30.06 63.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.764 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.21 -7.01 59.61 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.416 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.5 tm-20 -82.77 -26.92 31.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -83.13 -19.46 36.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.72 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 45.64 5.82 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 57' ' ' LEU . 2.1 mt -103.4 143.72 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -121.98 153.79 60.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.071 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 156.57 58.98 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.775 2.317 . . . . 0.0 112.491 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.91 2.14 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.505 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -104.12 156.1 18.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.99 0.424 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 p -88.92 125.87 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.464 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.28 138.11 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.351 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 131.93 56.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.341 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.5 161.07 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -139.24 151.77 46.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.212 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.655 0.264 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -108.02 148.9 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.841 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -134.41 156.86 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.65 153.64 19.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.682 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -138.97 118.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.979 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 116.41 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.14 0.495 . . . . 0.0 111.115 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -98.28 166.85 12.57 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.844 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 58.7 Cg_exo -54.54 -21.86 25.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.979 2.453 . . . . 0.0 113.617 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.45 -25.06 64.82 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.876 0.37 . . . . 0.0 110.377 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -8.55 55.1 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.375 -0.917 . . . . 0.0 114.386 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -92.22 163.34 13.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.533 0.666 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.1 p -115.96 156.31 26.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.33 150.15 52.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.14 122.41 46.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.77 149.13 47.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.72 117.84 33.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.746 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 179.17 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.227 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 15.3 p -135.26 165.1 39.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.266 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.2 -13.75 39.76 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 112.703 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.23 -7.3 58.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.04 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.3 m-85 -80.59 138.59 36.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.993 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -87.89 170.93 10.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.403 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.6 -32.25 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.044 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -72.11 -32.71 67.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.834 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.6 tt0 -72.25 -48.04 45.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.11 -34.61 75.22 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.786 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.72 -36.11 70.41 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -72.47 -24.91 61.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.619 0.247 . . . . 0.0 111.236 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.22 -50.34 28.25 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.831 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 tp -68.73 -33.05 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.876 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.32 66.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -70.45 -33.52 71.39 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -79.62 -26.63 41.11 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 -18.17 21.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.561 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.21 39.42 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.032 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.0 178.26 6.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.059 0.457 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.1 t -99.22 136.73 20.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.528 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.94 -17.27 51.39 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 123.164 2.576 . . . . 0.0 113.653 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.34 -21.73 58.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.668 0.27 . . . . 0.0 111.46 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.21 -28.28 16.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' SER . 1.2 mt -90.07 121.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.359 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -112.22 142.9 44.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.593 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.63 132.25 40.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.28 124.2 41.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 111.296 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -131.73 117.89 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.8 24.99 12.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.712 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.41 69.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.857 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.46 143.3 29.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 p -94.26 151.68 19.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.142 0.496 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.84 135.94 46.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.235 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.28 138.42 27.18 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.4 Cg_exo -63.78 -22.15 69.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.928 2.419 . . . . 0.0 113.759 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.6 p -78.83 -26.25 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -82.3 -174.59 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.334 0.587 . . . . 0.0 111.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -118.11 158.53 24.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.6 mt -73.21 -30.65 63.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.847 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.15 60.01 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.85 -27.95 30.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.427 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -83.23 -20.01 35.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.57 45.71 6.01 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.786 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -101.13 140.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.859 0.362 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -124.16 154.44 68.44 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.989 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.19 149.11 57.26 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.772 2.315 . . . . 0.0 112.339 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.46 6.59 54.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.408 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.2 t -106.45 161.6 14.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.898 0.38 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 p -93.17 121.22 34.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.34 126.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.032 0.444 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.13 143.76 32.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.669 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -117.61 161.81 19.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 111.054 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -136.26 132.2 35.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.337 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.768 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.776 0.322 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.2 p -111.67 150.39 30.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -129.96 160.35 41.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.684 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.422 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.36 129.29 56.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.11 0.481 . . . . 0.0 110.13 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -117.96 112.28 37.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.683 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.48 133.7 33.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.93 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -98.76 162.8 20.42 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.977 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.06 -1.11 9.02 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.221 1.947 . . . . 0.0 111.969 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.69 -16.86 27.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.75 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.95 50.89 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.286 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -106.03 149.02 27.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.138 0.494 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -105.31 153.88 21.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.668 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.92 149.86 51.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 125.24 50.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.003 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -127.96 147.01 50.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.51 115.57 30.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.6 174.8 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 12.7 p -137.74 166.12 28.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.55 -14.6 40.58 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.791 2.328 . . . . 0.0 112.65 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -85.38 -7.6 58.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.836 0.351 . . . . 0.0 111.19 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 19' ' ' THR . 3.3 m-85 -81.32 141.37 34.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 p -88.43 167.39 13.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.22 -33.96 67.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.069 0.461 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -71.44 -31.99 67.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.846 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 4.5 tt0 -72.91 -45.83 55.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.61 -36.5 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.395 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.34 67.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -73.74 -26.06 60.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.78 -45.9 48.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.118 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 tp -70.2 -32.79 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.712 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.7 77.35 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.634 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -65.73 -33.35 75.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -75.46 -25.75 57.67 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.06 -18.25 22.02 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.594 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.29 -5.69 83.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.544 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.83 176.54 5.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.223 0.512 . . . . 0.0 110.888 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 54.0 m -89.16 151.06 46.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.318 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 12.7 Cg_exo -69.04 -16.84 40.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.392 2.728 . . . . 0.0 113.051 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.12 -14.99 62.91 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.679 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.64 -20.88 18.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.36 148.03 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.999 0.428 . . . . 0.0 111.606 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -137.76 128.18 26.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.341 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.85 121.41 31.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.43 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.08 127.52 55.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.127 0.489 . . . . 0.0 111.384 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -138.35 120.03 15.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.339 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 65.01 24.93 12.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.789 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -19.42 50.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.906 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.45 149.9 22.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -94.49 150.13 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.07 135.84 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.23 137.55 29.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.66 -22.08 64.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.013 2.475 . . . . 0.0 113.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -77.36 -27.69 52.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.65 -174.02 4.38 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.337 0.589 . . . . 0.0 111.904 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 71.7 p -113.6 157.84 21.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.376 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.32 -30.16 63.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.06 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 -7.63 59.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -83.13 -32.0 26.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.522 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.92 -19.68 34.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.776 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.03 45.64 3.82 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.011 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.58 136.16 39.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.81 0.305 . . . . 0.0 111.056 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.38 157.71 58.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 138.52 37.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.6 7.71 33.77 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -98.93 170.05 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 110.75 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.422 HG22 ' ND2' ' A' ' 5' ' ' ASN . 10.0 p -95.58 122.4 38.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.18 129.83 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.4 126.98 55.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.513 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.575 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.5 161.01 14.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.75 145.89 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.363 179.533 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -110.38 151.97 26.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.74 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pt -131.18 156.12 42.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.519 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.598 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -120.92 112.69 36.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.73 133.93 33.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.94 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.73 162.44 21.14 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.817 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.46 -2.05 10.68 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.384 2.056 . . . . 0.0 111.801 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -91.17 -15.67 28.96 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.02 52.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.253 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -106.8 143.83 34.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 p -104.04 156.93 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.608 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.42 150.03 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.539 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.986 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 154.88 49.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.687 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.0 120.51 39.57 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.14 170.58 19.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.78 0.324 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 18.6 p -136.72 162.57 55.24 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.411 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.16 -14.92 44.95 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.741 2.294 . . . . 0.0 112.526 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.17 -3.64 59.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.898 0.38 . . . . 0.0 111.023 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.08 142.2 32.5 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.887 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.1 p -90.95 169.24 11.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 t -66.71 -33.55 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.94 0.4 . . . . 0.0 110.112 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.79 -34.3 69.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.803 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.21 -47.6 49.36 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.29 -35.55 77.62 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.759 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.02 69.87 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.95 -24.92 61.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.484 0.183 . . . . 0.0 111.444 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.81 -47.78 28.77 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -70.19 -32.71 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.9 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.84 -34.88 76.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.21 -33.59 75.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -88.11 -9.48 53.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.518 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.32 -18.12 20.21 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.209 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.84 82.7 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.13 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -120.8 164.39 16.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.47 0.635 . . . . 0.0 111.539 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -76.77 148.52 79.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.713 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.39 -16.77 53.81 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.368 2.712 . . . . 0.0 113.24 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.5 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.38 -27.04 14.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.388 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.13 128.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.77 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -121.9 141.88 50.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.31 126.51 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.59 127.08 55.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.99 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -136.83 121.23 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t30 64.39 26.5 13.56 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.68 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.47 -19.87 44.71 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.323 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -101.09 151.76 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.881 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 p -92.4 150.68 20.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.228 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.72 135.59 38.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.67 135.79 28.72 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.41 -22.16 59.88 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.019 2.479 . . . . 0.0 113.871 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.2 m -78.42 -27.84 46.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -88.89 -174.39 4.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.428 0.632 . . . . 0.0 112.041 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 42.1 p -110.05 155.85 21.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.466 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.34 -37.32 66.14 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.977 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.81 -14.42 62.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.96 -22.14 33.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.971 0.415 . . . . 0.0 110.822 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.68 -20.17 23.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.416 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.74 45.38 3.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.046 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.78 139.39 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.9 157.06 64.54 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.34 137.53 31.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.626 2.217 . . . . 0.0 112.135 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.98 14.91 29.94 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.118 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 t -99.74 169.85 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -95.21 123.21 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.694 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.75 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.33 125.6 54.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.45 161.22 14.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.63 152.8 44.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.468 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 -179.743 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.717 0.294 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 p -110.4 149.7 29.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.019 0.438 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.73 155.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.961 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -102.57 153.69 19.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -135.94 120.77 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.02 122.49 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.13 161.78 24.31 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.168 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 -1.03 7.75 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.358 2.039 . . . . 0.0 111.744 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.46 -19.51 23.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.81 51.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.413 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -106.22 146.05 30.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.066 0.46 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -105.14 152.19 23.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 149.87 52.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -114.79 126.73 55.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.874 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.3 tp -125.82 148.48 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.775 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.41 117.77 35.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 178.08 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 16.0 p -132.38 164.57 42.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.208 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.43 -14.39 43.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.742 2.295 . . . . 0.0 112.918 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.4 -10.85 53.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -75.27 136.33 40.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.17 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.8 p -88.21 172.14 9.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.156 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.64 -33.07 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 110.13 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -70.64 -35.17 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.719 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -71.58 -48.6 47.2 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.18 -40.16 89.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.952 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -30.17 67.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -70.62 -26.22 63.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.77 -49.51 25.1 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.78 -32.89 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.853 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.07 -28.17 66.28 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.701 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -72.56 -33.37 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.39 -34.28 58.86 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.66 -18.17 21.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.23 51.07 5.89 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.116 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -130.02 178.07 6.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.126 0.489 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 42' ' ' ILE . 11.9 t -105.57 141.98 23.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.438 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 22.9 Cg_exo -62.71 -17.41 58.87 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.86 2.374 . . . . 0.0 113.568 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.19 -21.51 58.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.303 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.69 -27.68 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.527 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' SER . 2.0 mt -87.07 134.67 27.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.957 0.408 . . . . 0.0 111.329 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -128.01 128.99 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -95.43 132.69 40.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.48 141.3 51.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.064 0.459 . . . . 0.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -145.12 106.47 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 67.17 25.22 9.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.71 74.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.943 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -102.27 139.68 37.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -93.25 145.69 24.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.54 135.89 36.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.308 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.22 138.98 22.9 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.92 -22.5 73.86 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.15 2.567 . . . . 0.0 114.019 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.2 p -81.85 -25.44 35.11 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -174.72 5.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.273 0.559 . . . . 0.0 111.752 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.9 p -117.19 161.89 18.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 9.9 mt -73.0 -32.78 65.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.749 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.49 -11.56 59.96 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.61 -20.73 35.81 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.997 0.427 . . . . 0.0 110.626 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.04 -19.87 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.176 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 45.5 4.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.71 137.97 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.18 157.19 65.02 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.904 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.75 144.67 54.84 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.762 2.308 . . . . 0.0 112.071 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.79 1.03 34.37 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.587 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -107.74 159.0 16.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 p -88.58 123.93 33.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.83 148.55 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.92 135.82 48.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.064 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.35 140.12 52.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.499 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -132.6 131.65 41.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.771 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.825 0.345 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -109.72 153.12 24.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.0 111.669 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.04 162.43 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.57 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.31 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.88 112.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.184 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 122.68 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.977 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 163.29 21.19 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.999 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.78 -1.68 9.71 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.239 1.96 . . . . 0.0 112.059 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -89.86 -19.54 24.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.8 51.07 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.474 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -102.44 150.02 23.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.73 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 p -111.76 152.22 28.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.736 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.82 150.07 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.471 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.37 121.95 46.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.126 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -132.34 159.47 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.604 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.17 134.01 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.754 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.24 147.23 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 111.436 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 p -138.76 157.28 72.12 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.32 -6.09 18.25 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -98.29 -12.46 21.53 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.244 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.36 142.43 31.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.312 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 p -96.42 170.67 9.07 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.42 -33.09 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 110.267 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -72.21 -37.14 69.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.36 -47.83 46.48 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.679 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.11 -31.57 71.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.03 69.88 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.823 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -71.14 -24.91 62.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.49 0.186 . . . . 0.0 111.35 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.12 -51.0 42.93 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.76 -33.95 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.764 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.23 -28.58 66.48 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -67.1 -33.56 75.73 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.9 -16.33 38.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.704 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -100.46 -18.35 16.73 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.579 0.228 . . . . 0.0 111.48 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.18 39.72 12.44 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.011 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -131.5 178.19 6.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.225 0.536 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 9.5 t -105.22 142.26 24.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.599 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.77 -18.95 59.21 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.06 2.507 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.29 -20.34 59.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.639 0.257 . . . . 0.0 111.622 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -94.8 -30.24 14.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.7 123.04 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.652 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -115.21 138.85 50.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.443 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.94 131.07 38.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.24 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.5 125.32 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.977 0.417 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -134.17 121.98 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 62.45 26.84 15.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.669 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.64 -17.76 55.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.366 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.77 149.31 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.829 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -97.11 153.83 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.119 0.485 . . . . 0.0 111.108 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.52 136.11 42.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.214 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -90.03 138.16 27.72 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.3 Cg_exo -65.01 -22.1 62.83 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.433 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -78.51 -24.98 45.54 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.58 -175.12 5.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.267 0.556 . . . . 0.0 111.673 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.9 p -115.32 161.86 17.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.312 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.35 -29.73 62.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.12 -8.35 59.65 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.88 -31.16 28.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.088 0.471 . . . . 0.0 110.572 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -81.75 -19.95 40.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.736 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 45.61 6.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.651 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -98.19 139.53 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 0.0 111.606 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -124.28 156.56 66.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.916 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.54 146.38 55.23 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.614 2.21 . . . . 0.0 112.25 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.5 6.59 50.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.573 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -102.89 162.27 13.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.1 p -90.03 122.16 32.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.06 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.3 mm -112.57 119.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.977 0.418 . . . . 0.0 110.761 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.23 123.44 48.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.71 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -96.63 159.29 15.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.132 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.346 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.697 0.284 . . . . 0.0 110.614 -179.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.734 0.302 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -111.15 152.05 27.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.21 153.82 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.22 135.06 43.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mm -111.92 111.71 37.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.68 119.66 34.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.5 161.44 24.53 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.19 -0.88 8.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.266 1.977 . . . . 0.0 111.759 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.96 -18.78 24.11 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.48 6.13 50.92 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.335 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -107.36 145.87 32.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.863 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 17.5 p -112.68 146.22 39.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.504 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.2 150.51 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.33 121.15 41.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.685 0.278 . . . . 0.0 110.881 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.04 142.24 49.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -101.77 133.1 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.75 176.58 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.631 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 p -135.98 165.58 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.185 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.44 -12.47 30.91 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 113.018 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.44 -14.36 43.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.41 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 m-85 -75.62 135.62 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 p -85.44 170.75 12.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.288 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.4 -33.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.059 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -72.11 -32.3 66.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.703 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.1 tt0 -72.0 -47.84 49.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.722 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.31 -36.18 79.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.703 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.0 70.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.301 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -72.26 -24.78 61.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.485 0.183 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.06 -49.67 27.35 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.877 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.83 -34.25 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.727 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.1 -27.88 65.99 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.825 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -69.35 -33.48 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -30.37 47.09 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.23 -18.15 20.26 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.47 49.3 5.88 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.073 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.61 178.24 6.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.429 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.0 t -105.33 142.03 23.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.563 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.85 -17.33 55.74 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.833 2.355 . . . . 0.0 113.377 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.33 -18.62 59.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.77 -29.78 12.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -89.48 126.23 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 0.0 111.441 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -121.89 135.29 54.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.794 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.18 133.85 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.67 129.52 47.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.294 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -130.38 125.22 34.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.399 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.94 32.39 1.83 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.95 . . . . 0.0 113.188 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.81 22.95 37.34 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.945 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -134.39 140.27 46.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.013 0.407 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -93.56 147.24 23.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.01 135.82 42.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.123 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.27 138.08 25.87 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.25 -22.36 66.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.1 2.533 . . . . 0.0 113.503 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.2 t -79.94 -28.11 39.73 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.42 -174.85 5.52 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 112.061 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 68.4 p -116.66 157.76 24.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.121 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 10.1 mt -73.05 -31.18 64.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.08 -15.04 59.72 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.68 -20.2 36.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.053 0.454 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -89.14 -20.26 24.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.57 45.46 4.61 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -111.61 137.67 43.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.932 0.396 . . . . 0.0 111.453 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.34 158.16 62.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.576 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.27 141.02 46.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.484 2.122 . . . . 0.0 112.002 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.09 3.16 36.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -100.45 165.35 11.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -88.12 126.31 35.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.5 mm -104.52 149.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.678 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.63 115.34 25.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.124 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.37 127.34 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.99 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.07 131.04 38.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.446 -179.674 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -109.68 152.15 25.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.469 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -130.13 156.69 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -98.49 153.75 18.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.88 0.372 . . . . 0.0 111.333 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.06 117.15 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.524 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 119.91 38.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.407 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 163.14 23.21 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 -1.0 9.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.268 1.978 . . . . 0.0 112.236 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -89.41 -18.21 27.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 5.75 51.56 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -105.47 146.41 29.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -108.85 154.78 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.383 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.74 149.99 46.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.317 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 126.01 52.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.069 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.5 tp -120.05 148.56 43.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.93 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.97 116.37 32.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 -179.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.2 p -137.92 165.12 36.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.241 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.3 -13.05 35.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.537 2.158 . . . . 0.0 112.676 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.08 -6.49 58.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.081 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 m-85 -81.22 144.95 31.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.072 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -91.43 168.47 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -67.54 -32.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.417 . . . . 0.0 110.251 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -71.72 -34.38 69.53 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -71.59 -47.97 51.3 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.19 -36.21 77.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.841 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.26 -37.59 71.93 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.9 pt-20 -71.2 -24.95 62.32 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.45 -50.63 20.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.595 0.236 . . . . 0.0 110.836 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 tp -69.6 -35.5 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -28.24 66.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -68.03 -33.57 74.83 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.38 -18.65 33.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.68 -18.21 18.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.594 0.235 . . . . 0.0 111.417 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.46 41.19 16.96 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.131 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.53 178.0 6.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.487 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 32.7 m -98.3 131.43 26.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.828 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 23.0 Cg_exo -63.18 -25.24 72.57 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.02 2.48 . . . . 0.0 113.542 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.24 -15.65 60.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.42 -28.11 14.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.439 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -88.79 123.66 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.85 0.357 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -110.73 137.68 48.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.33 133.51 35.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 128.9 46.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.069 0.462 . . . . 0.0 111.445 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -130.56 124.73 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.49 1.96 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.024 0.93 . . . . 0.0 113.399 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.9 22.92 37.13 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.839 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -132.31 135.41 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 p -89.25 149.35 23.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 136.11 54.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.04 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -95.03 145.31 29.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.725 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.92 -22.19 56.19 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.206 2.604 . . . . 0.0 113.958 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m -74.02 -26.92 60.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -174.41 5.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.244 0.545 . . . . 0.0 111.848 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -114.33 157.51 22.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.257 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.0 mt -73.04 -32.17 64.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.06 -11.52 59.96 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.88 -28.77 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -84.74 -19.79 32.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.59 45.67 6.35 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.008 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.9 142.95 13.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.851 0.358 . . . . 0.0 111.505 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.0 p -124.32 155.55 68.27 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.72 146.6 54.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.616 2.211 . . . . 0.0 112.3 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.16 10.95 53.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.0 p -106.7 157.68 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.011 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -90.97 122.16 33.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.94 127.49 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.72 137.69 39.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.292 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.17 161.22 15.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.955 0.407 . . . . 0.0 111.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -138.97 134.33 32.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.281 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.407 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 65.1 mtt . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -139.08 -8.14 1.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.18 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 p -107.93 150.95 26.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 111.429 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -126.43 162.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.811 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -117.34 136.63 53.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.995 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.67 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -126.12 116.35 45.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.005 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 119.26 32.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.541 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -99.41 163.18 19.09 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.828 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 11.4 Cg_endo -55.76 -21.07 30.85 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.946 2.431 . . . . 0.0 113.702 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.31 -22.01 63.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.808 0.337 . . . . 0.0 110.34 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.84 -18.55 49.7 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.609 -0.805 . . . . 0.0 114.093 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -84.34 173.22 11.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.53 0.665 . . . . 0.0 110.082 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -129.82 150.41 51.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.954 0.407 . . . . 0.0 111.488 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -119.77 149.84 41.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.797 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.76 123.28 49.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.151 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -136.36 159.95 40.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.05 139.25 34.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.712 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.9 148.78 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.748 0.309 . . . . 0.0 111.543 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 p -139.25 157.23 71.32 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.32 -6.7 19.29 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.648 2.232 . . . . 0.0 112.577 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -97.48 -12.11 23.03 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.325 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.22 144.99 28.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 p -97.56 169.55 9.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.93 -33.04 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.902 0.382 . . . . 0.0 110.05 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -72.43 -37.98 68.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 7.6 tt0 -71.18 -49.11 47.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.09 -34.96 74.19 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.349 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.17 70.79 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -70.66 -24.83 62.77 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -51.52 18.99 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 tp -69.33 -32.33 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.959 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.13 66.14 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.662 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -65.96 -33.35 75.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.874 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -80.3 -22.98 41.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.676 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 -18.22 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.682 0.277 . . . . 0.0 111.073 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.65 42.15 9.31 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.818 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mt -129.57 178.08 6.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.957 0.408 . . . . 0.0 111.18 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.7 p -108.15 145.15 30.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.85 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.39 -23.25 44.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.896 2.398 . . . . 0.0 114.078 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -75.51 -9.03 58.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.83 -27.72 10.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.509 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -91.11 132.46 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.934 0.397 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -123.52 134.94 53.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mt -91.14 132.8 35.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.215 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.61 125.79 43.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.056 0.455 . . . . 0.0 111.247 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -135.38 122.87 22.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 64.04 24.98 13.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.08 -14.95 62.15 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.115 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.33 148.83 23.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.897 0.379 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -96.98 154.98 16.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.074 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.8 135.84 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -93.43 141.15 23.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.3 Cg_exo -66.13 -22.01 54.92 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.221 2.614 . . . . 0.0 113.503 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -75.46 -25.16 57.18 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.55 -174.5 4.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.343 0.592 . . . . 0.0 111.752 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -115.27 164.4 14.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.254 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.31 -30.05 63.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.853 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.01 -9.09 59.67 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -82.94 -31.64 27.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.978 0.418 . . . . 0.0 110.469 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -82.17 -19.72 39.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.654 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.71 45.65 5.99 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.704 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.53 141.32 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.375 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -123.21 155.09 65.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.969 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.26 143.29 48.0 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.613 2.208 . . . . 0.0 112.112 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 98.67 11.49 47.12 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.728 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.8 m -99.44 164.98 11.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.408 . . . . 0.0 110.69 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 16.2 p -96.15 125.45 40.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.848 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.55 138.26 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.882 0.372 . . . . 0.0 111.22 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.13 130.34 55.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.602 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -103.55 161.48 13.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.56 147.74 36.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.786 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.3 145.58 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.372 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -102.2 128.58 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.529 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -114.62 149.75 36.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.61 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -128.36 135.1 49.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.643 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.33 -69.1 0.77 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.342 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.58 -139.3 3.29 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 78' ' ' LEU . 3.3 mm? -98.44 -46.82 5.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.4 . . . . 0.0 110.52 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.418 179.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.835 0.35 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.52 -6.74 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -113.65 149.74 34.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -130.81 159.17 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.775 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.461 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -110.24 129.25 55.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.511 . . . . 0.0 109.97 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.674 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -118.87 111.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 132.5 33.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.858 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.11 162.98 20.98 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.992 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -0.88 9.68 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.247 1.965 . . . . 0.0 112.152 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.02 -14.68 30.93 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.37 52.2 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.231 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -107.47 147.47 30.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.099 0.476 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.4 p -102.59 157.21 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 149.95 51.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.522 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.21 128.29 54.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.832 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 tp -128.83 152.04 48.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 106.18 17.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.336 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.1 174.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 7.4 p -141.17 161.31 53.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.311 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 19' ' ' THR . 19.3 Cg_endo -61.55 -15.29 40.49 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.653 2.235 . . . . 0.0 112.732 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -82.5 -9.93 59.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.749 0.309 . . . . 0.0 111.256 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.98 160.59 21.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.0 p -93.76 166.43 12.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.566 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -69.9 -31.35 47.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.018 0.437 . . . . 0.0 110.213 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -68.41 -36.67 79.44 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -70.58 -47.34 60.72 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.043 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -59.77 -39.13 83.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.07 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.68 70.94 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.2 pt-20 -74.14 -24.67 59.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.675 0.274 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -74.08 -46.7 41.36 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.7 -33.34 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.563 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.07 -28.12 66.23 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.788 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -71.56 -33.53 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -77.31 -31.48 54.71 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mp -97.26 -18.21 19.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.89 47.76 6.09 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.773 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.8 mt -131.69 178.6 6.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.965 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 42' ' ' ILE . 64.1 m -104.15 147.54 34.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.669 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.7 Cg_exo -66.06 -23.35 53.65 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.991 2.461 . . . . 0.0 113.215 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.26 -15.41 60.53 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 111.59 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -96.38 -32.28 12.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.252 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.23 117.74 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.293 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -109.6 133.11 53.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.93 125.42 39.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.74 126.06 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.083 0.468 . . . . 0.0 111.365 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -134.47 117.78 16.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.398 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 65.02 25.18 12.63 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.687 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.4 -15.11 63.04 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.023 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.93 144.0 29.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.41 . . . . 0.0 110.738 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.42 150.78 19.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.115 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.9 135.68 40.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 137.22 22.59 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -62.79 -22.41 73.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.02 2.48 . . . . 0.0 113.655 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -78.34 -27.04 46.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.9 -174.34 5.22 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.573 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 70.8 p -113.87 158.76 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.94 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.86 -31.79 64.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.865 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.17 -9.52 59.58 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.9 tp10 -82.73 -20.76 35.37 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.03 0.443 . . . . 0.0 110.55 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.2 -19.92 23.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.332 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.81 45.42 5.45 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.848 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.42 141.87 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 111.382 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.5 p -122.97 158.88 56.15 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.88 138.48 53.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.538 2.159 . . . . 0.0 112.014 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.02 3.44 26.37 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.632 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 p -98.86 172.26 7.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.461 HG22 ' ND2' ' A' ' 5' ' ' ASN . 11.8 p -95.84 120.44 36.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 126.07 74.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.72 128.73 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -97.67 161.5 13.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.041 0.448 . . . . 0.0 111.124 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -140.49 144.34 35.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.76 146.58 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.218 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -98.91 127.85 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -116.9 146.1 43.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.709 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -127.68 142.98 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.6 -91.59 0.14 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.671 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 78' ' ' LEU . . . 119.64 -116.7 3.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.712 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 16.8 mt 71.43 116.7 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.413 0.625 . . . . 0.0 111.85 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.154 -179.414 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.735 0.302 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.67 -9.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -111.15 152.13 27.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.083 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -126.37 161.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.676 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.46 129.58 56.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.78 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.679 HG22 HD23 ' A' ' 70' ' ' LEU . 1.3 mp -119.42 111.95 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.741 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.98 132.13 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.668 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.4 161.42 25.33 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.16 -0.51 9.23 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.087 1.858 . . . . 0.0 112.097 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -91.61 -14.61 29.91 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.58 5.48 51.49 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.2 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -111.34 144.68 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -104.76 155.42 18.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.844 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.58 150.0 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.28 122.09 43.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.144 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -134.25 161.84 33.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.185 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -96.44 146.89 24.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 110.799 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.77 148.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 p -140.36 157.03 69.42 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.03 -6.51 19.11 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.727 2.285 . . . . 0.0 112.55 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.29 -11.99 22.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.73 143.69 29.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 110.385 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.8 p -97.33 170.38 9.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.33 -31.91 55.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.994 0.426 . . . . 0.0 110.244 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 57.8 tttt -72.3 -39.97 67.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.878 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.8 tt0 -70.37 -47.13 62.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.798 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.68 -31.23 71.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -34.48 68.73 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.972 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -73.39 -24.88 60.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.618 0.247 . . . . 0.0 110.824 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.55 -49.68 52.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.328 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -69.43 -32.68 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.93 -28.36 66.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.887 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -70.94 -33.28 70.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -76.24 -29.2 57.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.92 -18.06 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.13 45.17 6.72 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.018 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 6.3 mt -132.07 178.55 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 110.796 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.1 p -105.13 147.44 34.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.644 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.1 Cg_exo -67.43 -17.72 49.17 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.049 2.499 . . . . 0.0 113.627 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.17 -20.32 59.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.53 -29.49 13.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.63 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.74 121.5 43.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -114.68 135.14 54.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.39 122.16 35.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.55 54.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.395 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -128.66 116.3 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.306 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 64.37 24.86 13.33 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.627 0.579 . . . . 0.0 111.774 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.04 76.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.867 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.54 142.12 33.38 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -92.98 151.03 20.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.203 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -100.22 135.97 40.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.425 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -85.78 130.97 48.7 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.248 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.2 Cg_exo -66.13 -22.14 54.74 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.061 2.508 . . . . 0.0 113.508 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -80.32 -27.96 38.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.7 mt -88.27 -174.56 4.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.411 0.624 . . . . 0.0 111.922 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.6 p -107.3 157.96 17.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.365 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.4 -32.3 64.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.829 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.98 -15.52 60.14 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.7 tt0 -82.79 -19.78 37.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.887 0.375 . . . . 0.0 111.027 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -89.87 -19.7 24.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.387 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.34 45.44 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.986 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.13 136.79 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -123.84 155.99 66.04 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.142 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.54 145.56 52.97 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.766 2.31 . . . . 0.0 112.173 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.01 10.56 48.79 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.633 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 m -100.86 164.6 11.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 HG22 ' ND2' ' A' ' 5' ' ' ASN . 9.8 p -96.86 119.69 35.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.176 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.94 138.85 48.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.353 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 126.51 52.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.679 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.05 161.52 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.288 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.84 134.38 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.626 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.26 142.69 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.632 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.5 119.97 25.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -133.43 135.98 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.954 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -132.49 130.51 40.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.54 151.59 23.64 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.781 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 159.3 62.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.182 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.86 129.87 44.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.921 0.391 . . . . 0.0 110.574 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.879 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.89 -6.28 2.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.126 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 p -111.75 148.88 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pt -129.58 154.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.416 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.8 136.08 48.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.715 HG22 HD23 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -130.53 113.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.067 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 123.1 32.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.067 0.461 . . . . 0.0 111.657 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.3 166.09 13.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.793 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.03 -23.3 34.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.957 2.438 . . . . 0.0 113.684 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.35 -24.53 65.72 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.438 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.4 -8.84 55.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.405 -0.902 . . . . 0.0 114.208 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -90.13 166.74 13.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.502 0.651 . . . . 0.0 110.16 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.7 p -106.61 148.23 28.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 150.17 40.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.191 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 124.96 44.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.923 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -129.58 146.06 51.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 115.19 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.76 176.76 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.0 p -136.31 165.47 35.29 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.07 -15.12 47.53 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.622 2.215 . . . . 0.0 112.651 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -85.75 -5.75 59.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -80.13 139.78 36.69 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.223 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 11.7 p -86.93 167.53 14.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.4 t -66.9 -34.13 67.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.352 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -70.91 -31.9 68.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.69 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.9 -48.93 32.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.31 -34.34 72.2 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -35.94 69.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.311 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -74.17 -24.6 59.41 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -44.74 35.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.997 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 tp -71.13 -34.26 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.405 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.8 -39.31 80.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -68.76 -33.39 73.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.36 61.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.16 -17.89 24.27 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.89 34.95 11.98 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.81 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.0 178.55 6.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.703 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 59.4 m -98.57 146.71 32.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.924 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.1 Cg_exo -68.28 -20.62 42.68 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.95 2.433 . . . . 0.0 113.054 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -75.08 -15.13 60.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.587 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -96.96 -37.11 10.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.69 121.72 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -115.94 137.75 51.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mt -93.47 133.29 36.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.1 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.64 128.63 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.238 0.542 . . . . 0.0 111.412 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -128.52 126.38 40.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.364 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.46 1.94 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.981 0.912 . . . . 0.0 113.227 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.61 22.96 41.16 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.06 -0.591 . . . . 0.0 114.046 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.0 141.33 44.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 p -89.99 149.25 22.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.0 111.228 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.42 136.04 39.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.384 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -88.62 127.52 56.12 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.212 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -64.36 -23.01 65.81 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.341 2.694 . . . . 0.0 113.864 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.9 m -79.05 -27.28 43.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.33 -174.0 4.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.334 0.587 . . . . 0.0 111.859 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 49.4 p -109.56 155.93 20.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.367 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 22' ' ' PHE . 11.1 mt -73.22 -34.39 65.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.81 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.38 -16.04 61.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.91 -20.27 35.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -90.18 -19.52 24.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.208 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.7 45.38 4.28 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.84 137.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.014 0.435 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.76 157.13 63.83 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.43 137.96 37.69 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.391 2.061 . . . . 0.0 111.964 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.52 13.94 31.35 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.346 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.6 t -103.64 161.94 13.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.416 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.2 p -88.16 121.91 31.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.157 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.94 128.38 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.727 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.37 130.67 54.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.715 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -101.72 160.99 13.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.028 0.442 . . . . 0.0 111.166 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -141.13 143.25 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.559 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.01 145.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.91 148.58 33.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.97 155.38 17.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -101.32 144.16 30.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.523 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.71 -114.05 1.91 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.8 -93.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.468 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.97 -43.37 6.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.728 0.299 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.412 179.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.0 -13.22 1.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.968 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -108.26 154.8 21.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.412 . . . . 0.0 111.3 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.47 160.63 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.431 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -105.44 131.28 53.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.077 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 13' ' ' THR . 5.3 mm -105.37 108.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.069 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -95.14 113.22 24.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 162.64 22.53 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.319 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.31 -0.46 9.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.7 -18.34 26.61 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.07 5.88 52.53 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.387 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -109.06 147.32 32.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 20.4 p -114.82 144.85 42.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.79 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -122.59 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.498 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.86 120.78 41.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 111.213 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.74 155.98 48.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.51 135.98 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.07 149.0 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 111.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -137.55 156.71 74.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.308 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.09 -6.38 18.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.761 2.307 . . . . 0.0 112.694 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.64 -9.76 22.78 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.733 0.302 . . . . 0.0 111.414 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.57 138.02 32.97 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.882 0.372 . . . . 0.0 110.407 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 p -93.87 169.75 10.06 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.7 t -66.98 -32.6 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 0.0 110.306 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -71.9 -36.05 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.646 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.7 tt0 -72.57 -49.46 32.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.633 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 tp -60.17 -32.23 70.87 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.04 -36.6 69.67 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.925 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.2 -24.87 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.289 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.18 -51.2 40.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.31 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 tp -70.58 -32.65 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.802 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.17 -29.82 67.9 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.808 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -67.22 -33.41 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.939 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -85.45 -17.3 36.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.789 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.6 mt -98.12 -18.05 18.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 111.421 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.67 33.29 22.29 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.009 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.3 mt -132.43 178.45 6.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.014 0.435 . . . . 0.0 110.997 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 42' ' ' ILE . 48.8 m -103.84 140.93 21.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.67 -18.45 58.75 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.179 2.586 . . . . 0.0 113.686 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.43 -21.67 57.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.716 0.293 . . . . 0.0 111.719 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.03 -28.9 15.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.536 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.76 128.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.461 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -109.84 134.17 52.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.69 129.08 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.182 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 132.27 53.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.125 0.488 . . . . 0.0 111.189 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -133.58 125.2 28.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.285 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.42 31.57 1.95 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.094 0.958 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.31 23.46 37.23 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.991 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -136.29 139.48 42.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.941 0.371 . . . . 0.0 110.805 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.4 p -92.51 145.65 24.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.18 135.98 41.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.42 138.11 27.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.6 Cg_exo -64.44 -22.26 65.81 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.747 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 p -78.55 -28.38 46.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.71 -175.46 5.82 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 112.036 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.5 p -115.74 162.4 17.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.239 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -73.3 -30.25 63.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.869 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.54 -8.74 59.76 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.91 -31.03 28.02 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.097 0.475 . . . . 0.0 110.521 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -82.08 -19.79 39.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.691 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.64 5.65 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.705 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.52 136.6 30.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.021 0.439 . . . . 0.0 111.488 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.4 p -123.74 156.67 64.68 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.859 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -69.74 136.33 32.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.627 2.218 . . . . 0.0 112.136 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.11 25.45 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.696 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.5 p -98.06 161.53 13.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.936 0.398 . . . . 0.0 110.763 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.431 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -93.47 123.24 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.679 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.62 146.7 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.267 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 110.3 16.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.2 0.524 . . . . 0.0 109.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.27 137.45 34.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.279 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -132.11 131.76 42.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.55 138.57 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.579 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -116.84 122.34 44.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.849 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -136.96 148.62 47.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -121.92 132.4 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.33 144.41 4.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.77 99.74 0.47 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.683 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 tt -107.42 128.44 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 110.484 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.818 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 63.1 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.746 0.307 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -134.06 -2.62 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.007 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 p -111.05 152.08 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.208 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 pt -128.48 156.94 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.148 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -99.32 154.42 18.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.296 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -136.44 114.64 14.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.704 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.03 122.07 39.62 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 111.786 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.32 163.86 19.71 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.11 -1.56 9.76 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.235 1.957 . . . . 0.0 111.895 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.87 -17.76 25.95 Favored 'General case' 0 N--CA 1.458 -0.057 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.62 6.03 50.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -106.9 142.47 36.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.079 0.466 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.3 p -111.17 153.86 25.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.367 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.43 150.16 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.573 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.29 128.33 55.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.187 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -125.28 145.39 50.03 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.3 120.65 40.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.069 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.25 -179.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.037 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.8 p -133.84 164.98 40.13 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.81 -15.41 50.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.593 2.195 . . . . 0.0 112.584 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -86.09 -4.75 59.23 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.4 m-85 -80.75 137.34 36.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -90.18 170.26 10.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.68 -33.04 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -71.24 -34.38 70.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.924 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.8 tt0 -72.7 -48.73 36.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.763 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.23 -36.13 77.01 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.906 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.76 -36.63 70.44 Favored 'General case' 0 C--O 1.227 -0.081 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.306 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.84 -25.17 61.87 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.93 -46.46 24.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.654 0.264 . . . . 0.0 111.176 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -72.01 -36.32 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.911 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.23 79.07 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.364 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 23.4 ttt180 -70.94 -33.41 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -26.96 61.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.452 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 mt -99.56 -18.22 17.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.62 47.66 5.29 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.15 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.28 177.93 7.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 110.994 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 42' ' ' ILE . 51.1 m -100.82 125.66 37.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.802 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.99 -20.21 71.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.133 2.555 . . . . 0.0 113.606 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.12 -19.96 59.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.39 -25.09 15.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.91 126.25 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.421 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -118.68 135.67 54.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.15 126.99 37.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.02 125.04 44.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 111.467 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -132.43 119.42 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.415 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 65.01 24.87 12.64 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.586 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -15.5 62.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.15 143.79 29.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -94.36 152.47 18.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 136.12 40.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.323 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -92.16 139.95 24.39 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.822 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.2 Cg_exo -63.7 -22.22 69.87 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.862 2.375 . . . . 0.0 113.408 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -82.26 -26.18 33.41 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.05 -174.72 5.23 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 111.659 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.5 p -115.25 160.73 19.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.868 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.14 -32.76 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.825 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.76 -10.05 59.64 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.488 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.69 -19.84 37.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.073 0.463 . . . . 0.0 110.715 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -89.38 -19.57 25.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.52 4.84 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.649 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -114.17 142.28 27.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.01 0.433 . . . . 0.0 111.469 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -118.2 157.33 49.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.739 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.09 148.08 68.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.767 2.311 . . . . 0.0 112.495 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 100.93 6.3 52.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.695 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.3 p -101.01 158.37 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 110.66 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p -88.51 122.62 32.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.57 132.99 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.239 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.45 134.84 48.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -106.84 161.21 14.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.78 0.324 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -137.44 138.65 40.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.679 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 mt -122.68 145.02 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.734 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.21 145.83 26.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.032 0.444 . . . . 0.0 111.073 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -105.98 146.85 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.822 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.63 152.58 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.858 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -102.68 -109.96 3.38 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.533 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -112.16 87.84 0.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.34 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.01 -43.77 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.711 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.651 0.262 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -133.99 -11.67 2.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.7 p -112.07 153.69 26.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.402 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' THR . 3.3 pt -120.98 160.72 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.056 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -97.71 151.87 19.69 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.181 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' THR . 16.4 mm -126.6 116.24 44.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.413 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.21 115.18 29.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 111.44 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.78 163.64 21.79 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.124 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.92 -2.27 11.25 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.295 1.997 . . . . 0.0 111.832 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.12 -18.22 26.23 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.42 5.53 51.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.168 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -104.23 145.07 30.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.195 0.521 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 13.7 p -113.73 151.51 31.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.286 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.08 145.04 45.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.354 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -108.08 123.13 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 111.479 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -124.59 153.38 42.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.05 131.8 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.748 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.28 147.55 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.985 0.421 . . . . 0.0 111.429 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.4 p -140.07 157.78 68.48 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.235 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.48 -6.28 18.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.695 2.263 . . . . 0.0 112.527 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -97.33 -14.93 20.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.349 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.8 140.64 32.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -94.17 171.05 9.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.3 -32.92 57.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -71.73 -37.45 70.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.993 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.4 tt0 -72.23 -47.83 47.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.716 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.76 -32.4 72.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.598 0.237 . . . . 0.0 111.126 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.75 -37.87 70.49 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.677 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.8 pt-20 -69.96 -24.67 63.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.39 0.138 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.57 -53.05 25.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 110.765 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.45 -32.67 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.84 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.7 -27.82 66.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.772 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.49 -33.28 74.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -75.62 -31.35 59.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.79 -18.27 19.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.49 48.29 5.99 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.085 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.66 178.22 6.8 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 111.097 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 42' ' ' ILE . 37.9 m -106.25 143.89 27.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.779 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 15.6 Cg_exo -66.87 -21.99 49.63 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.957 2.438 . . . . 0.0 113.305 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.26 -17.17 60.37 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 111.774 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -95.97 -30.29 13.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.367 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.37 122.54 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.437 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -110.53 129.3 55.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.27 130.1 39.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.163 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -122.36 127.19 49.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.01 0.433 . . . . 0.0 111.294 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -133.03 117.48 17.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 64.7 24.91 12.97 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.658 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.93 -13.89 66.55 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.744 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -100.18 140.79 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -91.96 151.56 20.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.128 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.47 136.04 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.301 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.8 t70 -95.38 138.02 21.97 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.949 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 21.5 Cg_exo -63.89 -22.28 68.81 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.05 2.5 . . . . 0.0 113.444 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -80.35 -27.12 38.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.56 -174.32 4.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.539 0.685 . . . . 0.0 111.548 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.6 p -115.55 166.48 11.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.092 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.12 -30.57 63.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.716 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.5 -7.7 59.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.84 -22.39 34.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.062 0.458 . . . . 0.0 110.853 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.34 -19.41 24.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.739 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.54 45.78 6.33 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.81 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.08 142.63 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -122.86 148.43 53.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.077 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.13 149.88 71.38 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.76 2.307 . . . . 0.0 112.572 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.51 1.76 35.06 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.631 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.0 m -107.88 159.44 16.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.846 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.5 p -89.1 127.0 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.77 121.08 54.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.853 0.358 . . . . 0.0 111.066 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.27 135.22 42.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -114.6 161.44 18.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.646 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -141.94 133.61 26.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.441 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.66 140.42 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.959 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -101.27 132.79 46.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -117.41 149.47 40.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.767 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -114.12 147.1 39.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.44 131.93 2.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.485 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.97 -112.35 0.91 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.7 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -99.53 -42.94 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.584 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.656 0.265 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -137.51 -19.35 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.98 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 p -109.31 153.54 23.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.76 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.34 162.12 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.556 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 129.35 56.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.926 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -119.83 113.13 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 135.08 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.968 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -101.14 162.35 20.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.728 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.25 -1.89 10.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.22 1.947 . . . . 0.0 111.696 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.01 -15.98 28.71 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.779 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.22 51.76 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -108.17 148.89 29.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -113.26 155.24 25.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.429 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -131.75 150.09 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.752 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.88 126.11 52.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.259 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -134.3 160.75 36.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.3 136.88 38.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.783 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.67 146.75 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 111.599 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.9 p -139.01 157.69 70.99 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.057 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.5 -6.03 18.08 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.78 2.32 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.18 -11.12 20.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.682 0.277 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.13 140.71 32.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.813 0.339 . . . . 0.0 110.363 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -94.88 171.92 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 t -68.22 -33.27 59.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.964 0.411 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.876 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.2 -47.86 54.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.14 -39.01 88.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.401 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.47 63.27 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.774 0.321 . . . . 0.0 110.772 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.99 -27.16 63.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.995 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.41 -50.87 23.25 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.705 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -66.14 -32.58 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.878 0.371 . . . . 0.0 111.442 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -69.37 -28.03 65.85 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.85 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -69.71 -33.59 72.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -76.66 -31.16 57.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mp -96.77 -18.01 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.84 5.5 Favored Glycine 0 C--O 1.228 -0.238 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.961 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 mt -132.25 178.53 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 6.4 p -109.61 147.53 36.29 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 13.2 Cg_exo -67.84 -17.69 47.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.131 2.554 . . . . 0.0 113.605 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.22 -19.95 59.51 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.01 -28.15 13.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.585 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -92.25 124.97 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 111.386 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -117.75 132.29 56.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.468 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -92.03 132.21 36.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.49 125.27 44.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -135.51 123.74 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.6 t30 64.61 25.14 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.853 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.87 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.771 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -100.66 150.04 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.067 0.46 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 p -93.38 158.41 15.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.333 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.37 135.8 43.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.016 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -88.96 135.19 32.11 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.011 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.8 Cg_exo -65.08 -22.28 62.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.072 2.515 . . . . 0.0 113.446 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 m -80.27 -27.45 38.58 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 mt -86.34 -174.91 5.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.365 0.602 . . . . 0.0 111.862 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.2 p -113.29 158.94 19.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.0 mt -73.39 -31.29 63.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.015 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 6.8 tt0 -82.77 -21.33 34.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.995 0.426 . . . . 0.0 110.909 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -88.28 -19.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 45.6 5.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.708 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.36 137.91 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.976 0.417 . . . . 0.0 111.514 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -123.34 156.95 62.92 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.925 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.81 146.14 52.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.722 2.282 . . . . 0.0 112.395 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.21 5.78 45.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.522 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.7 p -98.98 165.94 11.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.599 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.9 p -96.53 124.89 40.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.741 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.36 136.05 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.12 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.43 126.34 51.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.709 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -93.6 160.86 14.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.878 0.37 . . . . 0.0 111.252 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.47 149.51 45.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.39 145.3 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.473 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -123.58 137.77 54.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.893 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -107.75 148.65 29.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.687 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -125.89 146.27 49.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.79 76.32 1.07 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.784 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' LEU . . . 118.39 149.41 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.312 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 15.0 mt 76.61 -54.54 0.58 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.43 0.692 . . . . 0.0 111.673 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.624 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 65.8 mtt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.756 0.312 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.89 -11.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.036 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -107.91 151.37 25.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.093 0.473 . . . . 0.0 111.424 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.47 161.97 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.632 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.09 131.77 54.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.803 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.583 HG22 HD23 ' A' ' 70' ' ' LEU . 1.7 mp -120.08 113.48 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.298 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 132.96 35.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.935 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.78 161.8 22.69 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.884 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.02 -1.78 10.54 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.34 2.027 . . . . 0.0 111.812 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.25 -16.71 27.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.5 5.57 51.6 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.295 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -108.07 141.18 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.774 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.6 p -102.68 155.32 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -128.77 150.0 50.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.503 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.51 121.25 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -134.53 161.97 33.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.92 139.03 35.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.832 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -119.76 149.3 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.539 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 p -139.13 149.72 62.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.95 -9.57 26.34 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.635 2.223 . . . . 0.0 112.64 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -94.3 -9.34 36.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.94 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.55 145.85 26.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.936 0.398 . . . . 0.0 110.537 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.4 p -96.43 169.36 9.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.53 -30.54 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.402 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.3 -39.48 68.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.022 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.63 -47.95 51.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.949 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.73 -33.37 72.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.224 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.96 69.61 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.7 pt-20 -72.26 -25.15 61.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -51.06 26.27 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.531 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 tp -67.45 -32.78 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.873 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.08 69.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -68.31 -33.48 74.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -84.87 -13.86 49.65 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.6 mt -100.83 -18.09 16.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.612 0.244 . . . . 0.0 111.362 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.86 32.76 20.45 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.963 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -131.22 178.09 6.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.019 0.437 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.4 p -103.04 139.98 20.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.667 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.06 -17.04 45.82 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.015 2.476 . . . . 0.0 113.801 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.48 -21.5 58.01 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.37 -27.56 14.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.568 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 38' ' ' SER . 1.7 mt -87.52 123.4 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.432 . . . . 0.0 111.491 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.82 137.62 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.84 130.98 37.51 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.211 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.55 125.98 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -135.16 122.64 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.0 t30 62.87 26.56 15.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.793 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.8 -19.63 47.29 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.275 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -97.19 149.7 21.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -96.04 155.52 16.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.139 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 135.75 43.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.188 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -89.8 137.43 28.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.984 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 19.8 Cg_exo -65.1 -22.26 62.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.111 2.54 . . . . 0.0 113.388 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -77.7 -26.14 49.96 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.42 -174.88 5.24 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 77.2 p -115.25 163.89 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.356 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -73.37 -30.92 63.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.872 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.36 -7.77 59.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -82.9 -31.85 27.62 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.986 0.422 . . . . 0.0 110.658 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -81.63 -19.89 40.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.663 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.78 45.71 5.37 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.23 141.53 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.786 0.327 . . . . 0.0 111.365 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.7 p -124.81 156.66 68.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.24 137.86 38.04 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.693 2.262 . . . . 0.0 112.031 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 103.42 12.06 31.89 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.459 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t -101.71 160.1 14.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.881 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.9 p -87.52 124.38 33.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.181 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.02 127.63 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.983 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.25 125.44 53.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.581 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.583 HD23 HG22 ' A' ' 6' ' ' ILE . 2.2 pp -95.93 161.06 14.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -139.73 144.42 37.48 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.558 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -127.0 148.46 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.477 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -122.4 120.02 32.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.749 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -134.49 151.38 51.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -129.8 137.88 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.44 140.99 3.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.801 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 142.97 142.2 3.96 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.602 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -101.29 130.79 47.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.378 . . . . 0.0 110.723 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.945 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -137.17 -1.2 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.954 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.5 p -110.45 151.98 26.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.513 . . . . 0.0 111.382 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.66 157.66 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -101.7 153.92 19.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.391 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.79 113.1 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.266 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.31 121.69 38.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.935 0.398 . . . . 0.0 111.553 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.01 163.67 19.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.58 -1.27 10.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.321 2.014 . . . . 0.0 112.032 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.44 -17.93 26.3 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.64 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.31 5.49 52.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.385 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -104.43 146.42 28.87 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 110.717 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p -109.86 156.5 20.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.567 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 150.25 46.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.292 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.99 125.14 50.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.283 . . . . 0.0 111.329 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.1 165.53 20.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.95 143.15 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.86 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.42 148.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.381 . . . . 0.0 111.641 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 p -139.43 157.38 70.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.079 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.41 -5.99 18.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.691 2.26 . . . . 0.0 112.675 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -99.69 -13.94 19.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.375 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.53 141.36 32.69 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.759 0.314 . . . . 0.0 110.33 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 p -94.92 171.79 8.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.89 -32.57 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.045 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -71.83 -39.18 69.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.113 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 5.1 tt0 -72.15 -45.04 62.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.71 -31.15 72.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.824 0.345 . . . . 0.0 110.648 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.74 69.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.832 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -70.16 -26.19 63.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.408 0.147 . . . . 0.0 111.107 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.43 -53.35 29.81 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.332 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.94 -32.85 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.612 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.21 -27.97 65.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.96 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -68.54 -33.46 74.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -77.33 -28.52 53.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.897 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.32 -18.11 18.52 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.31 47.82 5.59 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.108 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.12 178.29 6.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 111.313 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.6 t -107.2 141.99 24.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.518 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.58 -23.23 64.24 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.94 2.426 . . . . 0.0 113.495 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.4 -15.71 60.43 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.736 0.303 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.69 -31.87 12.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.541 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.62 124.28 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.628 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -113.0 131.7 55.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.384 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.64 124.24 34.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.49 127.21 52.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.708 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.87 115.84 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.379 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.04 24.96 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.06 -7.54 78.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.743 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -102.44 138.74 38.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 p -91.06 151.2 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.321 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 136.12 42.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.321 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -87.29 132.71 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.236 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 16.8 Cg_exo -66.0 -22.31 55.47 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.09 2.527 . . . . 0.0 113.543 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.1 m -78.84 -26.26 44.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.96 -174.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.435 0.636 . . . . 0.0 111.663 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 47.4 p -108.93 160.71 15.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.261 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.16 -32.02 64.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.661 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -9.63 59.65 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.62 -23.76 34.16 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.07 0.462 . . . . 0.0 110.787 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.66 -19.75 23.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.631 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.27 5.53 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.862 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.34 136.71 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.786 0.327 . . . . 0.0 111.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -123.37 155.48 65.21 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.59 155.72 62.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.88 2.387 . . . . 0.0 112.5 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.63 3.19 57.36 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.4 m -107.85 153.3 23.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 0.0 110.732 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.5 p -88.61 127.08 35.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.642 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -110.91 129.52 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.69 135.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.514 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -107.57 161.05 15.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.935 0.397 . . . . 0.0 111.344 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -140.07 135.43 32.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.351 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.82 144.2 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.667 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.83 149.27 22.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -129.98 -44.2 1.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.96 148.19 37.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.1 -88.16 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.276 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.38 -98.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.331 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 mt -124.1 -43.52 2.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.903 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.694 0.283 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -141.23 -26.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 p -110.02 154.33 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -130.32 161.62 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.44 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.17 130.03 56.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.099 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.619 HG22 HD23 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -119.68 113.53 41.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.663 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.5 132.91 34.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.873 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -100.0 161.28 24.78 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.75 -1.08 9.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.162 1.908 . . . . 0.0 111.736 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.07 -15.33 29.68 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.43 6.02 51.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.442 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -109.6 151.82 26.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.035 0.445 . . . . 0.0 110.878 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -112.95 146.43 39.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.708 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.1 mm? -116.03 150.08 37.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.526 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.27 123.39 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 111.071 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.39 161.09 37.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.599 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.24 134.56 40.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.644 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.49 148.5 17.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.817 0.342 . . . . 0.0 111.647 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 p -139.39 157.19 71.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.213 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.4 -6.26 18.51 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.696 2.264 . . . . 0.0 112.58 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -100.31 -9.72 22.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.43 142.73 29.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.4 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.7 p -95.52 171.57 8.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -68.8 -32.78 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 0.0 110.076 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -72.49 -36.62 68.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.914 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.1 tt0 -71.32 -48.12 52.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.82 -33.82 74.83 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.145 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.41 69.47 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.077 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.627 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.4 pt-20 -70.24 -24.93 63.16 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.02 -50.18 30.72 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.807 0.337 . . . . 0.0 110.356 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tp -70.12 -32.95 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.0 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -67.98 -33.02 73.85 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -62.38 -33.47 74.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.817 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -87.56 -10.54 51.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.753 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.12 -18.84 19.84 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.314 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.22 -6.32 78.47 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.263 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.453 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -119.74 164.13 16.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 110.998 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -83.59 154.7 65.61 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.396 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.69 -16.34 53.0 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.715 2.943 . . . . 0.0 113.245 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.32 -23.84 66.01 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.08 -24.58 14.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.711 0.291 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mt -92.07 127.18 44.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -123.64 140.23 53.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.025 0.44 . . . . 0.0 110.516 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.7 135.39 36.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.413 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.54 126.12 35.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.679 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -137.23 127.05 25.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 63.98 25.02 13.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.609 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 -18.76 44.1 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.868 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -96.04 149.96 21.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.775 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.6 p -96.0 156.87 16.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.16 135.15 48.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.076 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -92.37 137.99 24.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.761 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.3 Cg_exo -63.96 -22.13 68.46 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.899 2.399 . . . . 0.0 113.525 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -79.51 -27.97 41.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -83.64 -175.06 5.63 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.283 0.564 . . . . 0.0 111.951 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.8 p -116.05 163.28 16.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.119 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.0 mt -73.23 -31.01 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.63 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.05 59.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.84 -24.54 33.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.973 0.416 . . . . 0.0 110.72 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.5 -20.2 26.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.498 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.98 45.29 5.73 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -98.91 141.91 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 111.549 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.6 t -122.5 144.49 42.33 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.569 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.6 Cg_exo -67.32 137.55 43.81 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.406 2.071 . . . . 0.0 112.097 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.96 4.65 27.61 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 t -99.4 168.54 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.44 HG22 ' ND2' ' A' ' 5' ' ' ASN . 12.5 p -93.75 122.61 36.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.12 134.75 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.24 128.41 55.57 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.619 HD23 HG22 ' A' ' 6' ' ' ILE . 2.0 pp -101.12 159.42 15.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.137 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -139.73 148.71 42.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.28 143.0 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.102 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -103.59 147.56 27.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -124.51 -46.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.73 133.43 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.14 -51.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.503 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.86 -46.6 1.89 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.66 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -98.93 125.32 44.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.889 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 120.846 0.355 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -138.12 -10.95 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.779 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.8 p -107.73 149.44 28.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.57 156.39 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.439 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -107.52 127.96 54.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.509 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.33 111.02 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.726 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 125.0 35.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.82 161.57 24.53 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.118 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.82 -0.53 7.09 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.326 2.017 . . . . 0.0 111.92 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.38 -18.23 24.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.3 52.03 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.495 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -109.34 140.91 42.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.094 0.473 . . . . 0.0 110.874 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -108.4 151.92 25.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.035 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.72 149.89 52.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.8 122.75 48.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tp -131.88 151.52 51.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.852 0.358 . . . . 0.0 111.084 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.84 120.8 41.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 27' ' ' LEU . 10.5 m -131.98 170.37 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.964 0.412 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 p -135.63 164.87 40.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.36 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.11 -12.5 35.74 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.875 2.383 . . . . 0.0 112.592 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -89.2 -6.1 57.17 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.878 0.371 . . . . 0.0 110.879 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.5 m-85 -80.91 139.82 35.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.119 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 p -91.0 169.29 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.77 -33.86 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.035 0.445 . . . . 0.0 110.169 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -70.96 -32.71 69.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.829 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.6 tt0 -72.62 -51.23 20.47 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.709 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' CD1' HG11 ' A' ' 18' ' ' VAL . 6.4 tt -57.88 -36.18 72.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.817 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.94 -37.09 70.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.201 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.0 pt-20 -71.92 -24.6 61.66 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -48.01 26.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.854 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.73 -33.27 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.543 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.11 65.76 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.24 -33.37 75.6 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.85 -21.1 34.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.776 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.72 -18.17 18.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.628 0.252 . . . . 0.0 111.436 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.63 9.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.105 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.97 177.82 7.0 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.105 0.479 . . . . 0.0 111.203 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG13 ' A' ' 42' ' ' ILE . 3.2 p -106.04 126.24 31.1 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.593 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 32.5 Cg_exo -59.18 -18.05 42.29 Favored 'Trans proline' 0 N--CA 1.475 0.44 0 C-N-CA 123.393 2.729 . . . . 0.0 114.017 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.04 -14.7 60.62 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -109.12 -20.65 12.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.535 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' SER . 1.4 mt -89.72 141.9 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -133.31 148.79 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 111.121 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.01 135.47 44.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.25 124.31 43.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -134.5 117.96 16.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.55 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 65.28 25.1 12.2 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.532 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.73 -16.47 60.14 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.824 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.26 146.77 25.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.2 p -95.26 149.43 21.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.165 0.507 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.06 135.82 44.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.01 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.79 141.79 24.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.015 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.9 -22.08 56.45 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.196 2.598 . . . . 0.0 113.548 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 m -76.12 -24.69 54.93 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.83 -174.63 4.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.4 0.619 . . . . 0.0 111.93 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 73.4 p -115.62 157.12 24.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.265 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.8 mt -73.33 -31.6 64.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.776 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.78 -17.21 60.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.431 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.7 tt0 -82.75 -19.96 36.86 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -90.34 -20.06 23.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.144 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.52 45.34 5.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.614 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.35 135.53 44.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -125.64 155.65 72.02 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.631 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -69.74 139.35 40.08 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.655 2.237 . . . . 0.0 112.031 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.92 -6.13 30.9 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.436 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -94.66 165.16 12.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.557 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.439 HG22 ' ND2' ' A' ' 5' ' ' ASN . 8.2 p -91.0 125.83 35.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.41 145.33 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.41 116.9 31.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.39 140.71 39.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.43 144.19 50.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.06 136.12 58.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.628 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -98.61 132.9 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.191 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 31.2 tttm -108.47 -53.0 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' LYS . 96.5 mttt 72.09 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.191 0.932 . . . . 0.0 111.878 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.78 -141.87 3.71 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 154.11 149.6 5.26 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.288 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.76 128.99 53.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.875 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.559 0.219 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.65 -18.07 1.44 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.197 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.3 p -108.95 152.34 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.036 0.446 . . . . 0.0 111.697 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.05 158.93 43.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -103.07 153.67 20.04 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.257 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -136.91 122.58 27.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.07 112.3 25.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 111.312 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.476 HD12 ' HB2' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -96.26 164.15 19.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.188 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 9.7 Cg_endo -54.35 -23.25 29.88 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.136 2.557 . . . . 0.0 113.583 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HB2' HD12 ' A' ' 8' ' ' LEU . 2.8 m-20 -67.27 -24.67 65.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.703 0.287 . . . . 0.0 110.541 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -6.17 52.88 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.441 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -94.35 167.62 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.552 0.676 . . . . 0.0 110.231 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.3 p -117.84 151.03 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.002 0.429 . . . . 0.0 111.733 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.43 150.08 49.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.225 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.25 123.0 48.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 17' ' ' THR . 6.8 tp -128.26 164.72 21.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.686 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.412 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -99.93 137.76 37.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.623 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.02 150.0 23.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.872 0.368 . . . . 0.0 111.547 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 p -138.73 156.87 72.73 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.344 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -72.98 -6.86 19.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.705 2.27 . . . . 0.0 112.564 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -98.23 -12.0 22.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.386 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.25 140.1 31.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.4 p -93.24 169.36 10.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.576 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.1 t -67.86 -30.35 48.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.857 0.361 . . . . 0.0 110.239 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -71.56 -39.9 70.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.149 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -71.01 -48.72 51.49 Favored 'General case' 0 CA--C 1.523 -0.071 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -60.27 -32.34 71.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.247 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.92 -37.27 70.08 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 6.8 pt-20 -71.16 -24.82 62.32 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -51.32 23.86 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-O 120.786 0.326 . . . . 0.0 110.695 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 tp -68.9 -32.76 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.936 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -28.41 66.67 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -69.07 -33.36 73.42 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -25.97 45.78 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.9 -17.98 21.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.39 41.61 9.94 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.235 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -131.94 178.12 7.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 42' ' ' ILE . 21.7 m -97.98 133.3 23.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.61 -21.19 46.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.975 2.45 . . . . 0.0 113.961 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -75.66 -14.76 60.37 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.65 -29.44 13.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.311 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 38' ' ' SER . 1.9 mt -85.69 124.11 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.305 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -114.04 133.93 55.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.489 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.31 134.48 34.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.205 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.21 125.21 44.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -134.86 122.92 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.67 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 t30 63.65 25.92 14.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.803 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.04 -19.83 46.71 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.341 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.99 150.43 21.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.947 0.404 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 p -95.63 155.89 16.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.082 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.54 135.97 41.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.067 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 2.2 t70 -88.42 133.49 36.38 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 18.5 Cg_exo -65.33 -22.21 60.38 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.051 2.501 . . . . 0.0 113.358 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 -27.97 32.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.62 -174.53 4.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.307 0.575 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 43.7 p -108.83 161.28 15.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.245 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' ILE . 9.3 mt -73.32 -30.06 63.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.764 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.21 -7.01 59.61 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.5 tm-20 -82.77 -26.92 31.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -83.13 -19.46 36.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.72 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.26 45.64 5.82 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 57' ' ' LEU . 2.1 mt -103.4 143.72 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -121.98 153.79 60.89 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.071 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 156.57 58.98 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.775 2.317 . . . . 0.0 112.491 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.91 2.14 56.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.505 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -104.12 156.1 18.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.99 0.424 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.1 p -88.92 125.87 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.464 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.28 138.11 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.351 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.89 131.93 56.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.341 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.5 161.07 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -139.24 151.77 46.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.64 137.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.212 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -98.22 131.64 44.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -133.37 -42.79 0.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -98.54 147.31 24.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.827 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.1 -73.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.287 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.05 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.457 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.72 109.73 22.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.672 0.272 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.131 -0.937 . . . . 0.0 111.674 179.421 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.669 0.271 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -136.85 -11.99 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.009 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -108.02 148.9 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.841 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -134.41 156.86 41.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.521 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.65 153.64 19.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.682 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mp -138.97 118.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.979 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 116.41 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.14 0.495 . . . . 0.0 111.115 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -98.28 166.85 12.57 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.844 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 58.7 Cg_exo -54.54 -21.86 25.85 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.979 2.453 . . . . 0.0 113.617 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.45 -25.06 64.82 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.876 0.37 . . . . 0.0 110.377 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -8.55 55.1 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.375 -0.917 . . . . 0.0 114.386 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -92.22 163.34 13.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.533 0.666 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 9.1 p -115.96 156.31 26.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.33 150.15 52.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.518 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.14 122.41 46.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.77 149.13 47.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.969 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.72 117.84 33.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.746 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 179.17 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.227 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 15.3 p -135.26 165.1 39.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.266 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.2 -13.75 39.76 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.789 2.326 . . . . 0.0 112.703 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.23 -7.3 58.04 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.04 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.3 m-85 -80.59 138.59 36.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.993 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -87.89 170.93 10.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.403 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.6 -32.25 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.044 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -72.11 -32.71 67.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.834 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.6 tt0 -72.25 -48.04 45.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.11 -34.61 75.22 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.786 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.72 -36.11 70.41 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.2 pt-20 -72.47 -24.91 61.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.619 0.247 . . . . 0.0 111.236 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.22 -50.34 28.25 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.831 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 tp -68.73 -33.05 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.876 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.32 66.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -70.45 -33.52 71.39 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -79.62 -26.63 41.11 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 -18.17 21.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 0.0 111.561 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.21 39.42 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.032 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.0 178.26 6.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.059 0.457 . . . . 0.0 111.144 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 8.1 t -99.22 136.73 20.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.528 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.94 -17.27 51.39 Favored 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 123.164 2.576 . . . . 0.0 113.653 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.34 -21.73 58.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.668 0.27 . . . . 0.0 111.46 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.21 -28.28 16.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' SER . 1.2 mt -90.07 121.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.359 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -112.22 142.9 44.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.593 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.63 132.25 40.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.28 124.2 41.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 111.296 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -131.73 117.89 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.644 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.8 24.99 12.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.712 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.44 -12.41 69.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.857 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.46 143.3 29.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 p -94.26 151.68 19.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.142 0.496 . . . . 0.0 111.136 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.84 135.94 46.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.235 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -90.28 138.42 27.18 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 22.4 Cg_exo -63.78 -22.15 69.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.928 2.419 . . . . 0.0 113.759 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.6 p -78.83 -26.25 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -82.3 -174.59 5.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.334 0.587 . . . . 0.0 111.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -118.11 158.53 24.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.6 mt -73.21 -30.65 63.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.847 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.15 60.01 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.85 -27.95 30.45 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.427 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -83.23 -20.01 35.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.57 45.71 6.01 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.786 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mt -101.13 140.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.859 0.362 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -124.16 154.44 68.44 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.989 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.19 149.11 57.26 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.772 2.315 . . . . 0.0 112.339 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.46 6.59 54.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.408 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.2 t -106.45 161.6 14.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.898 0.38 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 p -93.17 121.22 34.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.34 126.49 67.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.032 0.444 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.13 143.76 32.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.669 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -117.61 161.81 19.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 111.054 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -136.26 132.2 35.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.337 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 73' ' ' LYS . 3.2 tp -106.15 149.15 9.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.953 0.406 . . . . 0.0 110.768 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' N ' HG13 ' A' ' 72' ' ' ILE . 96.7 mttt -105.12 114.11 28.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -107.38 135.58 48.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -130.14 143.91 51.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.42 -87.97 0.74 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.628 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 154.11 80.88 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.149 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mp -103.52 131.94 50.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.049 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.948 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 63.8 mtt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -136.88 -4.82 1.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.2 p -111.67 150.39 30.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 111.247 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -129.96 160.35 41.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.684 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.422 ' ND2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.36 129.29 56.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.11 0.481 . . . . 0.0 110.13 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 70' ' ' LEU . 1.1 mp -117.96 112.28 37.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.683 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.48 133.7 33.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.93 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD12 HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -98.76 162.8 20.42 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.977 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.06 -1.11 9.02 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.221 1.947 . . . . 0.0 111.969 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.69 -16.86 27.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.75 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.95 50.89 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.286 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -106.03 149.02 27.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.138 0.494 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -105.31 153.88 21.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.668 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.92 149.86 51.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.494 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 125.24 50.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.003 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tp -127.96 147.01 50.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.51 115.57 30.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.096 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.6 174.8 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 12.7 p -137.74 166.12 28.73 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.55 -14.6 40.58 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.791 2.328 . . . . 0.0 112.65 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -85.38 -7.6 58.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.836 0.351 . . . . 0.0 111.19 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 19' ' ' THR . 3.3 m-85 -81.32 141.37 34.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 p -88.43 167.39 13.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.22 -33.96 67.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 121.069 0.461 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -71.44 -31.99 67.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.846 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 4.5 tt0 -72.91 -45.83 55.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.61 -36.5 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.411 . . . . 0.0 110.395 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.31 -33.34 67.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -73.74 -26.06 60.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.78 -45.9 48.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.118 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 tp -70.2 -32.79 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.712 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.75 -34.7 77.35 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.634 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -65.73 -33.35 75.67 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -75.46 -25.75 57.67 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.06 -18.25 22.02 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.594 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.29 -5.69 83.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.544 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.83 176.54 5.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.223 0.512 . . . . 0.0 110.888 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 54.0 m -89.16 151.06 46.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.318 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 12.7 Cg_exo -69.04 -16.84 40.89 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.392 2.728 . . . . 0.0 113.051 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.12 -14.99 62.91 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.679 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.64 -20.88 18.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.36 148.03 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.999 0.428 . . . . 0.0 111.606 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -137.76 128.18 26.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.341 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.85 121.41 31.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.43 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.08 127.52 55.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.127 0.489 . . . . 0.0 111.384 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -138.35 120.03 15.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.339 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 65.01 24.93 12.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.789 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.42 -19.42 50.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.906 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -99.45 149.9 22.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -94.49 150.13 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.1 mt -97.07 135.84 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.23 137.55 29.24 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.66 -22.08 64.76 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.013 2.475 . . . . 0.0 113.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -77.36 -27.69 52.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mp -88.65 -174.02 4.38 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.337 0.589 . . . . 0.0 111.904 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 71.7 p -113.6 157.84 21.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.376 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.32 -30.16 63.18 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.06 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.56 -7.63 59.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.7 tm-20 -83.13 -32.0 26.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.272 0.558 . . . . 0.0 110.522 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.92 -19.68 34.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.776 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.03 45.64 3.82 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.011 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.58 136.16 39.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.81 0.305 . . . . 0.0 111.056 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -122.38 157.71 58.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.02 138.52 37.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . 106.6 7.71 33.77 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -98.93 170.05 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 110.75 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.422 HG22 ' ND2' ' A' ' 5' ' ' ASN . 10.0 p -95.58 122.4 38.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.18 129.83 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.4 126.98 55.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.513 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.575 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.5 161.01 14.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.75 145.89 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.514 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -127.64 131.7 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.363 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -99.22 129.67 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.236 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -134.38 136.09 43.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -101.65 142.3 33.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.21 68.43 0.01 OUTLIER Glycine 0 C--O 1.228 -0.274 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.628 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.34 80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.926 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -130.92 126.72 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.455 0.169 . . . . 0.0 111.065 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.25 1.105 0 O-C-N 123.872 0.733 . . . . 0.0 111.604 179.291 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.564 0.221 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -134.79 -18.55 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.104 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 p -110.38 151.97 26.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.74 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pt -131.18 156.12 42.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.519 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.598 HG22 HD23 ' A' ' 70' ' ' LEU . 1.4 mp -120.92 112.69 36.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.748 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.73 133.93 33.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.94 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.73 162.44 21.14 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.817 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.46 -2.05 10.68 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.384 2.056 . . . . 0.0 111.801 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -91.17 -15.67 28.96 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.02 52.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.253 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -106.8 143.83 34.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.794 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.4 p -104.04 156.93 17.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.608 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.42 150.03 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.539 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.986 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.91 154.88 49.98 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.687 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.0 120.51 39.57 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.923 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.14 170.58 19.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.78 0.324 . . . . 0.0 111.529 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 18.6 p -136.72 162.57 55.24 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.411 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.16 -14.92 44.95 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.741 2.294 . . . . 0.0 112.526 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.17 -3.64 59.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.898 0.38 . . . . 0.0 111.023 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' THR . 0.6 OUTLIER -82.08 142.2 32.5 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.887 179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 26' ' ' GLU . 16.1 p -90.95 169.24 11.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.7 t -66.71 -33.55 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.94 0.4 . . . . 0.0 110.112 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.79 -34.3 69.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.803 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.21 -47.6 49.36 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.29 -35.55 77.62 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.759 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.91 -36.02 69.87 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.5 pt-20 -71.95 -24.92 61.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.484 0.183 . . . . 0.0 111.444 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.81 -47.78 28.77 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 tp -70.19 -32.71 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.9 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 37' ' ' LEU . . . -68.84 -34.88 76.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.21 -33.59 75.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -88.11 -9.48 53.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.518 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.32 -18.12 20.21 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.209 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.84 82.7 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.13 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -120.8 164.39 16.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.47 0.635 . . . . 0.0 111.539 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.4 t -76.77 148.52 79.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.713 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.39 -16.77 53.81 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.368 2.712 . . . . 0.0 113.24 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.5 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.38 -27.04 14.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.388 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.13 128.87 43.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.77 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -121.9 141.88 50.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.31 126.51 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.616 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.59 127.08 55.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.082 0.468 . . . . 0.0 110.99 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -136.83 121.23 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.5 t30 64.39 26.5 13.56 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.68 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.47 -19.87 44.71 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.323 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -101.09 151.76 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.881 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 p -92.4 150.68 20.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.228 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.72 135.59 38.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.67 135.79 28.72 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.41 -22.16 59.88 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.019 2.479 . . . . 0.0 113.871 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.2 m -78.42 -27.84 46.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -88.89 -174.39 4.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.428 0.632 . . . . 0.0 112.041 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 42.1 p -110.05 155.85 21.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.466 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.34 -37.32 66.14 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.977 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.81 -14.42 62.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.96 -22.14 33.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.971 0.415 . . . . 0.0 110.822 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.68 -20.17 23.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.416 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.74 45.38 3.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.046 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.78 139.39 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -123.9 157.06 64.54 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.34 137.53 31.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.626 2.217 . . . . 0.0 112.135 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.98 14.91 29.94 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.118 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 t -99.74 169.85 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 12.9 p -95.21 123.21 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.694 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.75 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.33 125.6 54.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 6' ' ' ILE . 2.1 pp -94.45 161.22 14.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.63 152.8 44.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.468 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.32 136.11 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -125.66 149.34 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -127.16 153.69 45.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.553 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.91 132.69 44.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.79 89.92 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.653 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.6 73.62 0.03 OUTLIER Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.392 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -120.57 -43.62 2.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.203 -0.904 . . . . 0.0 110.694 179.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.18 -2.42 2.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 p -110.4 149.7 29.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.019 0.438 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.73 155.96 41.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.961 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -102.57 153.69 19.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -135.94 120.77 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.02 122.49 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 111.098 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.13 161.78 24.31 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.168 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 -1.03 7.75 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.358 2.039 . . . . 0.0 111.744 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.46 -19.51 23.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.69 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.51 5.81 51.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.413 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -106.22 146.05 30.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.066 0.46 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -105.14 152.19 23.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.373 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 149.87 52.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -114.79 126.73 55.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.874 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.3 tp -125.82 148.48 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.775 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.41 117.77 35.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.85 178.08 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 16.0 p -132.38 164.57 42.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.208 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.43 -14.39 43.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.742 2.295 . . . . 0.0 112.918 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.4 -10.85 53.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.713 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' THR . 1.8 m-85 -75.27 136.33 40.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.17 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.8 p -88.21 172.14 9.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.156 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.64 -33.07 59.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 110.13 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -70.64 -35.17 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.719 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -71.58 -48.6 47.2 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.18 -40.16 89.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.952 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -30.17 67.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.063 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -70.62 -26.22 63.39 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.77 -49.51 25.1 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.78 -32.89 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.853 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.07 -28.17 66.28 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.701 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -72.56 -33.37 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.39 -34.28 58.86 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.66 -18.17 21.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.23 51.07 5.89 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.116 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -130.02 178.07 6.81 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.126 0.489 . . . . 0.0 111.26 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 42' ' ' ILE . 11.9 t -105.57 141.98 23.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.438 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 22.9 Cg_exo -62.71 -17.41 58.87 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.86 2.374 . . . . 0.0 113.568 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.19 -21.51 58.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.303 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.69 -27.68 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.527 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' SER . 2.0 mt -87.07 134.67 27.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.957 0.408 . . . . 0.0 111.329 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -128.01 128.99 46.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -95.43 132.69 40.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.48 141.3 51.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.064 0.459 . . . . 0.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -145.12 106.47 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 67.17 25.22 9.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.072 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.71 74.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.943 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -102.27 139.68 37.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.765 0.317 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 p -93.25 145.69 24.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.54 135.89 36.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.308 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.22 138.98 22.9 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.704 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.92 -22.5 73.86 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.15 2.567 . . . . 0.0 114.019 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.2 p -81.85 -25.44 35.11 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 mt -85.34 -174.72 5.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.273 0.559 . . . . 0.0 111.752 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 67.9 p -117.19 161.89 18.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 9.9 mt -73.0 -32.78 65.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.749 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.49 -11.56 59.96 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 2.7 tp10 -82.61 -20.73 35.81 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.997 0.427 . . . . 0.0 110.626 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.04 -19.87 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.176 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 45.5 4.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.71 137.97 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 0.0 111.229 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.18 157.19 65.02 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.904 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.75 144.67 54.84 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.762 2.308 . . . . 0.0 112.071 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.79 1.03 34.37 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.587 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -107.74 159.0 16.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 p -88.58 123.93 33.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.83 148.55 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.92 135.82 48.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.064 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.35 140.12 52.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.499 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -132.6 131.65 41.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.88 143.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.771 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.34 143.89 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -108.5 155.46 20.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.575 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.08 4.87 47.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.347 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.03 151.89 21.12 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -155.05 68.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.227 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.7 mt -102.3 132.93 47.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.833 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.779 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.7 mmm . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.646 0.26 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -139.22 -14.93 1.13 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.003 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -109.72 153.12 24.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.0 111.669 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.04 162.43 39.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.57 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.31 54.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.88 112.77 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.184 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 122.68 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.977 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.17 163.29 21.19 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.999 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.78 -1.68 9.71 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.239 1.96 . . . . 0.0 112.059 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -89.86 -19.54 24.5 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.622 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.57 5.8 51.07 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.474 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -102.44 150.02 23.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.73 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 p -111.76 152.22 28.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.736 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.82 150.07 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.471 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.37 121.95 46.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.126 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 tp -132.34 159.47 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.604 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.17 134.01 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.754 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.24 147.23 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 111.436 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 p -138.76 157.28 72.12 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.32 -6.09 18.25 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -98.29 -12.46 21.53 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.244 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -83.36 142.43 31.04 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.312 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.7 p -96.42 170.67 9.07 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.42 -33.09 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 110.267 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -72.21 -37.14 69.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -72.36 -47.83 46.48 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.679 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.11 -31.57 71.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.736 0.303 . . . . 0.0 111.056 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.03 69.88 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.823 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -71.14 -24.91 62.36 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.49 0.186 . . . . 0.0 111.35 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.12 -51.0 42.93 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 tp -70.76 -33.95 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.764 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.23 -28.58 66.48 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -67.1 -33.56 75.73 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.9 -16.33 38.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.704 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -100.46 -18.35 16.73 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.579 0.228 . . . . 0.0 111.48 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.18 39.72 12.44 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.011 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -131.5 178.19 6.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.225 0.536 . . . . 0.0 111.42 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 9.5 t -105.22 142.26 24.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.599 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.77 -18.95 59.21 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.06 2.507 . . . . 0.0 113.408 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.29 -20.34 59.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.639 0.257 . . . . 0.0 111.622 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -94.8 -30.24 14.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.376 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -91.7 123.04 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.652 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -115.21 138.85 50.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.443 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.94 131.07 38.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.24 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.5 125.32 45.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.977 0.417 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -134.17 121.98 22.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.526 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 62.45 26.84 15.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.669 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.64 -17.76 55.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.366 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -97.77 149.31 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.829 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 p -97.11 153.83 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.119 0.485 . . . . 0.0 111.108 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.52 136.11 42.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.214 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.5 t70 -90.03 138.16 27.72 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 20.3 Cg_exo -65.01 -22.1 62.83 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.433 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.5 m -78.51 -24.98 45.54 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.58 -175.12 5.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.267 0.556 . . . . 0.0 111.673 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 72.9 p -115.32 161.86 17.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.312 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.35 -29.73 62.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.12 -8.35 59.65 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 1.6 tm-20 -82.88 -31.16 28.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.088 0.471 . . . . 0.0 110.572 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -81.75 -19.95 40.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.736 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 45.61 6.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.651 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -98.19 139.53 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 0.0 111.606 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -124.28 156.56 66.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.916 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.54 146.38 55.23 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.614 2.21 . . . . 0.0 112.25 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.5 6.59 50.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.573 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -102.89 162.27 13.07 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.1 p -90.03 122.16 32.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.06 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.3 mm -112.57 119.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.977 0.418 . . . . 0.0 110.761 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.23 123.44 48.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.71 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp -96.63 159.29 15.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.132 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.346 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.85 141.75 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.697 0.284 . . . . 0.0 110.614 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -121.93 137.54 54.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.098 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -116.09 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -129.17 135.3 48.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.68 62.58 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.706 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.89 149.53 5.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.569 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -102.03 133.17 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 110.871 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.857 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mmm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.52 -11.31 1.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.058 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -111.15 152.05 27.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.21 153.82 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.699 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.22 135.06 43.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.958 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' THR . 3.8 mm -111.92 111.71 37.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.68 119.66 34.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.5 161.44 24.53 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.19 -0.88 8.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.266 1.977 . . . . 0.0 111.759 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -90.96 -18.78 24.11 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.48 6.13 50.92 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.335 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -107.36 145.87 32.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.976 0.417 . . . . 0.0 110.863 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 17.5 p -112.68 146.22 39.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.504 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.2 150.51 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.394 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.33 121.15 41.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.685 0.278 . . . . 0.0 110.881 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.04 142.24 49.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -101.77 133.1 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.75 176.58 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.631 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 p -135.98 165.58 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.185 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.44 -12.47 30.91 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 113.018 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.44 -14.36 43.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.2 m-85 -75.62 135.62 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 p -85.44 170.75 12.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.288 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.4 -33.16 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.059 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -72.11 -32.3 66.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.703 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 4.1 tt0 -72.0 -47.84 49.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.722 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.31 -36.18 79.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 110.703 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.0 70.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.301 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 8.3 pt-20 -72.26 -24.78 61.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.485 0.183 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.06 -49.67 27.35 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.877 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 tp -68.83 -34.25 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.727 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.1 -27.88 65.99 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.825 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -69.35 -33.48 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.51 -30.37 47.09 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.23 -18.15 20.26 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.47 49.3 5.88 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.073 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.61 178.24 6.89 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.429 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 42' ' ' ILE . 13.0 t -105.33 142.03 23.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.563 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 16.2 Cg_exo -65.85 -17.33 55.74 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.833 2.355 . . . . 0.0 113.377 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.33 -18.62 59.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.77 -29.78 12.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.397 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -89.48 126.23 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 0.0 111.441 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -121.89 135.29 54.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.794 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.18 133.85 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.67 129.52 47.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.294 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -130.38 125.22 34.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.399 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 46.94 32.39 1.83 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.95 . . . . 0.0 113.188 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.81 22.95 37.34 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.945 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -134.39 140.27 46.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.013 0.407 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 p -93.56 147.24 23.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.01 135.82 42.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.123 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.27 138.08 25.87 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.25 -22.36 66.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.1 2.533 . . . . 0.0 113.503 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.2 t -79.94 -28.11 39.73 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.42 -174.85 5.52 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 112.061 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 59' ' ' GLU . 68.4 p -116.66 157.76 24.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.121 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 22' ' ' PHE . 10.1 mt -73.05 -31.18 64.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.08 -15.04 59.72 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 56' ' ' THR . 7.5 tt0 -82.68 -20.2 36.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.053 0.454 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -89.14 -20.26 24.48 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.57 45.46 4.61 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 mt -111.61 137.67 43.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.932 0.396 . . . . 0.0 111.453 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -124.34 158.16 62.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.576 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.27 141.02 46.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.484 2.122 . . . . 0.0 112.002 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.09 3.16 36.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -100.45 165.35 11.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -88.12 126.31 35.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.5 mm -104.52 149.66 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.678 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.63 115.34 25.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.124 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.37 127.34 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.99 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.07 131.04 38.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.664 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.21 144.5 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.446 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -100.04 129.57 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 110.646 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -102.29 150.86 22.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.583 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -110.48 142.95 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.785 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.36 5.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.852 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.62 -154.51 16.7 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.573 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 tt -106.99 127.94 53.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.633 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.72 179.79 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.577 0.227 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -142.53 -7.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.4 p -109.68 152.15 25.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.469 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -130.13 156.69 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -98.49 153.75 18.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.88 0.372 . . . . 0.0 111.333 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.06 117.15 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.524 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 119.91 38.88 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.407 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.77 163.14 23.21 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.24 -1.0 9.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.268 1.978 . . . . 0.0 112.236 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -89.41 -18.21 27.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.44 5.75 51.56 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -105.47 146.41 29.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -108.85 154.78 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.383 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.74 149.99 46.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.317 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 126.01 52.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.069 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.5 tp -120.05 148.56 43.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.93 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.97 116.37 32.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 -179.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 17.2 p -137.92 165.12 36.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.241 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.3 -13.05 35.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.537 2.158 . . . . 0.0 112.676 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -87.08 -6.49 58.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.081 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 m-85 -81.22 144.95 31.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.072 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -91.43 168.47 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -67.54 -32.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.417 . . . . 0.0 110.251 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -71.72 -34.38 69.53 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.811 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 5.3 tt0 -71.59 -47.97 51.3 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.19 -36.21 77.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.841 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.26 -37.59 71.93 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.9 pt-20 -71.2 -24.95 62.32 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.45 -50.63 20.64 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.595 0.236 . . . . 0.0 110.836 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 tp -69.6 -35.5 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.03 -28.24 66.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -68.03 -33.57 74.83 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -85.38 -18.65 33.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.68 -18.21 18.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.594 0.235 . . . . 0.0 111.417 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.46 41.19 16.96 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.131 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.53 178.0 6.79 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.487 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 32.7 m -98.3 131.43 26.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.828 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' SER . 23.0 Cg_exo -63.18 -25.24 72.57 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.02 2.48 . . . . 0.0 113.542 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.24 -15.65 60.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.42 -28.11 14.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.439 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 38' ' ' SER . 1.3 mt -88.79 123.66 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.85 0.357 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -110.73 137.68 48.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.33 133.51 35.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 128.9 46.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.069 0.462 . . . . 0.0 111.445 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -130.56 124.73 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.06 32.49 1.96 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.024 0.93 . . . . 0.0 113.399 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.9 22.92 37.13 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.839 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -132.31 135.41 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 p -89.25 149.35 23.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.427 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.94 136.11 54.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.04 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -95.03 145.31 29.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.725 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 17.1 Cg_exo -65.92 -22.19 56.19 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.206 2.604 . . . . 0.0 113.958 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m -74.02 -26.92 60.69 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -174.41 5.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.244 0.545 . . . . 0.0 111.848 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -114.33 157.51 22.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.257 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 22' ' ' PHE . 12.0 mt -73.04 -32.17 64.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.06 -11.52 59.96 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.88 -28.77 29.8 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -84.74 -19.79 32.14 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.59 45.67 6.35 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.008 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.9 142.95 13.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.851 0.358 . . . . 0.0 111.505 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.0 p -124.32 155.55 68.27 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.72 146.6 54.71 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.616 2.211 . . . . 0.0 112.3 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.16 10.95 53.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.804 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.0 p -106.7 157.68 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 111.011 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -90.97 122.16 33.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.94 127.49 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.018 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.72 137.69 39.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.292 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.17 161.22 15.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.955 0.407 . . . . 0.0 111.498 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -138.97 134.33 32.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.281 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.92 144.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.407 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -113.3 146.17 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -115.37 147.77 40.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.777 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -129.39 152.64 48.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.7 -60.82 0.53 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.616 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.7 47.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.23 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.5 mt -131.9 127.66 36.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.72 0.295 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.697 179.911 . . . . . . . . 0 0 . 1 stop_ save_